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Abstract 
The Early Growth Response genes 2 and 3 (Egr2/3) are zinc finger 
transcription factors that play an important role in the immune system. These 
transcription factors have reported functions in T cell receptor signaling, 
differentiation of effector T cell subsets and the development of lupus-like 
autoimmune diseases. Using CD2-Egr2-/- Egr3-/- mouse model, I investigate the 
development of inflammation pathology, differentiation of T follicular helper (Tfh) 
cells and the formation of germinal centers (GC) following viral challenge within 
these mice.  
The onset of inflammation pathology in CD2-Egr2-/- Egr3-/- mice was 
discovered to correlate with high levels of pro-inflammatory cytokines in the serum 
and the development of autoimmune diseases as previously reported by Li et al, 
2012. Most importantly, a novel role for the Egr2/3 genes in the differentiation of T 
follicular helper (Tfh) cells was identified.  
Tfh cells are responsible for T cell dependent antibody immune response in 
the GC. They support the differentiation of GC B cells into plasma cells producing 
long lived high-affinity isotype-switched antibodies and memory B cells. Tfh cell 
differentiation is regulated by Bcl6 however; the regulators of Bcl6 during Tfh 
differentiation remain largely unknown. We have now discovered that Egr2/3 genes 
are required for Bcl6 expression during Tfh cell differentiation. In the absence of the 
Egr2 and 3 genes, Tfh cell differentiation is severely impaired and GC formation and 
functions were defective in response to Vaccinia Virus Western Reserve strain 
(VVWR) infection. Further investigation revealed that Egr2 regulated Bcl6 expression 
in a Tfh-specific manner as adoptive transfer of WT CD4+ T cells into Egr2-/- Egr3-/- 
mice was able to rescue Bcl6 expression, Tfh differentiation and GC formation. 
When the molecular mechanism of how Egr2 regulated Bcl6 was investigated, it 
was uncovered that Egr2 directly bound to the promoter region of Bcl6 gene in CD4 
T cells to regulated Bcl6 expression. Indeed constitutive expression of either Egr2 or 
Bcl6 in CD2-Egr2-/- Egr3-/- CD4+ T cells rescued Tfh cell differentiation and GC 
formation. Our results inferred that the Egr2/3 genes are essential for Tfh 
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differentiation and GC formation by regulating Bcl6 expression in CD4 T cells under 
Tfh condition. 
Our studies thus suggest that the Egr2/3 genes are paramount for 
minimising immunopathology and are also critical for efficient antibody production 
by regulating Tfh cell differentiation.  
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The immune system is a complex network of physical barriers, tissues, cells and 
serum proteins, which mediate the body’s defences against harmful substances. It 
is composed of the innate and the adaptive immune systems that orchestrate a 
mechanism known as the immune response. The study of the immune system has 
expanded a great deal since the time of the great plague of Athens in 430BCE. 
Today, through the works of immunologists, we have increased our knowledge of 
the biology of mediators of this system, mechanisms used within the immune 
system to eliminate harmful pathogens, limitations as well as defects associated 
with the immune system. Using this knowledge, immunologists have been able to 
design very successful therapeutics for disease causing pathogens like the small pox 
vaccine developed by Edward Jenner in 1798. They have also fostered the 
development of therapeutics in tumour immunology where research is looking into 
understanding and enhancing anti-tumour immune responses. This review 
summarises the current literature on the inflammatory responses within the 
immune system, the regulation of T follicular helper (Tfh) cells, their roles in 
germinal centre mediated immune responses and the role of the early growth 
response genes (Egr) 2 and 3 in the regulation of the immune system. 
 
1.1 Innate Immune System  
The innate immune system is evolutionarily conserved amongst multicellular 
organisms and is responsible for immediate defense of the body against danger 
signals and pathogens (Turvey and Broide, 2010). Although it lacks the ability to 
discriminate between specific pathogens, innate immune cells are able to use their 
germ-line encoded pathogen recognition receptors (PRR) to recognise pathogen 
associated molecular patterns (PAMP) on microbe (Cooper and Alder, 2006; 
Medzhitov and Janeway, 2000b). PAMPs are often required for the survival of such 
pathogens.  Their recognition leads to initiation of signaling pathways that 
culminate with the activation of AP-1 and NF-κβ which induce inflammation and 
proliferation of effector cells (Turvey and Broide, 2010; Medzhitov and Janeway, 
2000b). Due to an apparent lack of specificity, anatomical barriers against microbial 
pathogens including uncompromised skin, lysozyme in saliva and tears, mucus and 
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PH levels in the gut are often included as constitutive innate defense mechanism 
(Turvey and Broide, 2010; Medzhitov and Janeway, 2000a). Cellular components 
active within the innate immune system include the granulocytes and monocytes. 
Granulocytes comprise of neutrophils, basophils, eosinophils, and mast cells while 
the monocytic lineage is made up of macrophages and dendritic cells including 
follicular dendritic cells (FDC).  The mechanism of innate immune response includes 
the following:  
1.1.1 Inflammation 
Toxic substances released by the activities of virulence factors, allergens, 
foreign bodies and necrotic cells are stimulants for inflammatory responses (Ashley, 
Weil and Nelson, 2012; Medzhitov, 2008). Inflammation initiates a physiological 
response to deregulated homeostasis due to stimulants. This allows the 
recruitment of non-residential leukocytes to the local sites of infection or tissue 
injury (Ashley, Weil and Nelson, 2012; Turvey and Broide, 2010). The mediators of 
inflammation; the cytokines (interleukins, interferons, and chemokines), 
eicosanoids and vasoactive amines, are triggered when innate immune PRR 
receptors e.g. transmembrane Toll-like receptors (TLR) and intracellular nucleotide-
binding oligomerization-domain proteins (NOD)-like receptors (NLR) on tissue-
resident macrophages recognise PAMPs or damage-associated molecular patterns 
(DAMPs) (Turvey and Broide, 2010; Medzhitov, 2008; Tosi, 2005). In recent years, 
keratinocytes in the skin have been reported to produce cytokines that initiate 
active inflammation (Gröne, 2002). Inflammation is marked by;  
 Redness (rubor) due to hyperemia 
 Swelling (tumor) caused by increase permeability of the blood vessels and 
protein leakage 
 Heat (calor) arising from increased blood flow and the metabolic activities of 
cytokines 
 Pain (dolor) due to changes in perivasculature 
  Loss of function (function laesa) due to disruption of normal organ function 
involved in the inflammatory process 
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Inflammation may be acute, leading to the resolution of inflammation or chronic 
with persistent presence of inflammatory cells and molecules (Ryan and Majno, 
1977).  
1.1.1.1 Acute inflammation 
This is a protective well-regulated response mounted by the immune system 
to eliminate harmful pathogens and toxic substances (DELGADO et al., 2003). 
Initiation of the acute phase inflammatory response is marked by the enlargement 
of blood vessels to allow the exudation of polymorphonuclear neutrophils and 
plasma proteins into extravascular tissues spaces (Ashley, Weil and Nelson, 2012; 
Medzhitov, 2008). Activated neutrophils eliminate their targets indiscriminately by 
the release of toxic substances including Reactive Oxygen Species (ROS), reactive 
nitrogen species, cathepsin G, proteinase 3 and elastase (Medzhitov, 2008).  
Following pathogen elimination, pro-resolution molecules including lipoxin, an anti-
inflammatory agent promotes the recruitment of monocytes (Medzhitov, 2008; 
Ryan and Majno, 1977). These differentiate into phagocytic macrophages upon 
activation to promote resolution and repair of damaged tissues (Medzhitov, 2008; 
Ryan and Majno, 1977). Other lipid mediators like resolvins, protectins and 
transforming growth factor-β (Tgf-β) are also important in the resolution of 
inflammation by inhibiting further neutrophil recruitment (Medzhitov, 2008) 
1.1.1.2 Chronic inflammation  
Control of inflammatory responses is crucial in maintaining homeostasis and 
avoiding pathological conditions. Hence the balance between pro-inflammatory and 
anti-inflammatory mediators has to be tightly regulated (DELGADO et al., 2003). 
Chronic inflammation involves persistent signaling from pro-inflammatory 
mediators (DELGADO et al., 2003). Chronic inflammation results in the presence of 
circulating mononuclear macrophages and lymphocytes within the tissues and is 
often associated with tissue destruction, autoimmunity. Due to the prolonged 
nature of the chronic inflammatory response, the host attempts to repair damaged 
tissue by replacing them with either cells of the same type or fibrous connective 
tissues. In some cases, the host is unable to repair extensively damaged tissue thus 
leading to fatality. Chronic inflammation has also been known to lead to the 
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development of cancers and other severe systemic inflammatory diseases (Lu, 
Ouyang and Huang, 2006; DELGADO et al., 2003; Ryan and Majno, 1977) 
  
1.1.2 Complement system 
The complement system is made up of about 30 proteases, found in the 
serum. They are sequentially cleaved to activate a cascade of other protease which 
support immune responses (McGeer, Klegeris and McGeer, 2005; Carroll, 2004). 
These unique proteins are considered components of innate response however; 
they have receptors on a varied range of cells from leukocytes to stroma cells 
(Carroll, 2004). They facilitate antibody response in adaptive immune response 
(Pepys, 1976). There are 3 pathways for complement activation: the classical, 
alternative and mannan-lectin pathway (McGeer, Klegeris and McGeer, 2005). The 
classical pathway is driven by antigen:antibody complex formation, the alternative 
pathway is driven by polysaccharides and the mannan-lectin pathway by mannose 
or N-acetyl glucosamine bearing microorganisms (Carroll, 2004; Parkin and Cohen, 
2001). Activation of any complement pathways initiates cleavage of other 
complements which climaxes with the formation of the membrane attack complex 
(MAC) on targeted cells leading to the eventual cell lysis (Parkin and Cohen, 2001) 
1.1.3 Phagocytosis 
Originally described by Metchnikoff in 1905 (Tosi, 2005), phagocytosis is 
induced in host innate defenses where it functions in pathogen and dying cell 
clearance (Henneke and Golenbock, 2004). Phagocytic cells like tissue resident (TR) 
and circulating macrophages, dendritic cells (DC) and granulocytes are trafficked to 
the site of infection by cytokine signaling and the upregulation of integrins on 
endothelial cells (Tosi, 2005). Recognition of PAMPs using TLRs causes them to 
extend pseudopods which form phagosome that ingests the pathogen (Tosi, 2005). 
Phagosomes mature by fusion with lysosome to form phagolysosome. This destroy 
the pathogen via biochemical processes including reduction of nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase (Parkin and Cohen, 2001), 
hydrolysis, low pH and enzymatic cleavage of bacteria cell walls (Tosi, 2005; 
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Henneke and Golenbock, 2004).  Tagging of invading microorganisms or dying cells 
by antibodies in a process known as opsonisation, greatly enhances efficiency of 
phagocytosis 
1.1.4 Professional Antigen presentation 
Antigen presentation is a process by which processed antigenic peptides are 
presented on major histocompatibility complexes (MHC) to cluster of 
differentiation 4 (CD4) or CD8 T cells along with co-stimulatory molecules. All cells 
express the MHC I for presentation of intracellular pathogens to CD8 T cells via the 
endogenous pathway. Here, infections by virus result in the translation of non-self 
proteins in the ribosome (Villadangos and Schnorrer, 2007). These ribosomal 
products are broken down in the proteasome and then transported by the TAP 
complex into the endoplasmic reticulum where they are loaded on MHC I prior to 
transfer to the cell surface (Figure 1.1) (Villadangos and Schnorrer, 2007).  
A specialized subset of innate immune cells have the MHC II complex that 
allows presentation of antigens as peptide fragments to CD4 T cells in the 
exogenous pathway (Vander Lugt et al., 2014). These specialized cells are known as 
professional antigen presenting cells (APC) with DC regarded as the most potent of 
them (Platt et al., 2010; Santambrogio et al., 1999). The exogenous pathway 
involves the internalization of extracellular antigens via macropinocytosis, receptor-
mediated endocytosis or phagocytosis (Figure 1.1) (Villadangos and Schnorrer, 
2007). The antigens are tagged for digestion by proteases in the lysosomes. They 
are then processed and loaded onto the MHC II complex, which is located in the 
endosomal compartments or MHC II compartments (MIIC) (Platt et al., 2010; Vyas, 
Van and Ploegh, 2008). From here they are trafficked to the cell membrane and 
presented to CD4 T cells in secondary lymphoid organs (Platt et al., 2010; Vyas, Van 
and Ploegh, 2008).  
Antigen presentation forms the major link between the innate and 
adaptive immune response. It functions in the activation of naïve T cells and 
directing T cell immune response by cytokine secretion thus facilitating transition to 
antigen specific immunity (Platt et al., 2010; Turvey and Broide, 2010; Lee and 
Iwasaki, 2007). 
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Figure 1.1: Antigen presentation via the MHC class I and II pathways (Villadangos 
and Schnorrer, 2007). 
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1.2 Adaptive immunity 
Adaptive immune system is sometimes referred to as the acquired immune 
system, and it is present in all jawed vertebrates (Pancer and Cooper, 2006).  It 
mediates a temporarily delayed immune defense in response to antigens (Palm and 
Medzhitov, 2009). Its functions span cell-mediated immunity and antibody-
mediated humoral immunity and are mediated by T and B cells (LeBien and Tedder, 
2008). Some of its characteristics are briefly described below: 
 
1.2.1 Specificity and diversity of receptors 
Just as there are many antigens, T and B cells have also evolved a plethora 
of receptors that can each respond to specific epitopes of an antigen. This increases 
the range and efficiency of antigen response (Eisen and Chakraborty, 2010). 
Diversity arises through Recombination Activation Genes (RAG)-mediated somatic 
recombination of the variable (V), diverse (D) and joining (J) gene segments of the T 
cell receptor (TCR) on T cells or the heavy (H) and light (L) chains of the 
immunoglobulin receptors for B cells (Eibel et al., 2014; Medzhitov, 2007; Cooper 
and Alder, 2006).  Once these diverse clones specific for different epitopes have 
been established in primary lymphoid organs, they exit into the peripheral 
lymphoid organs where they await recognition by cognate APCs. 
 
1.2.2 Central and Peripheral tolerance 
Rearrangement of the VDJ gene segments in order to generate diverse 
receptors inevitably, leads to the generation of receptors that are responsive to 
self-antigens (Mathis and Benoist, 2004). In order to prevent destruction of self and 
the development of autoimmune diseases, the adaptive immune system has 
evolved mechanism to distinguish between self and non-self antigens (Mathis and 
Benoist, 2004).  These include central and peripheral tolerance.  
Central tolerance takes place in the primary lymphoid organs. Newly 
assembled TCR are tested for MHC binding affinity in a process termed positive 
selection. Receptors with no affinity for MHC die by neglect. Following that, 
Immature T lymphocytes are presented with antigens derived from surrounding 
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thymic medullary epithelial cells (MEC) (Eibel et al., 2014; Xing and Hogquist, 2012; 
Mathis and Benoist, 2004). Those that bind with high affinity to self-peptides are 
condemned to 3 fates including clonal deletion leading to cell death by apoptosis or 
receptor editing to further rearrange the TCR (Eibel et al., 2014; Vale and Schroeder 
Jr., 2010; LeBien and Tedder, 2008). The third fate for self-reactive T cells is clonal 
diversion where self-reactive clones develop suppressive functions leading to the 
generation of natural regulatory T cells (Xing and Hogquist, 2012). For B 
lymphocytes, assembled IgM are presented with bone marrow antigens, B 
lymphocytes that interact with high affinity for self-antigens undergo clonal 
deletion or receptor editing leading to further rearrangement of light chains before 
they eventually exit the bone marrow to the secondary lymphoid organs (Eibel et 
al., 2014; Vale and Schroeder Jr., 2010; LeBien and Tedder, 2008) 
Due to the limited range of self-antigens presented in the primary lymphoid 
organs during central tolerance, some self-reactive clones manage to escape and 
localize in the periphery hence the need for peripheral tolerance (Xing and 
Hogquist, 2012; Goldrath and Hedrick, 2005). The mechanisms of peripheral 
tolerance include anergy, peripheral deletion by apoptosis and Treg activity. Anergy 
arises from the absence of CD28 ligation leading to inhibition of TCR signaling (Xing 
and Hogquist, 2012; Medzhitov and Janeway Jr, 1998), peripheral deletion by 
apoptosis is induced by the expression of the death domain receptors FAS upon 
repeated stimulation by self-antigen while Treg activity results in the production of 
anti-inflammatory cytokine IL-10 (Xing and Hogquist, 2012).  
1.2.3 Clonal expansion 
In secondary lymphoid organs, mature but naïve lymphocytes are presented 
with antigens from their cognate APC (Pancer and Cooper, 2006). Upon receptor 
engagement, signals are transmitted with cause activation of these naïve cells. 
Activated CD4 T cells go through an expansion phase where they differentiate into 
antigen specific effector phenotype and subsequently proliferate (Pulendran and 
Ahmed, 2006). This stage is referred to as clonal expansion and is promoted by the 
release of IL-2, a cytokine that promotes T cell proliferation (Stittrich et al., 2010).                               
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Clonal expansion has to be regulated to prevent hyper-proliferation and the 
development of organ pathology. To that effect, following pathogen clearance, 
around 90% of these effectors cells die off via programmed cell death in what is 
understood to be a contraction phase (Gourley et al., 2004). It was reported that 
blocking B cell clonal expansion mitigated the onset of experimental EAE (Cantor, 
2014).  Negative regulators of clonal expansion like FOXO1 are important in 
suppressing hyper-proliferation. MicroRNAs like miR-182 promote clonal expansion 
by targeting FOXO1 (O'Neill, 2010; Stittrich et al., 2010).  
After the contraction phase, the rest of the cells go on to assume a memory 
phenotype (Gourley et al., 2004). In the absence of pathogenic invasion, 
lymphocytes numbers are maintained in a state of equilibrium by a process known 
as homeostasis.      
 
1.2.4 Immunological Memory 
The ability to remember previously encountered pathogens in order to protect 
from re-challenge by stimulating a quicker and more robust immune response is 
termed immunological memory (Ma et al., 2012). This can last for months, years or 
even a lifetime (Ahmed and Gray, 1996). For T cells, after the elimination of 
pathogens, some effector T cells differentiate to become memory T cells. However, 
in B cells, the current concept is that B cell memory arises from germinal centre 
(GC) reactions. As this is a T cell dependent pathway, strides are being made to 
understand the protection from re-infection by T cell independent antigens 
(Defrance, Taillardet and Genestier, 2011; Pulendran and Ahmed, 2006) 
Once memory cell populations have been established they home to 
different sites of the body. Central memory T (TCM) cells home to the secondary 
lymphoid organs from where they are recalled (Shenoy et al., 2012; Woodland and 
Kohlmeier, 2009). Effector memory T cells (TEM) on the other hand are localised to 
peripheral tissues or site of infections providing prompt response upon re-exposure 
(Woodland and Kohlmeier, 2009). In the absence of antigenic stimulation, memory 
cells are maintained by IL-7 and IL-15 driven homeostatic proliferation (Woodland 
and Kohlmeier, 2009; Pulendran and Ahmed, 2006). 
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During secondary infection, reports suggest that memory cells can be 
activated either in an antigen independent manner by the production of pro-
inflammatory cytokines such as, IL-12, IL-18 and IFNγ (Raué et al., 2004; Geginat, 
Sallusto and Lanzavecchia, 2003) or in an antigen dependent manner by DC present 
in tissues (Gourley et al., 2004).   
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1.3 T lymphocytes  
1.3.1 Development in the thymus  
Hematopoietic progenitors cells (HPC) arise in the bone marrow (BM) before 
migrating to the thymus where development and commitment to the T cell lineage 
begins (Germain, 2002). These HPCs enter the thymus as double negative (DN) cells 
bearing neither CD4 nor CD8 receptors (Figure 1.2). DN thymocytes undergo 4 
developmental stages – DN1, DN2, DN3 and eventually culminating in DN4 stage 
based on the expression of CD44 and CD25 (Germain, 2002). The process of DN 
stage results in the expression of pre-T cell receptor (pre-TCR) that is required for 
expansion of T cell precursors (Ma, Wei and Liu, 2013; Germain, 2002) 
.  
 
Figure 1.2: T cell development in the thymus (Germain, 2002). 
 
Following pre-TCR signaling, the DN cells then progress to CD4 and CD8 double 
positive (DP) cells with expression of both TCRα and TCRβ chains and the CD3 co-
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receptor (Ma, Wei and Liu, 2013; Germain, 2002). These DP cells carrying 
somatically rearranged TCR undergo positive and negative selection before 
developing into mature CD4 or CD8 single positive T cells (Germain, 2002). During 
selection, DP thymocytes are presented with self-peptides on MHC I or II complexes 
(Eibel et al., 2014; Xing and Hogquist, 2012; Mathis and Benoist, 2004).  Positive 
selection selects for thymocytes with functional TCR that go on to become single 
positive (SP) cells (Ma, Wei and Liu, 2013; Xing and Hogquist, 2012). Negative 
selection selects for cells with a strong binding affinity for self-peptide on MHC 
complex. These cells undergo clonal deletion, clonal diversion or receptor editing 
(Ma, Wei and Liu, 2013; Xing and Hogquist, 2012). Thymocytes that have passed 
these checkpoints have minimum self-responsive ability and are eventually 
exported from the thymus to the periphery where they respond to specific 
pathogens. Natural killer T (NKT) cells are also generated from these DP cells (Hu 
and August, 2008). 
1.3.2  T cell Activation and differentiation 
3 signals are essential for T cells to become activated and differentiate into 
effector phenotypes (Figure 1.3). The first signal is initiated upon sustained 
engagement of TCR with antigenic peptides borne on MHC complexes on APCs 
(MacDonald and Nabholz, 1986). The TCR recognise a sequence of 8-20 amino acids 
known as peptides (Savina and Amigorena, 2007). Along with the antigenic 
complex, APCs also provides the co-stimulatory signal which is the second signal 
needed for T cell activation. Co-stimulation ensures ligation of the B7 molecules 
(CD80 and CD86) on the surface of DC with the CD28 receptor on the T cell surface. 
Several other co-stimulatory molecules have been identified including CD40:CD40L, 
PD1:PDL1, ICOS:ICOSL. In the absence of co-stimulatory molecules, T cells undergo 
anergy. Cytokine signaling is reported to be essential for the differentiation of 
activated CD4 T cells into effector phenotypes. In CD8 T cells, IL-12 and Interferon 
α/β (IFNα/β) signaling from APC are said to be essential and a lack of these cytokine 
is said to have abrogated CD8 differentiation and effector function (Curtsinger and 
Mescher, 2010) 
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Engagement of the TCR with pMHC complex initiates TCR signaling via 
receptor associated tyrosine kinase which activates protein kinase C and DAG 
mediated pathways inducing NF-Kβ, NFAT and MAPK pathways. TCR signaling 
results in the increased level of intracellular Ca2+ (Smith-Garvin, Koretzky and 
Jordan, 2009). This activates the Ca2+ dependent transcription factor NFAT that 
initiates different transcriptional programmes. Signaling through the NFAT/AP-1 
pathway promotes IL-2 dependent T cell proliferation in CD4 and CD8 T cells while 
NFAT/FOXP3 signaling is necessary for Treg cells (Smith-Garvin, Koretzky and 
Jordan, 2009; MacDonald and Nabholz, 1986).  
In order to carry out their functions, activated T cells are aided by 
interleukin 2 (IL-2), interferon γ (IFNγ), IL-12, IL-4, IL-17, IL-21 and IL-10. Once 
activated, T cells release IL-2 which functions in an autocrine manner to upregulate 
the expression of IL-2 receptors (IL-2R) (Malek and Ashwell, 1985) and send 
proliferation signals to the T cells (MacDonald and Nabholz, 1986). IL-2 also induces 
cytotoxic activity of CD8 T cells (MacDonald and Nabholz, 1986).  
 
Figure 1.3: 3 signals are required for activation and diffentiation of T cells 
(Gutcher and Becher, 2007).  
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1.3.3 Contributions of cytotoxic T cells (CTL) to immune response 
This group of T lymphocytes is distinguished from the others by the 
expression of CD8 co-receptors on their cell surface. They are employed in cytotoxic 
immunity where they initiate a process that leads to programmed cell death in their 
target cells (Lieberman, 2010). With the exception of those activated by cross-
presentation by APCs, Th1 cells activate cytotoxic T cells. Transcriptional regulators 
required for cytotoxic T cell differentiation into effector phenotypes include Tbet, 
Blimp1, ID3 and STAT4 (Kaech and Cui, 2012). Eomesodermin (EOMES), Bcl6, ID3 
and STAT3 are reported to promote differentiation into cytotoxic memory T cell 
phenoytype (Kaech and Cui, 2012). In order to mediate cytotoxic activity, CD8 T 
cells act by calcium dependent granule exocytosis. This combines the use of 
perforin to disrupt the cell membrane, granule enzyme (granzyme), a serine 
protease that pass through perforin channels into target cells and granulysin 
(Lieberman, 2010; Barry and Bleackley, 2002). Perforin is of utmost importance in 
cytotoxic immunity as perforin KO mice developed tumours and had difficulty 
mounting optimal immune response to viruses (van den Broek et al., 1996; Kagi et 
al., 1994).  Other mechanisms employed by CD8 T cells to initiate cytotoxic activity 
include the FAS pathway and the secretion of TNF and IFN-γ (Lieberman, 2010; 
Barry and Bleackley, 2002). 
1.3.4 CD4 T helper (Th) cells and immune reposnse 
CD4 Th cells are aptly named because of the help they provide to activate B 
cells and cytotoxic T cells. They are very crucial in adaptive immune responses and 
the regulation of inflammation (Dong, 2006). They express CD4 co-receptor, which 
binds solely to MHC class II molecules.  In addition of CD4, they can be identified by 
the expression of cell surface markers CD44, CD69 and CD62L, which differ in 
expression between the naïve and activated states (Hu and August, 2008). CD4 Th 
cells are heterogeneous. CD4 cells differentiate into different effector phenotypes 
when activated depending on the nature of antigen, dose received, cytokine signal 
evoked on the APC by the pathogen, co-stimulatory molecules engaged and genetic 
modifiers (Liu, Nurieva and Dong, 2013; Li, Zhang and Sun, 2011; Curtsinger and 
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Mescher, 2010; Romagnani, 1999). The first Th cells discovered were Th1 and Th2 
by Mosmann and Coffman in 1989. They discovered that depending on the 
cytokines environment 2 different T helper subsets developed and they were 
named T helper 1 (Th1) and T helper 2 (Th2) (Mosmann and Coffman, 1989). These 
cytokines once expressed are reported to inhibit the differentiation of other Th 
subsets and moderate signal transducers and activators of transcription (STAT) 
signaling (Liu, Nurieva and Dong, 2013; Gutcher and Becher, 2007). STATs facilitate 
the expression of more lineage specific cytokines and of the unique signature 
transcription for each Th subset (Liu, Nurieva and Dong, 2013; Gutcher and Becher, 
2007). Since 1989, more Th subsets have been discovered including Th17, follicular 
helper T (Tfh) and Treg cells (Figure 1.4). These effector phenotypes are delineated 
further below.  
 
Figure 1.4: Schematic demonstrating effector T helper cell differentiation from 
naïve CD4 T cells (Nurieva and Chung, 2010).  
1.3.4.1 T helper 1 (Th1) 
Signature cytokines directing commitment to this lineage are IFNγ and 
interleukin IL-12 (Schroder et al., 2004). These cytokines induce the expression of 
STAT1 and 4 which then activates the transcription factor for the Th-1 lineage T-bet 
(Liu, Nurieva and Dong, 2013; Dong, 2006). Activated Th1 cells secrete IFNγ and IL-
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12 and activate cytotoxic CD8 T cells (Liu, Nurieva and Dong, 2013; Li, Zhang and 
Sun, 2011; Dong, 2006). Th1 has been implicated in autoimmune diseases, organ 
rejection and spontaneous abortions (Zhu et al., 2008; Gutcher and Becher, 2007; 
Romagnani, 1999). 
1.3.4.2 T helper 2 (Th2)  
CD4 T cells activated in the presence of IL-4 will upregulate STAT6 that will 
in turn activate the transcription factor GATA-binding protein 3 (GATA3) (Liu, 
Nurieva and Dong, 2013; Dong, 2006). A Th2 response is potentiated by the 
presence of allergens and parasitic nematodes (Romagnani, 1999). Activated Th2 
cells produce IL-4, IL-5, IL-9, IL-13 and IL-25 cytokines that are important in humoral 
immunity. These effector cytokines help to induce class switching of B cells to 
generate IgE antibodies that aid in the clearance of parasites, activation of innate 
immune cells and regulating macrophage (Liu, Nurieva and Dong, 2013; Li, Zhang 
and Sun, 2011; Schroder et al., 2004; Romagnani, 1999). Th2 immune response is 
linked to airway inflammation and allergic asthma with studies showing high IgE 
levels and the presence of Th2 related cytokines at these sites of allergic immune 
response (Li, Zhang and Sun, 2011). 
1.3.4.3 T helper 17 (Th17) 
This subset of Th cells were uncovered by Langrish and her colleagues when 
they discovered a subset of IL-17 producing Th cells that differentiated in a manner 
independent of Th1 and Th2 pathways(Langrish et al., 2005). IL6, IL-21, IL23 and IL-1 
are reported to induce the STAT3 driven transcription of the orphan nuclear 
regulators RORγt and RORα necessary for the differentiation of CD4 cells into the 
Th17 lineages (Du et al., 2014; Liu et al., 2014; Miao et al., 2013; Liu, Nurieva and 
Dong, 2013). IL-17 regulates immune responses by controlling tissue inflammation. 
Studies involving mouse models demonstrated that IL-17R knockout (KO) mice 
failed to generate optimal immune response to pulmonary Klebsiella Pneumonaea 
infection and had a mortality rate of 100% 48 hours after challenge (Deenick et al., 
2010; Ye et al., 2001). However, overexpression of the same cytokine in lung 
epithelium induced increased chemokine production and infiltration of the lungs by 
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leukocytes (Park et al., 2005). Most recently, IL-17 has been linked to the pathology 
of MS (Miao et al., 2013) 
 
1.3.4.4 Induced Regulatory T cells (iTreg) 
As earlier mentioned, Treg cells may arise naturally in the thymus with the 
expression of the transcription factor fox head box P3 (FOXP3) or be induced in the 
periphery (Sakaguchi et al., 2009; Miyara and Sakaguchi, 2007) by the IL-10 
dependent expression of transforming growth factor β (TGFβ) which leads to the 
transcription of FOXP3 (Sakaguchi et al., 2008). IL-6 and IL-2 have also been 
reported to facilitate the differentiation of iTreg in vivo. iTreg like their naturally 
occurring counterparts help to maintain the body’s immune homeostasis and self-
tolerance, preventing immune mediated inflammation and autoimmunity (Zhou, 
Chong and Littman, 2009). They are able to do this via a number of mechanisms 
including the killing of self-reactive T cell subsets, induction of cyclic AMP which 
inhibits cell proliferation and IL-2 production, antagonizing the CD80 and CD86 
receptors on APC and the induction of cytolytic enzymes like indoleamine 2, 3-
dioxygenase (IDO) which kill neighbouring T cells (Sakaguchi et al., 2009). 
Epigenetically, iTreg are reported to be different from natural occurring Treg cells 
and are also less stable in the expression of defining Treg related molecules 
(Ohkura, Kitagawa and Sakaguchi, 2013). 
1.3.4.5 Other T helper groups 
Tr1 cells have regulatory function and thus promote immunological 
tolerance (Gregori et al., 2012). They are characterized by a distinct cytokine 
expression profile including the secretion of very high levels of IL-10, normal levels 
of TGF-β and IFN-γ, low levels of IL-2 and in some reports, very low levels of IL-4 and 
lL-17 (Gregori et al., 2012; Andolfi et al., 2012). They transiently express FOXP3 and 
produce granzyme B and Perforin used in the cytotoxic killing of myeloid cells 
(Gregori et al., 2012; Sakaguchi et al., 2008).  
  Th3 cells are generally regarded as subsets of Treg cells that are 
distinguishable from other Treg cells by the large amounts of TGF-β they secrete  
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(Carrier et al., 2007). They have also been reported to release IL-4 and IL-10 at low 
levels (Carrier et al., 2007). They can be generated in vitro by culturing CD4 T cells in 
the presence of TGF-β, IL-4, IL-10 and anti-IL-12 (Sakaguchi et al., 2008; Weiner, 
2001).  
Th9 cells were initially described in 1994 (Schmitt et al., 1994). They are the 
major producers of IL-9 cytokine (Nowak and Noelle, 2010). Tgf-β, IL-4 and the 
transcription factor PU.1 are essential for the generation of this T cell subset in 
mouse and human cell lines (Chang et al., 2010; Nowak and Noelle, 2010; 
Dardalhon et al., 2008). Although their functions have not been fully established, 
they have been implicated in the pathology of autoimmune diseases and allergy 
(Jäger et al., 2009) 
Th22 cells secrete IL-22, TNF-α, FGFs and sometimes IL-10 but not IFN-γ, IL-4 
or IL-17 (Eyerich et al., 2009). Their transcription programme is also unique from 
other Th subsets with the absence of T-bet, GATA3 and RORα/γ but with increased 
expression of transcription factors BNC2 and FOXO4 (Eyerich et al., 2009). They 
function in immune defense in keratinocytes and in wound healing in an IL-22 
dependent manner (Kim et al., 2012; Eyerich et al., 2009).  
 
  
                                                                                                      Chapter 1 – Introduction 
 
20 
 
1.4 T Follicular helper cells (Tfh) 
Follicular helper T cells are so named due to their localization to the B cell 
follicles after activation. This subset of CD4 T cells were identified by a number of 
groups between 1999 and 2001 as T helper cells specialized in providing help to GC 
B cells (Liu, Nurieva and Dong, 2013; Ma et al., 2012; Crotty, 2011; Kim et al., 2001; 
Breitfeld et al., 2000; Schaerli et al., 2000; Walker et al., 1999). They were described 
as CXCR5 expressing CD4 T cells with an ability to home to B cell follicles (Kemeny, 
2012). They were christened T follicular helper cells in 2004 (Chtanova et al., 2004). 
As a subset, their differentiation is regulated by Bcl6 and they are identified by the 
expression of cell surface molecules inducible co-stimulators (ICOS), programmed 
death 1 (PD-1) and the follicle trafficking cytokine CXCR5 (see table 1.1, Figure 1.6) 
(Ma et al., 2012).  
Gene name Function(s) Reference 
CXCR5 CXCL-13 gradient dependent localization 
of T cells at the T-B cell border. 
(Liu et al., 2014b) 
ICOS Co-stimulatory signal during cognate T-B 
cell engagement.Facilitation of Tfh entry 
into follicular zone.  
(Xu et al., 2013; 
Bollig et al., 2012)  
 
CD40L Co-stimulatory molecule. Engagement of 
CD40:CD40L prevents terminal 
differentiation of GC B cells while driving 
isotype switching and proliferation.  
(Crotty, 2011; Yu and 
Vinuesa, 2010) 
 
PD-1 Inhibition of excessive Tfh proliferation in 
the GC. Cytokine synthesis for optimal Tfh 
function and quality. 
(Good-Jacobson et 
al., 2010) 
BTLA Tfh cell inhibitory receptor. (Murphy and 
Murphy, 2010) 
SH2D1A Signal transducing molecule required for 
maintaining Tfh cell engagement to 
cognate B cells. 
(Crotty, 2011; 
Cannons et al., 2010; 
Qi et al., 2008) 
SLAM family 
(CD84) 
Maintaining optimal Tfh:B cell 
interactions. 
Transmits adhesion signals for T-B cell 
engagement at border. 
(Cannons et al., 
2010) 
  Table 1.1: List of molecules reported to be involved in Tfh cell functions 
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1.4.1 Transcription programme regulating Tfh differentiation  
Tfh differentiation is mediated by B cell lymphoma 6 (Bcl6) and inhibited by 
B lymphocyte-induced maturation protein-1 (Blimp1), produced by the Prdm1 gene.  
Other transcription factors that play a role in their development include Acheate 
schute homologue 2 (Ascl2), Basic leucine zipper transcription factor ATF-like 
(BATF), mammalian interferon regulatory factor 4 (IRF4) and cellular homolog of 
avian viral V Maf gene (cMaf) (see table 1.2) (Liu et al., 2014b; Liu, Nurieva and 
Dong, 2013; Bollig et al., 2012; Gómez-Martín et al., 2011).  
Owing to the fact that systemic knockout of the Bcl6 gene leads to growth 
retardation and severe myocardial injury resulting in early death, the majority of in 
vivo studies of Bcl6 physiological function in lymphocytes involve the transfer of 
bone marrow cells from Bcl6-/- mice into Rag-/- mice (Tetsuya Fakuda et al., 1997, 
Ye Bihui H et al, 1997, Dent A. L. 1997, Robert Johnson et al, 2009). Bcl6’s role in Tfh 
differentiation was identified by a number of research groups in 2009 as the master 
transcription factor for Tfh cell subset (Yu and Vinuesa, 2010; Johnston et al., 2009). 
It promotes Tfh differentiation via a number of mechanisms. It inhibits Blimp1 
expression by actively repressing its transcription (Figure 1.5) (Yu et al, 2009). Bcl6 
actively represses genes that code for signature transcription factors of other 
subsets like Th1, Th2 and Th17 (Liu, Nurieva and Dong, 2013). For instance, Bcl6 
represses Th2 differentiation by inhibiting GATA3 transcription (Kusam et al., 2003). 
It is also reported that Bcl6 inhibits a large number of microRNAs like miR-17-92 
that repress the function of the key Tfh molecule CXCR5 (Liu, Nurieva and Dong, 
2013; Ma et al., 2012; Yu and Vinuesa, 2010; Yu et al., 2009). Bcl6 is also reported 
to promote the survival of Tfh cells by minimising apoptosis due to increased PD-1 
expression on Tfh cells (Hollister et al., 2013). Bcl6-/- T cells are reported to show 
defects in the differentiation to Tfh cells and the initiation and sustenance of GC 
immune responses (Yu and Vinuesa, 2010). Constitutive expression of the Bcl6 gene 
has been reported to be able to drive Tfh differentiation in in vivo studies (Johnston 
et al., 2009).  
Blimp1 acts antagonistically to Bcl6 in a STAT5 dependent manner to 
promote IL-2 production and the differentiation to non-Tfh CD4 cells and CD8 T 
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cells (Figure 1.5) (Liu, Nurieva and Dong, 2013; Crotty, 2011; Johnston et al., 2009; 
Rutishauser et al., 2009). Constitutive expression of Blimp1 in CD4 cells was 
reported to hinder Tfh differentiation (Johnston et al., 2009). Other transcription 
factors reported to be involved in Tfh cell development are listed below in table 1.2 
 
 
Figure 1.5: Bcl6 and Blimp function in Tfh and GC B cell development (Crotty, 
Johnston and Schoenberger, 2010). 
 
Transcription factor Function(s) References 
Bcl6 Tfh cell differentiation and 
development.  
(Yu and Vinuesa, 2010) 
Blimp 1 (Prdm1) Direct inhibition of Bcl6 
transcription and Tfh cell 
differentiation. 
(Crotty, 2011) 
IRF4 Tfh cell differentiation, plasma 
cell maturation and class 
switch recombination.  
(Bollig et al., 2012) 
Ascl2 Tfh cell migration by 
upregulation of CXCR5. 
(Liu et al., 2014b) 
cMAF Regulation of Tfh-related 
genes like ICOS, CXCR5, PD-1, 
CXCR4, IL-21 and IL-4. 
(Kroenke et al., 2012)  
BatF Regulating the expression of 
Bcl6 and cMAF. 
(Ise et al., 2011) 
Table 1.2: Transcription factors involved in Tfh cell regulation 
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Figure 1.6: Cellular and molecular interaction involved in Tfh cell differentiation 
(Pissani and Streeck, 2014) 
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1.4.2 Tfh differentiation models 
Several models have been proposed on the ontogeny of Tfh cells. Crotty in 
2011 summarised the current literature on Tfh differentiation into 3 models (Figure 
1.7). The first model proposed a cytokine-environment driven differentiation for Tfh 
where IL-6 and IL-21 were essential (Crotty, 2011). The second model was 
dependent on engagement of activated CD4 cells with cognate B cells. The third 
described a model where Tfh differentiation was dependent on prior Th1, Th2, 
Th17 and Treg differentiation, giving rise to Tfh1, Tfh2, Tfh17 and Tfhreg. These 
models were however not sufficient and were soon disputed (Eto et al., 2011; 
Eddahri et al., 2008). Some opponents countered the model by showing that 
cognate B cells interaction was not necessary to drive Tfh differentiation and CD4 T 
cells will differentiate into Tfh cells in mice with B cell lacking MHC II complex 
(Deenick et al, 2010).  
 
Figure 1.7: The 3 models of Tfh cell differentiation (Eto et al., 2011; Crotty, 2011)  
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All these posited a need for unified model for Tfh differentiation, which was 
again proposed by Crotty (2011) (figure 1.8). The prevailing concept in terms of Tfh 
differentiation is that, upon reception of stimulus, IL6 and IL-21 induce the 
expression of STAT3. STAT3 in concert with other transcription factors and 
molecules including co-stimulatory molecule ICOS, will drive the expression of Bcl6, 
CXCR5 and repress IL-2 production thus generating pre-Tfh cells (Liu, Nurieva and 
Dong, 2013; Crotty, 2011; Nurieva et al., 2008). At this point, there is a requirement 
for maintenance of the Tfh phenotype, which is dependent on cognate interaction 
of Pre-Tfh cell with follicular B cells. CXCR5 allows Tfh cells to migrate in a CXCL13 
dependent gradient towards the B cell follicles. At the T-B cell border, it interacts 
with cognate B cells. This interaction leads to the eventual fully polarized Tfh 
phenotype localized in the GC where they express highest levels of Bcl6 and CXCR5 
(Figure 1.8). This model proposes a fate where GC Tfh and pre-Tfh have a cyclical 
relationship and can migrate between GC region and follicles and is supported by 
studies that show that GC Tfh cells migrate from the GC into the surrounding 
follicular areas regularly depending on engagement of antigen specific GC B cells (Qi 
et al., 2008).  
 
Figure 1.8: Integrated model of Tfh cell differentiation (Crotty, 2011)  
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1.4.3 Follicular regulatory T (Tfr) cells  
3 groups originally described these cells in 2011 as a subset of CD4 T cells 
arising from nTreg cells in the thymus (Linterman et al., 2011; Chung et al., 2011; 
Wollenberg et al., 2011). They express Foxp3+, Bcl6, CXCR5, PD-I but not IL-21 
(Linterman et al., 2011; Chung et al., 2011). Like nTreg and iTreg cells, Tfr cells 
maintain tolerance to prevent the development of autoimmunity by suppressing GC 
dependent immune responses (Sage et al., 2014; Linterman et al., 2011; 
Wollenberg et al., 2011). Similar to Tfh cells, they are regulated by Bcl6, which 
promotes their differentiation (Linterman et al., 2011; Chung et al., 2011). Blimp1, 
CD28 and SLAM proteins are also reported to regulate this subset of T cells 
(Linterman et al., 2011). Blimp1 is credited with regulating the size of the Tfr 
population and in the absence of Blimp1, the number of Tfr cells doubled 
(Linterman et al., 2011). Asides regulating Tfh cell numbers during T cell dependent 
humoral immune response in the germinal centre, Tfr cells also promote the 
selection of high affinity B cell clones and regulate the differentiation of plasma 
cells (Linterman et al., 2011; Chung et al., 2011; Wollenberg et al., 2011). 
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1.4.4 T helper plasticity 
The concept of T helper cell plasticity arose when studies showed that 
polarised T helper cells might be able to redirect their transcription program in 
conditions that favour the generation of a different T helper subset (Liu, Nurieva 
and Dong, 2013; Zhou, Chong and Littman, 2009). This notion challenged the 
opinion that T helper subsets were terminally differentiated in a mutually exclusive 
manner and expressed only their signature transcription factors (Nakayamada et 
al., 2012; Zhou, Chong and Littman, 2009). This was partly because under re-
differentiating conditions, these ‘terminally differentiated’ subsets, expressed 
cytokines and transcription factors akin to other T helper subsets (Figure1.9) 
(Nakayamada et al., 2012).  
Warren and colleagues were able to demonstrate that in the presence of IL-
6, iTreg cells are able to induce the differentiation of CD4 cells into Th-17-like cells 
and themselves re-differentiated into IL-17 producing cells in a TGF-β dependent 
manner (Xu et al., 2007). Treg cells in the Peyer’s patch of mice have also been 
reported to differentiate into Tfh upon interaction with B cells (Tsuji et al., 2009). In 
the presence of helminthic antigens some Th2 cells displayed features of Tfh cells 
with expression of Bcl6, CXCR5 and PD-1 (Zaretsky et al., 2009). These cells were 
also GATA3 positive (Zaretsky et al., 2009). Th2 cells can re-programme to express 
T-bet and IFN-γ in response to Th1 inducing lymphocytic choriomeningitis virus 
(LCMV) (Hegazy et al., 2010) and Th9 has been reported to be able to be produced 
from Th2 cells in vitro in the presence of TGF-β (Veldhoen et al., 2008). Th17 cells 
are notoriously unstable and have been reported to re-differentiate in the presence 
of appropriate cytokines into Th1 or Th2 cells (Lee et al., 2009). 
Review of published studies on plasticity indicates intrinsic and extrinsic 
factors dictate plasticity. Cytokine microenvironment, cell-cell interactions, 
antigenic stimulants and epigenetic modifications of signature cytokine loci or 
transcription factors may be linked to the multidirectional differentiation potential 
of some Th subsets (Zaretsky et al., 2009; Wei et al., 2009; Zhou, Chong and 
Littman, 2009).  
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Figure 1.9: Adapted model of T helper cell plasticity showing some cytokines 
involved in these pathways (Nakayamada et al., 2012)  
T helper plasticity, although with beneficial properties including the maximal 
use of resources for optimal immune response, may also have far reaching 
detrimental effects. In transplant patients or autoimmune disease patients with 
high Th-17 inducing cytokine levels, Treg cell therapy may increase inflammation 
through induced Th17 differentiation (Xu et al., 2007). Conversely a lack of Th17 
cells due to plasticity could result in a loss of normal cellular functions of Th17 in 
protecting the intestinal epithelial integrity (Zhou, Chong and Littman, 2009).  
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1.5 B Lymphocytes 
1.5.1 Development in the Bone marrow 
B lymphocytes are so named because of their origin in the bone marrow 
(BM) where they begin their journey which ends in the peripheral lymphoid organs 
(LeBien and Tedder, 2008). The fate of Hematopoietic stem cells (HSC) within the 
BM is committed to the B cell lineage by the expression of transcription factors 
paired box protein 5 (PAX5), E2A and early B cell factor 1 (EBF1) (Eibel et al., 2014; 
Vale and Schroeder Jr., 2010; LeBien and Tedder, 2008). Pro-B cells express the Pro-
BCR complex Igα and Igβ (LeBien and Tedder, 2008; Monroe et al., 2003) and 
upregulate the RAG1 and RAG2 genes. This initiates rearrangement of the D-J locus 
of the heavy chain followed by a V/D-J rearrangement on the same heavy chain 
(Vale and Schroeder Jr., 2010; LeBien and Tedder, 2008). Nucleotides are added to 
the rearranged gene segments by an enzyme called terminal deoxynucleotidyl 
tranferase (TdT) thereby further diversifying the antigen receptor repertoire (Vale 
and Schroeder Jr., 2010). The Pre-B cell stage follows next. Here, V and J segments 
of the immunoglobulin light chains are rearranged with the help of RAG genes. This 
leads to the expression of kappa (κ) or lambda (λ) light chains and a functional BCR 
receptor (Eibel et al., 2014; Vale and Schroeder Jr., 2010; LeBien and Tedder, 2008).  
Aiolos, a zinc finger transcription factor is important in regulating light chain 
rearrangement in the Pre-B cell developmental stage (Eibel et al., 2014). FOXO1, 
PU.1 (Liu, Nurieva and Dong, 2013), Ikaros and E12/E47 are associated with 
rearrangements of immunoglobulin gene loci (Eibel et al., 2014; Vale and Schroeder 
Jr., 2010; LeBien and Tedder, 2008). The expression of IgM hallmarks the immature 
B cell developmental stage (Vale and Schroeder Jr., 2010). In order to tackle self-
reactivity, IgM are tested for affinity to bone marrow antigens, high affinity IgM 
receptor are either deleted or undergo receptor editing (Eibel et al., 2014; Vale and 
Schroeder Jr., 2010; LeBien and Tedder, 2008; King and Monroe, 2000; Levine et al., 
2000). After this stage, B cells now known as transitional immature B cell may leave 
the bone marrow for the periphery (Giltiay, Chappell and Clark, 2012). Alternative 
splicing within the IgM immunoglobulin receptor permits the production of IgD 
expressing B cells (Eibel et al., 2014). These IgM+ IgD+ B cells known as naïve mature 
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B cells await antigen encounter in the peripheral lymphoid organs (Vale and 
Schroeder Jr., 2010; LeBien and Tedder, 2008).  
1.5.2 B cell activation and differentiation 
In the periphery, naïve mature B cells become activated by exposure to 
antigens carried by APCs or by encounter with antigens themselves (Vale and 
Schroeder Jr., 2010). Activation is determined by affinity for antigen, dose of 
antigen and presence of innate signals at site of activation (MacLennan et al., 
2003). Depending of the molecular composition of the antigen, primed B cells can 
function in a T cell dependent (TD) or T cell independent (TI) manner. B cell immune 
response mounted against non-peptide antigens like lipopolysaccharide (LPS - a 
composition of cell walls in gram negative bacteria) or lipid based pathogens are 
done in a TI manner (LeBien and Tedder, 2008). In TD B cell responses, after priming 
by cognate antigen, B cells will solicit help from MHC II restricted Th2 or Tfh cells 
(Vale and Schroeder Jr., 2010; LeBien and Tedder, 2008). Antigen experienced B 
cells then differentiate into marginal zone B cells, extrafollicular B cells or germinal 
centre (GC) B cells. Absence of Notch 2 receptor expression on B cells is reported to 
favour the commitment to a follicular fate at the expense of a marginal zone fate 
where Notch 2 receptor expression is required (Hampel et al., 2011; Pillai and 
Cariappa, 2009).  
 
1.5.2.1 Marginal zone (MZ) B cells  
These are non-recirculating B cells with a less diversified receptor and are 
capable of recognizing conserved antigenic patterns on pathogens (Cerutti, Cols and 
Puga, 2013; MacLennan et al., 2003). They express high levels of co-stimulatory 
molecules, CD21 and IgM (Cerutti, Cols and Puga, 2013; MacLennan et al., 2003). 
They are strategically placed in the marginal zone of the spleen where they utilise 
BCRs and TLRs to engage antigens initiating a TI antibody immune response 
producing IgM, IgG2 and IgA (Cerutti, Cols and Puga, 2013; MacLennan et al., 2003). 
MZ B cells are also responsible for the production of natural antibodies and are able 
to respond to pathogen carried in the blood in an innate-like manner before the 
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onset of conventional adaptive immune response (Cerutti, Cols and Puga, 2013; 
Vale and Schroeder Jr., 2010).  
 
1.5.2.2 Extrafollicular B cells 
Extrafollicular B cells can be found in the marginal sinuses of the spleen, 
which is enriched with APCs (MacLennan et al., 2003). Shortly after antigen 
encounter, these extrafollicular B cells downregulate co-stimulatory molecules and 
MHC II complex while expressing high levels of Blimp1 (MacLennan et al., 2003). 
Blimp1 promotes their terminal differentiation by the suppression of PAX5 and Bcl6 
(MacLennan et al., 2003). Immune response mediated by these cells lead to robust 
but short-lived antibody production (Pissani and Streeck, 2014; MacLennan et al., 
2003). Although the cellular interactions that mediate extrafollicular B cell 
responses are still being investigated, it has been proposed that, depending on the 
nature of the antigen, generation of plasmablasts via extrafollicular B cell activity 
can be T cell dependent or independent (Sweet et al., 2011; MacLennan et al., 
2003). It should be noted that T cell dependent extrafollicular response is mediated 
by Bcl6 expressing CD4 T cells (Lee et al., 2011).  
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1.6 Germinal Centre (GC) B cells 
These subsets of B cells express CXCR5 that enables their localization in the B 
cell follicles (Bollig et al., 2012; Nutt and Tarlinton, 2011). Here, they engage with 
follicular dendritic cells (FDC) that present antigens to them. Once FDC signal is 
received, they seek cognate Tfh cells by migrating to T-B cell border. They interact 
with Tfh cells using CD40 receptor, ICOS and PDL-1 (Ma et al., 2012; Giltiay, 
Chappell and Clark, 2012; Nutt and Tarlinton, 2011).  Activated GC B cells 
upregulate Bcl6 that promotes proliferation, survival, inhibits Blimp 1 expression 
and the expression of genes involved in DNA damage (Nutt and Tarlinton, 2011). In 
addition to Bcl6, Pax5 and Bach2 are also upregulated to suppress plasma cell 
differentiation and promote the expression of activation induced (cytidine) 
deaminase (AID) (Nutt and Tarlinton, 2011; LeBien and Tedder, 2008; Shapiro-
Shelef and Calame, 2005).  B cells in the GC undergo clonal proliferation, somatic 
hypermutation (SHM) and class switch recombination (CSR). Molecular regulators 
of GC B cells are highlighted in figure 1.10 and Table 1.3. 
 
Figure 1.10: Schematic diagram showing genes involved in GC B cell 
differentiation, maintenance and the terminal differentiation of plasma cells 
(Shapiro-Shelef and Calame, 2005) 
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Gene Function(s) References 
Bcl6 Promoting GC B cell differentiation  
while inhibiting DNA damage response 
elements; inhibition of plasma cell 
differentiation 
(Crotty, Johnston and 
Schoenberger, 2010; Reljic 
et al., 2000) 
Blimp 1 
(Prdm1) 
Master regulator for plasma cell 
differentiation and secretion of 
immunoglobulin from plasma cells. 
Repressor of Bcl6 and Pax5. 
(Shapiro-Shelef and 
Calame, 2005; Shapiro-
Shelef et al., 2003; Turner 
Jr., Mack and Davis, 1994) 
IRF4 Transiently expressed after T:B cell 
receptor engagement to induce Bcl6 and 
AID. Sustained expression promotes 
terminal differentiation of GC B cells 
into plasma cells by Blimp1 
upregulation. 
(Ochiai et al., 2013; 
Mittrücker et al., 1997) 
Bach2 Activation of AID to promote SHM and 
CSR. Repression of Blimp1. 
(Nutt and Tarlinton, 2011; 
Muto et al., 2004)  
Pax5 Maintaining mature B cells and 
activation of AID. 
(Gonda et al., 2003) 
BatF Directly regulating the expression of AID 
to control CSR in GC B cells. 
(Ise et al., 2011) 
XBP-1 Terminal differentiation of GC B cells to 
induce plasma cell phenotype and 
secretion of immunoglobulin by plasma 
cells. 
(Shaffer et al., 2004; 
Shapiro-Shelef et al., 
2003) 
MTA3 Preventing plasma cell differentiation by 
repression of Blimp1 expression.  
(Fujita et al., 2004) 
STAT3 Induction of Blimp1.  (Reljic et al., 2000) 
IL-21 GC B cell differentiation, CSR, antibody 
secretion. 
(Bollig et al., 2012)  Kristin 
Hollister et al, 2013 
CD40 Survival and proliferation of GC B cell. It 
has also been reported to drive class 
switching and antibody secretion in 
plasma cells.  
(Wykes, 2003) 
ICOSL Promotes GC B cell survival and 
function.  
(Liu et al., 2015) 
 
PDL-1 Enhance B cell survival.  (Good-Jacobson et al., 
2010) 
 
Mitf Inhibit plasma cell differentiation by 
suppressing IRF4 expression.  
(Lin, Gerth and Peng, 
2004) 
 
 
Table 1.3: Molecules reported to be involved in GC B cell regulation and functions 
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1.6.1 GC Reactions 
As mentioned earlier, GCs are birthed as a result of T cell dependent 
immune response and are manifested a 1-2 weeks after initial infection (Vale and 
Schroeder Jr., 2010; MacLennan et al., 2003).  GC reactions begin with the priming 
of GC B cells by FDC which bear antigenic immune complexes (Ma et al., 2012; 
Giltiay, Chappell and Clark, 2012; Vale and Schroeder Jr., 2010). Primed B cells 
upregulate T cell homing receptor CCR7 while downregulating the follicular homing 
receptor CXCR5. They migrate to the border of the T cell zone where they solicit for 
help from follicular helper T cells (Reif et al., 2002). Cognate engagement with Tfh 
increases GC B cell survival chances through CD40:CD40L signaling and the 
induction of Bcl6 along with other molecules necessary for GC B cell proliferation in 
the GC (see table 1.3). Once activated by Tfh cells, GC B cells along with cognate Tfh 
cells migrate into the follicles to form the GC. 
The GC is the site for clonal expansion of activated GC B cells (Ma et al., 
2012). B cells entering the GC first migrate into the dark zone as centroblasts where 
they undergo active proliferation with affinity maturation of immunoglobulin 
receptors through somatic hypermutation (SHM) (Vale and Schroeder Jr., 2010). An 
enzyme, AID that is capable of RNA editing catalyzes SHM and class switch 
recombination (CSR) (Giltiay, Chappell and Clark, 2012). Another enzyme, uracil-
DNA glycosylase (UNG), removes the edited nucleotide (Giltiay, Chappell and Clark, 
2012; Vale and Schroeder Jr., 2010; Han et al., 2007; Muramatsu et al., 2000). 
During SHM, AID causes point mutations to occur in the variable region of the 
immunoglobulin heavy (IgH) and light (IgL) chains permitting the generation of 
antibodies with a higher affinity for pathogens (Ma et al., 2012; LeBien and Tedder, 
2008; Han et al., 2007).  Following SHM, immunoglobulin receptors undergo CSR. 
During CSR, the constant (C) region of the IgH chain structure is modified 
through non-homologous recombination to generate other classes of antibodies 
with a wider range of effector function and location (Eibel et al., 2014; Vale and 
Schroeder Jr., 2010; LeBien and Tedder, 2008; Teng and Papavasiliou, 2007; 
Muramatsu et al., 2000). Following SHM and CSR, centrocytes in the light zone 
interact with FDC and selectively bind antigens based on affinity (Eibel et al., 2014). 
  
                                                                                                      Chapter 1 – Introduction 
 
35 
 
B cells that bind with higher affinity to antigen complex are positively selected to 
compete for help and survival signals administered by Tfh cells while B cells with 
lower antigen affinity die by apoptosis (Eibel et al., 2014; Nutt and Tarlinton, 2011). 
The nature of the antigens initiating the immune response determines what class of 
immunoglobulin would be produced following recombination of switched 
transcripts (MacLennan et al., 2003). Bacteria would generally initiate an IgG2 
response while viruses and protein immunisation generate IgG1 and IgG3 antibody 
production (MacLennan et al., 2003). Cytokines have been reported to facilitate CSR 
with studies showing that CSR can be induced in B cells by the presence of IL-4 (Ma 
et al., 2012).  Once centrocytes have been positively selected, they upregulate 
plasma cell differentiating transcription factor Blimp1 to promote plasmablast 
generation and memory B cell differentiation (LeBien and Tedder, 2008). Han et al, 
2007 reported that SHM and CSR can occur outside of the GC and without the need 
for T cell help (Han et al., 2007). Indeed CSR have been reported in marginal zone B 
cells (Cerutti, Cols and Puga, 2013).  However, SHM and CSR associated with the 
production of long lived plasma cells is limited to the GC (Eibel et al., 2014). 
B cell immunological memory mainly arises from GC reactions although; 
there are reports of GC-independent memory B cell generation (Takemori et al., 
2014). The memory B cell population predominantly resides in the spleen where 
they are capable of rapid differentiation into plasmablasts to provide a more robust 
immune response upon re-exposure (Ma et al., 2012; Tangye and Tarlinton, 2009; 
LeBien and Tedder, 2008). It has been proposed that memory B cells are maintained 
by TLR stimulation (Bernasconi, Onai and Lanzavecchia, 2003), Bcl6 expression 
(Scheeren et al., 2005) and BAFF-R and TACI expression (Salzer et al., 2008), the 
underlying cellular and molecular mechanism responsible for the maintenance of 
memory B cell is still very much unclear.   
  
  
                                                                                                      Chapter 1 – Introduction 
 
36 
 
1.6.2 Antibodies as mediators of adaptive humoral immunity 
Antibodies are ‘Y’ shaped structures made up of 2 heavy and 2 light chains. 
They have a variable region on the top branches of the ‘Y’ structure and a constant 
region at the base which serves as an effector site (Figure 1.11) (Hansel et al., 
2010). Based on the amino acid composition of the constant region, there are 5 
classes of antibodies: IgM, IgD, IgG, IgE and IgA. IgG is the most dominant antibody 
in the serum mediating cytotoxic activities, complement activation and 
neutralisation while IgA is found on mucosal surfaces, secretion and skin (Tomasi, 
1970). IgE is useful in immunity against helminthic pathogens and also plays a role 
in allergy (Tomasi, 1970).  
 
Figure 1.11: Typical structure of a monomer antibody complex showing antigen 
binding sites and effector site. Image adapted from (Nossal, 2003). 
 
Within the variable region of antibodies, affinity maturation by SHM takes 
place creating a repertoire of antibody that binds with heightened affinity to a 
specific epitope (Beck et al., 2010; Wang et al., 2007). Once released from plasma 
cells, this variable region can then bind to specific antigenic targets (Nossal, 2003). 
Using the constant region, other effector cells are able to attach to an antibody-
antigen complex to initiate antibody dependent cell-mediated cytotoxicity (ADCC) 
(Wang et al., 2007). Aside cells, complements protein (C1q) is also able to utilise the 
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Fc region to tag cells for destruction through complement dependent cytotoxicity 
(CDC) (Hansel et al., 2010). Antibodies are also capable of facilitating traffic of 
phagocytes to pathogens through opsonisation (Wang et al., 2007 and Hansel et al., 
2010). This leads to efficient clearing of pathogens (Wang et al., 2007 and Hansel et 
al., 2010). Aside ADCC, CDC and opsonisation, another function of antibodies is the 
neutralisation of pathogens as in the case of viral infection and bacteria toxins 
(Klasse, 2014; Willey and Aasa-Chapman, 2008). During viral infection, neutralising 
antibodies (NAb) bind to viral receptors to antagonise viral docking on target cells 
(Klasse, 2014). If virus has already made contact with cell, NAb binds to viral 
epitopes to inhibit subsequent steps including replication (Klasse, 2014; Willey and 
Aasa-Chapman, 2008). These actions abrogate the pathogenic effect of viral 
invasion (Klasse, 2014; Willey and Aasa-Chapman, 2008). Antibodies are also able to 
bind to mast cells causing them to release chemical signals that induce allergic 
reactions like sneezing aimed at expelling immunogen.  
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1.6.3 Diseases arising from defective host immune responses 
Both innate and adaptive arms of the immune system are tightly regulated 
in order to achieve optimal responses against immunogens while minimising 
pathology that may arise due to deregulation of the mechanisms mediating 
immune responses. Dysregulated immune responses have been implicated in the 
development of autoimmunity, primary and secondary immunodeficiency diseases, 
cancers and allergies. For the purpose of this review, the focus will be on 
autoimmunity and immunodeficiency diseases. 
1.6.3.1 Autoimmunity  
Autoimmune diseases are a consequence of immune responses mounted 
against harmless self-antigens. In autoimmune diseases, self–reactive immunocytes 
are constitutively activated in the absence of overt immunization causing the 
pathological symptoms associated with these diseases (Table 1.5) (Davidson and 
Diamond, 2001). It is reported that genetics may predispose individuals to the onset 
of autoimmune diseases. There is increased susceptibility to autoimmunity when 
genes involved in regulating lymphocyte activity are mutated as observed in CD45 
E613R mutated mice that developed lupus like autoimmune diseases (Majeti et al., 
2000). Mice with CTLA-4 downregulation have increased T cell activation with Type 
1 diabetes and Graves ’ disease (Kouki et al., 2000). Loss of regulatory T cell 
function, environmental triggers, infection with pathogens that mimic self-antigens 
and hormones are other factors that may contribute to the development of 
autoimmune diseases (Davidson and Diamond, 2001). Cytokines play a role in the 
progression of these diseases contributing immensely to the observed pathology 
(Table 1.4) (Davidson and Diamond, 2001). Th1, Th2 and Th17 cytokines are often 
associated with autoimmunity (Miao et al., 2013; Damsker, Hansen and Caspi, 
2010). Th1 cytokines IFNγ and IL-12 have been linked with the development of 
multiple sclerosis, lupus like autoimmune diseases, rheumatoid arthritis and Crohns 
disease (Zhu et al., 2008; Gutcher and Becher, 2007; Romagnani, 1999). Th2 
cytokines have been implicated in reactive arthritis following persistent intracellular 
bacterial infection (Lafaille, 1998).  Th-17 and IL-17 have well documented roles in 
organ pathology and autoimmunity including experimental autoimmune 
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encephalomyelitis (EAE), inflammatory bowel diseases (IBD), systematic lupus 
erythematosus (SLE) and rheumatoid arthritis (Miao et al., 2013; Dong, 2006). Tfh 
responses have been associated with the development of Systemic lupus 
erythematosus SLE, Sjogren syndrome, and juvenile dermatomyositis (Ma et al., 
2012).  
 
Table 1.4: Deregulated cytokine expression in autoimmune diseases. Reproduced 
with permission from Davidson and Diamond 2011, Copyright Massachusetts 
Medical Society. (Davidson and Diamond, 2001).  
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Disease Pathogenesis Reference 
SLE  Genetic alterations, environmental factors, 
hormones and diet promote disease initiation 
which manifest as Vasculitis, deposition of 
immune complex in kidney, atherosclerosis 
and presence of anti-dsDNA. 
(Mok and Lau, 
2003) 
Sjoren 
Syndrome 
Lymphocytic infiltration and subsequent 
destruction of salivary and lacrimal glands, 
liver, kidney and lungs. Glomerulonephritis 
and lymphoproliferative disorders are also 
reported. 
(Goules, 
Tzioufas and 
Moutsopoulos, 
2014) 
Rheumatoid 
Arthritis 
Unknown etiology however disease is 
presented with Synovitis and synovial 
hyperplasia, cartilage, joint and bone 
damage. 
(Gibofsky, 
2012) 
Multiple 
sclerosis (MS) 
A combination of genetic susceptibility and 
environmental interactions may promote 
chronic inflammation in the central nervous 
system resulting in organ damage and severe 
disability. Th17 cells have also been reported 
to be involved in MS. 
(Loma and 
Heyman, 2011; 
Li et al., 2011) 
Table 1.5: Some autoimmune diseases and their associated pathology    
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1.6.3.3 Immunodeficiency 
Immunodeficiency diseases are characterised by an inability to mount 
optimal immune response against invading pathogens and an increased 
susceptibility to infections. They may arise due to single or multiple mutations on 
genes (primary immunodeficiency) or due to pathogenic infections (secondary 
immunodeficiency) (Table 1.6) (Bonilla and Geha, 2003). They manifest in various 
forms from antibody deficiency to a lack of effector functions in immunocytes and a 
deficiency in complement proteins (Bonilla and Geha, 2003).  
Disease Pathogenesis Reference 
Severe Combined 
Immunodeficiency 
Group of disease arising due to defects 
in a number of genes. Leads to an 
absence of T and sometimes B cell 
function. Bacterial infection, lung 
granulomas and lymphoid malignancies 
develop.  
(Maggina and 
Gennery, 
2013; 
Notarangelo, 
2013; 
Roifman et 
al., 2012)  
X-Linked 
Agammaglobulinemia 
(Bruton's Disease) 
Defects in B cell development arising 
from aberrant BTK gene expression. 
Neutropenia and severe bacterial 
infections are common in sufferers.  
(Notarangelo 
et al., 2009; 
Bonilla and 
Geha, 2003) 
Common variable 
immunodeficiency 
disorders (CVIDs) 
Sufferers present with increased 
susceptibility to bacterial infections. 
They may also develop autoimmune 
diseases, lymphoproliferative and 
granulomatous diseases.  
(Notarangelo 
et al., 2009) 
Wiskott-Aldrich 
syndrome (WAS) 
Mutations in the WAS protein family of 
genes leading to Lymphopenia, 
defective actin modelling in 
cytoskeleton leading to failure in 
immune synapse formation.  
(Nonoyama 
and Ochs, 
2001) 
Hyper  IgM syndrome Varied cause. Defective CD40:CD40L 
signaling and defective AID expression. 
Pathology include Failure in SHM and 
CSR leading to an inability to produce 
highly specific antibody or other 
antibody isotype and susceptibility to 
infections.  
(Etzioni and 
Ochs, 2004) 
 Table 1.6: List of immunodeficiency diseases and their pathogenesis  
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1.8 The Early Growth Response Genes 
The early growth response (Egr) genes are a family of transcription factors. 
They include Egr1 (NGFI-A), Egr2 (Krox20), Egr3 (Pilot) and Egr4 (NGFI-C). They 
contain an evolutionarily conserved DNA binding domain (81 – 93% homology) with 
3 zinc finger transcription motifs bearing Cys2-Hys2 zinc fingers (Gabet et al., 2010; 
Gómez-Martín et al., 2010). Each zinc finger motif binds to 3 nucleotide base pairs 
on G-C rich promoter regions on DNA of target genes (Zheng et al., 2012; Gabet et 
al., 2010; Gómez-Martín et al., 2010; Poirier et al., 2008). This is known as the Egr 
response element (ERE).  As a family, the Egr genes regulate growth, activation and 
differentiation of cells in the nervous system and immune system (Gabet et al., 
2010; Gómez-Martín et al., 2010; Poirier et al., 2008). Within the nervous system, 
they control the proliferation and differentiation of Schwann cells (Gabet et al., 
2010; Gómez-Martín et al., 2010). Some members of the family are upregulated to 
mediate the differentiation of precursor lymphocytes, the maturation and 
activation of B and T cells as well as the induction of tolerance (Li et al., 2011; 
Gómez-Martín et al., 2010). Egr1 acts as a positive regulator of immune cell 
activation promoting macrophage cell lineage differentiation (Gómez-Martín et al., 
2010; Ramón et al., 2010; Krishnaraju, Hoffman and Liebermann, 2001) and also in 
the positive selection of single positive CD4 and CD8 cells (Bettini et al., 2002). Egr2 
functions as regulators of T cell activation and effector function by the regulation of 
IFN-ƴ and IL-17 expression (Zhu et al., 2008, Li et al., 2012). Egr2 also promote T cell 
anergy and apoptosis (Lawson, Weston and Maurice, 2010; Ramón et al., 2010; 
Safford et al., 2005). Egr3 is reported to function in the transition from double 
negative (DN) to double positive (DP) T cells (Li et al., 2011; Gómez-Martín et al., 
2010; O'Donovan et al., 1999) and in the induction of tolerance through its 
interaction with type III histone deacetylase sirtuin 1 (Sirt1) (Gao et al., 2012). Egr4, 
the last member of the family, is an auto-regulatory transcription repressor of c-
FOS protein. Mutations within the Egr family of genes have been linked to the 
development of lupus-like autoimmune diseases (Gómez-Martín et al., 2010; Zhu et 
al., 2008), reduction in bone mass (Gabet et al., 2010) neuropathies like Charcot-
marie tooth type 1, congenital hypomyelinated neuropathy (Warner et al., 1998), 
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and sensory ataxia (Tourtellotte and Milbrandt, 1998).  Absence of Egr4 is known to 
cause the appearance of infertile male phenotypes in Egr4 knockout mice due to its 
expression in male germ cells and involvement in germ cell maturation 
(Hadziselimovic et al., 2009; Tourtellotte and Milbrandt, 1998). 
 
 
1.8.1 The Egr2 gene 
Egr2 is located on chromosome 10q21.1 in humans and 10qB5.1 in mice. It 
is a 49kDa protein with 470 amino acids (aa). It binds to a GCGTGGGCG sequence 
on target genes to regulate their transcription (Swirnoff and Milbrandt, 1995). 
Functions of Egr2 have been reported in cognitive process and lymphocyte 
regulation (Miao et al., 2013; Li et al., 2012; Li et al., 2011; Zhu et al., 2008; Poirier 
et al., 2008; Dong, 2006). Increased Egr2 expression can be seen early in Schwann 
cell development suggesting a vital role in regulating genes involved in Schwann cell 
differentiation and proliferation (Warner et al., 1998). The Egr2 gene is also 
required for the development of the hindbrain with a mutation of this gene being 
associated with deregulated hindbrain segmentation, development of myelopathies 
like congenital hypomyelinated neuropathy, Charcot Marie tooth disease and early 
fatality in neonates (Gómez-Martín et al., 2010; Swanberg et al., 2009; Topilko et 
al., 1994). Egr2 Function within the immune system includes regulating the 
development and activation of T and B cells, maintaining immune homeostasis and 
regulating TCR signaling (Li et al., 2012; Lawson, Weston and Maurice, 2010; Zhu et 
al., 2008). Egr2 has also been reported to play a role in apoptosis where it 
upregulates the expression of FasL and induce expression of apoptotic agent 
BNIP3L and BAK (Gao et al., 2012; Lawson, Weston and Maurice, 2010; Unoki and 
Nakamura, 2003). Egr2 function is regulated by co-repressors DdX/DP103 (Gillian 
and Svaren, 2004) or the NAB proteins (Svaren et al., 1998). 
 
1.8.2 The Egr3 gene 
Egr3 is the third member of the early growth response genes family of transcription 
factors. It is closely related to Egr2 in function (Poirier et al., 2008; Safford et al., 
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2005). It is located on chromosome 8p21.3 in human and 14qD2 in mice (Zhang et 
al., 2012). It is a 42kDa protein with 387aa. Egr3 is essential for the development of 
muscle spindle. Egr3 Knockout mice exhibited a phenotype that lacked muscle 
spindles and show signs of severe muscular abnormalities akin to gait ataxia 
(O'Donovan et al., 1999; Tourtellotte and Milbrandt, 1998). Egr3 knockout mice also 
display scoliosis, tremors, ptosis and increased perinatal mortality (O'Donovan et 
al., 1999; Tourtellotte and Milbrandt, 1998). Egr3 was also identified to function in 
the negative regulation of T cell activation and the induction of T cell anergic state 
(Safford et al., 2005). Like Egr2, Egr3 also upregulates FasL and promote apoptosis 
in Fas bearing cells (Yang et al., 2002; Mittelstadt and Ashwell, 1998). Egr3 bears 
the closest homology to Egr2 and has been reported to be capable of functionally 
compensating for the loss of Egr2 (Li et al., 2012; Poirier et al., 2008; Safford et al., 
2005). For this study, I would be investigating the role of Egr2/3 in organ pathology 
and Tfh differentiation (Li et al., 2012; Poirier et al., 2008; Safford et al., 2005; Xi 
and Kersh, 2004) 
.   
  
                                                                                                      Chapter 1 – Introduction 
 
45 
 
1.8.3 Current knowledge on the role of Egr2 and Egr3 genes in the 
immune system 
1.8.3.1  Induction and Maintenance of peripheral tolerance  
Anergy, apoptosis and the action of regulatory T cells are the mechanisms 
used by the immune system to maintain tolerance to self-antigens and prevent the 
development of autoimmunity (Schwartz, 2003; Hargreaves et al., 1997).  Egr2/3 
genes are able to induce anergy in both in vitro and in vivo conditions (Zheng et al., 
2013; Zheng et al., 2012; Collins et al., 2008).  ChIP-Seq analysis associated Egr2/3 
genes with the direct regulation of genes associated with anergy (Zheng et al., 
2013; Zheng et al., 2012; Collins et al., 2008). Global gene expression analysis 
identified sustained Egr2 and Egr3 expression in anergic A.E7 cells and transient Eg2 
expression in fully stimulated A.E7 cells (Safford et al., 2005; Harris et al., 2004). 
Genetically modified T cells with a knock down of Egr2 were less susceptible to 
induction of an anergic state whilst overexpression of the Egr2 gene had the 
opposite effect (Gómez-Martín et al., 2010; Zhu et al., 2008; Safford et al., 2005; 
Warner et al., 1998). Research has shown that one of the ways by which Egr2 and 
Egr3 are able to control peripheral tolerance is via their interaction with NFAT 
leading to the induction of anergy (Müller and Rao, 2010). In anergic cells, NFAT 
dephosphorylation downstream of TCR engagement leads to the formation of 
complexes between NFAT and transcription factors such as Egr2 and 3 that 
promote the expression of proteins, for example the E3 ubiquitin ligase and CBL-B, 
which are involved in anergy (Martinez et al., 2015; Müller and Rao, 2010; Macián 
et al., 2004; Macián et al., 2002). NFAT also plays a role in the induction of 
apoptosis by regulating the expression of the FasL (Rengarajan et al., 2000). NFAT 
knockout mice have been reported to exhibit hyperproliferation in lymphoid tissues 
and impaired expression of the death receptor ligand – FasL (Rengarajan et al., 
2000). Safford et al in 2005 hypothesized that the E3 ubiquitin ligase, Cbl-b may 
play a role in anergy induction by Egr2/3 genes (Safford et al., 2005). Upregulation 
of Cbl-b results in ubiquitinisation of signaling components and inhibition of key 
pathways necessary for TCR mediated immune response (Safford et al., 2005). Egr2 
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is also said to be expressed in CD4+ CD25- LAG3+ Treg cells and may play a role in the 
maintenance of peripheral tolerance via these cells (Okamura et al., 2009). 
1.8.3.2  T and B cell development and activation 
Egr2 and 3 regulate the differentiation and maturation of cells of the 
lymphoid lineage including NKT cells (Li et al., 2011; Gabet et al., 2010; Lazarevic et 
al., 2009b). Egr2/3 genes are expressed during T and B cell development in the 
thymus and bone marrow respectively (Li et al, 2011). Development of DN 
thymocytes post β-selection is very much dependent on Egr2/3 genes upregulation 
(Xi et al., 2006; Carleton et al., 2002). Overexpression of Egr2 after Pre-TCR 
signaling results in aberrant numbers of DP thymocytes and immature B cells. Egr2, 
however, facilitates the transition from double positive (DP) to SP cells and together 
with Egr3, they can induce phenotypic changes associated with maturation of 
thymocytes in vitro and in vivo (Li et al., 2011; Carleton et al., 2002). A similar 
phenotype was observed in B cells in Egr2 overexpression models where they 
showed enhanced maturation of B cells in the periphery (Li et al, 2011). This 
suggests a need for differential expression of these genes during lymphocyte 
development (Li et al, 2011). Following TCR engagement Egr2 and 3 are transiently 
induced and are reported to act as negative regulators of T cell activation in the 
periphery (Collins et al., 2008). T cells from single Egr2 or Egr3 knockout mice show 
enhanced proliferation and IL-2 production following anti-CD3 or PMA and 
Ionomycin stimulation (Collins et al., 2008) while overexpression of Egr2 and Egr3 
genes using lentiviral constructs significantly reduced IL-2 production in Jurkat cell 
lines (Safford et al., 2005).  Li et al., (2012) suggested that high IL-2 production in 
single Egr2 knockout mice may be as a result of compensation by Egr3 genes. 
Recently, we have found that Egr2/3 genes are necessary for the maintenance of 
homeostasis and to promote antigen receptor induced proliferation in vitro (Li et 
al., 2012). T and B cells from Egr2-/- Egr3-/- mice showed severe defects in 
proliferation and IL-2 production after antigenic receptor stimulation in vitro (Li et 
al., 2012). This was due to a lack of Egr2 interaction with BATF causing BATF to bind 
to the AP-1 complex and result in the inhibition of AP-1 activity downstream of TCR 
signaling (Li et al., 2012). This newly discovered role for the Egr2/3 genes indicates 
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that they are regulators of not just immune homeostasis but also optimal immune 
response (Li et al., 2012).                                                                                                                                                                                                                   
1.8.3.3  Autoimmunity and inflammation 
In line with its role in the maintenance of peripheral tolerance, Egr2/3 
transcription factors play a monumental role in the regulation of inflammatory 
responses and the development of systemic autoimmunity (Li et al., 2012; Zhu et 
al., 2008). Studies in Egr3 null mice found that transfer of Egr3-/- T cells into WT 
mice led to increase pathology and death due to autoimmune pneumonitis (Collins 
et al., 2008). Studies conducted on Egr2 conditional knockout mice have shown that 
a decreased expression of Egr2 in T lymphocytes resulted in the increased levels of 
STAT 1 and 3, which facilitate the production of pro-inflammatory cytokines, such 
as IFN- gamma and IL-17 (Miao et al., 2013; Li et al., 2012; Zhu et al., 2008). Double 
knockout of Egr2 and Egr3 genes in mice also resulted in the presence of an 
increased level of Th1 and Th17 cytokines IFN-gamma and IL-17, lymphocyte 
infiltrates into multiple organs including the lungs, kidney and liver and production 
of autoantibodies and immunoglobulin deposits in the kidney (Miao et al., 2013; Li 
et al., 2012). Our group reported that the Egr2/3 genes regulate SOCS1/3 to 
prevent STAT1/3 phosphorylation and the subsequent activation of Th1 and Th17 
thus controlling inflammatory responses (Figure 1.15) (Li et al, 2012). The Th1 
cytokine, IFN-γ has been implicated in autoimmunity and is reported to acts 
synergistically with TNF alpha causes necrotizing inflammatory myopathies and 
damage of tissue morphology (Li et al., 2012; Okamura et al., 2009). Furthermore, 
Tregs cells expressing Egr2 can actively inhibit the development of intestinal 
inflammation in mice models (Okamura et al., 2012). 
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1.9 Aims of the study 
In past years, a number of studies, including those done by our group, have 
looked into delineating the roles of the Egr2 and Egr3 transcription factors. A lot of 
these studies have highlighted roles in the central nervous system, inflammation, 
lymphocyte development, and autoimmunity (Li et al., 2012; Gómez-Martín et al., 
2010; Topilko et al., 1994; Schneider-Maunoury et al., 1993). We recently found 
that the Egr2-/- Egr3-/- mice have high levels of Th1 and Th-17 cytokines and showed 
defective TCR signaling after in vitro receptor stimulation (Li et al, 2012). These 
suggested a possible role for Egr2/3 genes in the maintenance of immune 
homeostasis and optimal immune responses in vivo. So far, using Egr2 conditional 
knockout mice, 2 studies have looked at the possible role of the Egr2 gene in 
adaptive immune response after in vivo pathogenic challenge (Du et al., 2014; 
Ramón et al., 2010) 
. Though they elucidated some hitherto unknown roles of the Egr2 genes in 
immune responses, these studies did not take into account the functional 
compensation by the Egr3 gene in the absence of Egr2. Using our model of CD2-
specific Egr2-/- mice crossed with systemic Egr3-/- mice, I further investigated the 
roles of these genes in inflammation pathology, the differentiation of Tfh cells in 
vivo and the development of germinal centers after antigenic challenge in vivo.  The 
aims of this study were therefore to: 
 Characterize the phenotype of the Egr2-CD2 CRE -/- Egr3 -/- mouse model. 
 Investigate the development of systemic inflammation pathology in the 
Egr2-/- Egr3 -/- mouse model.  
 Investigate the role of the Egr2-/- Egr3 -/- gene in Tfh differentiation and the 
initiation of GC reactions after in vivo antigenic stimulation.  
 Identify the molecular mechanism by which Egr2/3 regulate the Tfh cell 
genetic program. 
The hypothesis of my study is that the Egr2/3 genes are essential for the control of 
systemic inflammatory pathology and are also critical for the differentiation of 
follicular helper T cells  
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Chapter 2 Materials and 
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2.1 Experimental model 
All mice used for the purpose of this study including hCD2-Cre-Egr2-/-Egr3-/- 
mice and RAG-/- mice were approved under the U.K Home Office project license 
authority. They were maintained in the Biological Services Unit at Brunel University 
according to the Guidance on the Operation of Animals, Scientific Procedures Act 
1986.  
2.1.1 hCD2-Cre specific Egr2-/- MICE 
Systemic knockout of the Egr2 gene results in the birth of lethal phenotypes 
with defects in hind brain development (Gabet et al., 2010). As these mice die 
within a few hours after birth, this necessitated the generation of conditional 
knockout of the Egr2 gene in mice using the Cre-Loxp system (Gabet et al., 2010; 
Turgeon and Meloche, 2009). Briefly, target genes are floxed with the Loxp gene at 
both ends and Cre, a recombinase enzyme recognise and cuts at these Loxp sites. 
hCD2-cre mice (a gift from Dr P. Charnay, Institut National de la Santé et de la 
Recherche Médicale, Ecole Normale Supérieure, Paris) and Egr2LoxP/LoxP mice (a gift 
from Dr D. Kioussis, National Institute for Medical Research, London) were crossed 
to generate the CD2-specific Egr2-/- mice (de Boer et al., 2003; Taillebourg, Buart 
and Charnay, 2002). As the CD2 promoter is lymphocyte specific, Egr2 is deleted 
only in T and B cells. All Egr2-/- mice used for the purpose of this study were further 
backcrossed on a C57BL/6 background to purify the line.  
 
2.1.2 Egr3-/- mice 
Egr3-/- mice were a gift from the Tourtellotte group (Washington University 
School of Medicine, St Louis, USA).  They cloned the entire Egr3 gene into a 
pBluescript vector and then disrupted transcription of the gene using a 1.5kb 
fragment containing a neomycin resistance positive selection cassette pMC1NeopA. 
This deleted over 1Kb fragment of the Egr3 gene taking away the DNA binding 
domain and the carboxyl terminus of the protein (Tourtellotte and Milbrandt, 
1998).  
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2.1.3 CD2-specific Egr2-/- and Egr3-/- mice 
These mice were generated by crossing hCD2-specific Egr2-/- and Egr3-/- 
mice. These are then backcrossed on a C57BL/6 background for at least 10 
generations. For the purpose of this thesis, they would be referred to as Egr2-/- 
Egr3-/- mice from here on.  
2.1.4 Genotyping of Egr2-/- Egr3-/- mice 
Prior to use in any experimental procedure, mice were genotyped to 
confirm complete excision of the Egr2 and Egr3 genes. DNA was extracted from 
mouse tail or ears using REDExtract-N-Amp Tissue PCR Kit (Sigma) according to the 
manufacturer’s protocol. Briefly, Extraction buffer and tissue preparation buffer 
were added to the sample and heated with agitation at 55˚C for 30 minutes. This 
allows the protease enzyme present in the buffers to break down proteins. This was 
then followed by heat-controlled denaturing of the enzyme by heating the samples 
at 95˚C for 3 minutes. Neutralising solution was added to stop the reaction. 
Extracted genomic DNA was then diluted in water as necessary.  
Polymerase Chain Reaction (PCR) was then performed to amplify genomic 
DNA from mouse samples using 0.5μM of gene specific sense and antisense 
primers. The Primers are used to amplify a region containing the gene of interest on 
nucleic acids. The PCR technique uses DNA polymerase from Thermus aquaticus 
(Taq) which is thermostable and hence remains active even at high temperatures. 
Taq polymerase produces new copies of the gene of interest by adding nucleotides 
onto newly synthesised single strand DNA using dNTPs. The PCR conditions were as 
highlighted in table 2.1. PCR products obtained from the amplification were then 
loaded onto 2% agarose gels which were run in an electrophoresis tank containing 
1X TAE Buffer (Sigma), at 100V. Gels were visualized under ultraviolet (UV) light 
using a BioRad Imager. 
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Gene Primers (5’ – 3’) PCR Conditions Product 
Cre Sense: CCA ACA ACT 
ACC TGT TCT GCC G  
Step 1: 95˚C for 5 min  
Step 2: 94˚C for 40 sec  
Step 3: 56˚C for 40 sec    
Step 4: 72˚C for 40 sec  
Repeat step 2-4 (30x) 
Step 5: 72˚C for 5 min  
Keep in 4˚C 
150bp 
Antisense: TCA TCC TTG 
GCA CCA TAG ATC AGG  
LoxP Sense: GTG TCG CGC 
GTC AGC ATG CGT  
Step 1: 95˚C for 5 min  
Step 2: 94˚C for 40 sec  
Step 3: 56˚C for 40 sec    
Step 4: 72˚C for 40 sec  
Repeat step 2-4 (30x) 
Step 5: 72˚C for 5 min  
Keep in 4˚C 
WT allele: 
190bp 
LoxP allele: 
210bp 
Antisense: GGG AGC 
GAA GCT ACT CGG ATA 
CGG  
Egr3 Sense: CTA TTC CCC CCA 
GGA TTA CC  
Step 1: 95˚C for 5 min  
Step 2: 94˚C for 40 sec  
Step 3: 57˚C for 40 sec    
Step 4: 72˚C for 40 sec  
Repeat step 2-4 (30x) 
Step 5: 72˚C for 5 min  
Keep in 4˚C  
  
WT allele: 
400bp 
Neo allele: 
800bp 
Antisense: TCT GAG CGC 
TGA AAC G  
Neo: GAT TGT CTG TTG 
TGC CCA GTC  
Table 2.1: PCR cycles and product sizes for genotyping primers used in the 
generation of Egr2-/- Egr3-/- mice 
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2.2 Cell line 
Human thymidine kinase deficient 143 (TK143) cell line (Sourced by Dr. Su-
Ling Li at Brunel University, London) was used for the propagation of vaccinia virus 
and for assays requiring in vitro virus culture including viral titre and Plaque 
Reduction Neutralization Tests (PRNT).  These TK143 cells show cytopathic activity 
to vaccinia virus, which is visible by the formation of plaques indicating cell lysis.  
TK143 cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) + 
GLUTAMAX supplemented with 2% sodium pyruvate, 10% HEPES buffer, 10% Foetal 
Bovine Serum (FBS), 50μM β-mercaptoethanol (2-ME), 50μg/ml gentamycin (all 
purchased from invitrogen).  
2.3 Vaccinia Virus Western Reserve (VVWR) strain 
propagation  
VVWR (Sourced by Dr. Su-Ling Li at Brunel University, London) is a virus from 
the pox family of viruses (Poxviridae). Although non-pathogenic in humans, the 
VVWR is a potent neurovirulent immunogen in mouse capable of generating specific 
and non-specific immune responses involving NK cells and lymphocytes.  VVWR was 
propagated in TK143 cells. TK143 cells were cultured in 10ml of DMEM in T-75 
flasks. When TK143 cells were at 100% confluency, they were infected with 5μl of 
VVWR and incubated at 37°C, 5% CO2 for 48-72 hours to allow all cells to show full 
cytopathic effect. The supernatant containing viruses released from these lysed 
cells was then collected and used to infect another fully confluent TK143 cells in T-
150 flask. These cells were incubated at 37°C, 5% C02 until all cells were fully lysed. 
Cells were then harvested using a cell scraper and collected into a 15ml tube in 5ml 
of DMEM medium. To liberate the virus, these fully lysed TK143 cells were freeze-
thawed in liquid nitrogen (Freeze) and 37°C water bath (thaw) 3 times for 5 minutes 
each. This causes the cell membrane to become perforated and the cells burst 
open.  Viral particles were then collected by high speed centrifugation at 1300rpm 
(300xg) for 5 minutes. Freshly prepared VVWR were then quantified by infecting 
TK143 cells with newly propagated VVWR using a pre-titred VVWR with known viral 
titre as standard. Virus was stored in liquid nitrogen until ready for use 
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2.4 Virus Infection  
Baseline weights of sex, age and weight-matched WT and Egr2-/-Egr3-/- mice 
were determined on the day of the infection. Mice were then given an intranasal 
(I.N) injection of sub lethal dose of 2 X 105 plaque forming unit (PFU) of VVWR. VVWR 
Infected mice were observed and weighed daily to assess clinical pathology. 
Percentage decrease in weights from day 0 (baseline) was determined using the 
formulae below: 
Weight on day 0 – weight at day x     X   100  
Weight on day (0) 
Mice were also observed daily for signs of dehydration, lethargy, fur appearance 
and agility. Mice were sacrificed between 8 to 70 days post-infection with VVWR. 
Serum, spleen, lymph nodes and lungs were harvested from culled mice for further 
analysis.  
2.5 Virus plaque assay  
Pathogen clearance of VVWR in Egr2
-/-Egr3-/- mice was determined by viral 
plaque assay. Harvested lung tissues from infected and uninfected WT and Egr2-/-
Egr3-/- mice were weighed and then homogenised. Supernatant from lung tissue was 
diluted in DMEM to give a standardised concentration of 200mg/ml lung tissue. 
Using a 10-fold dilution; serial dilution of lung homogenates were made for fully 
confluent TK143 cells seeded in 24 well co-star plates (Corning Inc., Corning, NY). 
These cells were then infected with supernatant from lung tissue and then 
incubated at 37°C, 5% C02.  After 48 hours, cells were fixed with formalin and 
stained with 2% crystal violet in 40% methanol. Plaques were counted under a light 
microscope.  
2.6 Plaque Reduction Neutralization Tests (PRNT) 
Sera from infected and uninfected WT and Egr2-/-Egr3-/- mice were serially 
diluted in DMEM medium using a dilution factor of 1/10. Serially diluted sera were 
then co-incubated with an equal volume of pre-determined TCID50 of 2 x 104 
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PFU/ml for VVWR and allowed to incubate overnight at 37°C, 5% CO2. The next day, 
TK143 cells already seeded into a 24-well Co-star plate (Corning Inc., Corning, NY) 
and rinsed in serum-free medium. 100μl of virus-serum mixture was added to each 
well in duplicate and left to adsorb for 60 minutes at 37°C with periodic swirling. 
Following this, wells were washed with serum free medium and then normal 
growth medium was added and incubated for 48 hours at 37°C, 5% CO2 to allow 
plaques to form. After 48 hours, cells were fixed and stained with 0.1% crystal violet 
in 20% ethanol, and the plaques were quantified over a light microscope.  
2.7 Protein immunisation 
Baseline weights of sex, age and weight-matched WT and Egr2-/-Egr3-/- mice 
were determined on the day of immunisation. For protein immunisation, 250ug of 
OVA protein emulsified in complete Freund’s adjuvant (CFA) was administered by 
intraperitoneal (I.P) injection. OVA immunised mice showed no clinical pathology. 
Mice were also observed daily for dehydration, lethargy, fur appearance and agility. 
Serum was collected from mice by bleeding from the tail every 7 days from day 0 
through day 54 post OVA protein immunisation.  Serum, spleen and lungs were 
harvested from culled mice for further analysis.  
 
2.8 Enzyme linked immunosorbent assay (ELISA) for 
antibody isotyping  
Sandwich ELISA for antibody isotype was performed using antibody isotyping 
Kit (Sigma Aldrich) according to manufacturer’s instructions. Briefly, 96 well plates 
(Nunc, MaxiSorb) were coated with IgG1, IgG2a, IgG2b, IgG3, IgM and IgA 
antibodies diluted in carbonate-bicarbonate coating buffer (Sigma) and incubated 
overnight at 4°C. The following day, unbound antibodies were washed off the plates 
5 times for 5 minutes each using 0.05% Tween 20 in 1X PBS. Plates were then 
blocked in 10% FBS diluted in 1x PBS for 1 hour at room temperature to minimise 
unspecific binding and reduce background noise. Following blocking, Plates were 
washed again and 1/10000 dilution of sera from WT or Egr2-/-Egr3-/- mice were 
added.  
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For anti-OVA ELISA, plates were coated with 5ug/ml OVA protein diluted in 
carbonate-bicarbonate coating buffer (Sigma) and left to incubate overnight at 
4°C.the next days, plates were washed in 0.05% Tween 20 in 1X PBS and blocked 
using 10% FBS diluted in 1x PBS for 1 hour at room temperature. Following 
blocking, a pre-determined 1/1000 dilution of sera form OVA immunised mice or 
unimmunised mice for control were then added to the plates and left to incubate at 
RT for 1 hour. For antibody secreting cell polarisation assay, supernatant from cell 
culture were added to the wells at this stage. Samples were then allowed to 
incubate at room temperature for 1 hour.  
Following incubation of serum, samples were washed off and wells were 
incubated with HRP-conjugated rabbit anti-mouse immunoglobulins for 1 hour at 
room temperature. The wells were then washed and HRP substrate, 3,3', 5,5’-
Tetramethylbenzidine (TMB) solution (eBioscience) was added into each well to 
develop the detection enzyme. Plates were subsequently read on a photometer at 
450nm wavelength and optical density (OD) obtained.   
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2.9 Tissue preparation for histological analysis 
Fresh tissue samples were collected from sacrificed mice and placed in 1x 
PBS. For paraffin embedded sections, tissues were fixed immediately in freshly 
prepared 4% paraformaldehyde (PFA) at 3:1 w/v of tissue sample to fixative. This is 
done in order to preserve the tissue. Fixation with 4% PFA crosslinks proteins 
present within the tissue by covalent bonds. This prevents enzymatic degradation 
of the basic tissue component. Following overnight fixation at 4˚C, 4% PFA was 
replaced with 70% ethanol to wash out fixative. Tissues sections were then placed 
in embedding cassettes and passed through a process of dehydration, clearing and 
paraffin wax infiltration in a Shandon hypercenter XP tissue processor (table 2.2). 
Ascending concentrations of alcohol progressively dehydrates the tissue while 
xylene enables paraffin wax to permeate the tissues and also improve optics for the 
imaging of tissues. Following embedding, tissue samples were transferred into 
moulds which was then infiltrated with melted wax to form a cassette block that 
allows for easy handling and cutting on the microtome. Moulded sections are 
stored in a -20˚C freezer. 5µm-thick tissue sections are cut using a microtome. 
Sections were expanded at 45˚C in a water bath, collected and allowed to adhere to 
slides by heating at 65˚C for about 1 minute. 
For frozen sections, tissue samples were snap-frozen in liquid nitrogen. They 
were embedded in Tissue-Tek™ CRYO-OCT Compound (Thermo scientific) prior to 
sectioning on a cryostat. 8µm-thick sections were cut and left to air dry for about 30 
minutes. This was then followed by fixation in 1:1 acetone: methanol solution at 
-20˚C for 10 minutes. Sections were allowed to air dry for another 10 minutes 
before storing in -80˚C freezers.  
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Program Immersion Time  Drain time 
70% Alcohol  2 hours 15 seconds 
90% Alcohol 2 hours 15 seconds 
95% Alcohol 2 hours 15 seconds 
95% Alcohol 2 hours 15 seconds 
95% Alcohol 2 hours 15 seconds 
95% Alcohol 2 hours 30 seconds 
Xylene  2 hours 15 seconds 
Xylene 2 hours 30 seconds 
Wax 2 hours 1 minute 
Wax 2 hours 2 minutes 
Table 2.2: Program used for processing of tissue sections for H and E staining 
2.10 Haematoxylin and Eosin (H and E) staining 
H and E staining was done on paraffin embedded tissue sections in order to 
investigate morphology changes within these tissues (Fischer et al., 2008). 
Haematoxylin stains the chromatin of the nucleus blue while Eosin provides a 
contrast stain by staining the cytoplasm and other organelles reddish - pink.  The 
procedure for H and E staining involved de-paraffin of tissue sections in xylene for a 
total of 15 minutes. The tissue sections were then rehydrated in solutions of 
descending alcohol concentration for 3 minutes each in the following order: 100% 
X2 and 95% X 2. Following rehydration, slides were then dunked in distilled water 
before being incubated for 6 minutes in filtered acidified Harris haematoxylin 
solution. Slides were rinsed under running tap water and then bleached by dipping 
in acid alcohol. The bluing step was done by incubating sections in 0.2% ammonium 
solution for 40 seconds. This was followed by counterstaining using Eosin dye for 45 
seconds. After Eosin treatment, tissue sections are then dehydrated in ascending 
concentrations of alcohol and then cleared in xylene before mounting using a 
xylene based mounting agent, Histomount (National Diagnostics, HS-103). Stained 
sections were then allowed to dry overnight. Analysis of sections was done using a 
light microscope (Axioscope). Tissue sections were examined in a blind manner. 
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2.11 Immunofluorescence  
For paraffin sections, tissue sections were de-paraffined by heating at 65°C 
for 15 minutes followed by xylene treatment for another 15 minutes. Paraffin 
sections were then rehydrated in descending concentrations of alcohol (100%, 90% 
and 70%). Antigen retrieval was done by incubating sections in 10mM Tris/1mM 
EDTA, pH 9.0 for 20 minutes at sub boiling temperatures. This was done in order to 
release crosslinks formed by fixative and thus expose epitopes for maximal 
antibody-antigen binding. Following antigen retrieval, sections were blocked for 1 
hour at room temperature in 10% normal goat serum (Invitrogen,10379332) or 0.1g 
skimmed milk in 0.1% Triton X (Sigma,T-9284) diluted in 1X PBS. Primary antibodies 
were then added and incubated overnight at 4°C. The next day, excess unbound 
antibodies were washed off thrice in 1X PBS for 10 minutes each. Fluorochrome 
conjugated secondary antibody was then added to the sections and allowed to 
incubate for 1 hour at room temperature. This was followed by a wash step done 3 
times in 1X PBS for 10 minutes each.  Sections were then allowed to air dry and 
mounted using Vectashield (Vector laboratories, H-1200) which also counter stains 
the nucleus with DAPI. All antibody used for Immunofluorescence of paraffin 
embedded sections are listed in table 2.3.  
 
Antibody Company information Dilution  
Rabbit anti-Human/mouse CD3 DAKO, A0452 1/100 
Rat anti-Mouse CD45R/B220 BD BIOSCIENCES, 550286 1/20 
PNA-Biotin Sigma Aldrich, L1635 1/100 
Extravidin Tritc Sigma Aldrich, E3011 1/100 
Goat anti Rabbit Alexa Fluor 
594 
Invitrogen  A11037 1/400 
Goat anti Rat IgG FITC  Sigma Aldrich, F6258 1/200 
Table 2.3: List of antibodies used for Immunofluorescence staining of paraffin 
sections  
For frozen sections, tissue sections were incubated for 1 hour at room 
temperature with directly labeled primary antibodies for CD4-FITC (eBiosciences, 
11-0042-86), Alexafluor-647 conjugated IgD (Biolegend, 405708) and PNA TRITC 
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(Sigma Aldrich, L3766) or PNA-Biotin (Sigma Aldrich, L1635) that was detected using 
Extravidin TRITC (Sigma Aldrich, E3011).  Excess unbound antibodies were washed 
off thrice in 1X PBS before being left to air dry. Tissue sections were mounted using 
Vectashield (Vector laboratories, H-1200).  
Analysis of all sections from Immunofluorescence staining was done using a 
Zeiss fluorescence microscope equipped with a CCD camera and the Smart Capture 
software (Digital Scientific Cambridge, UK). 
2.12 Cell Isolation 
Secondary lymphoid organs were harvested from mice and homogenized to 
acquire single cell suspensions. Cells were washed in 1X PBS and collected by 
centrifugation at 1300rpm (300xg) for 5 minutes at room temperature. Red blood 
cells (RBC) were depleted by incubating cells in 0.8% ammonium chloride solution 
at 37°C for 5 minutes.  This causes lysis of the RBCs while maintaining the integrity 
of the white blood cell (WBC) population. The reaction was neutralized by the 
addition of 1x PBS and cells were then collected by centrifugation at 1300rpm 
(300xg) for 5 minutes. CD4+ or CD19+ cells were isolated using positive selection on 
Magnetic Activated Cell Sorting (MACS) kit (Miltenyi Biotec) according to the 
manufacturer’s instructions which are as follows; cells were suspended in beads 
buffer (PBS + 0.5% RPMI medium) and incubated with magnetic beads conjugated 
anti-CD4 (clone L3T4) (Miltenyi Biotec,130-049-201) or anti-CD19 (Miltenyi Biotec, 
130-052-201) antibodies at 4°C for 20 minutes with periodic agitation. Unlabeled 
beads were then washed and centrifuged at 1300rpm (300xg) for 5 minutes at 
room temperature. The cell pellet was then resuspended in beads buffer and 
passed through a moist LS+ magnetic column (Miltenyi Biotech, 130-042-401). 
Negative cells flow through the column while magnetic beads bound cells remain 
within the column, which was then washed. To elute cells, column was removed 
from magnetic field and passed through fully supplemented Roswell Park Memorial 
Institute (RPMI) 1640 medium. CD4+ and CD19+ cells were maintained in a 
humidified incubator at 37°C in 5% CO2 and grown in RPMI 1640 medium 
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supplemented with 300mg/L L-glutamine, 10% fetal bovine serum (FBS), 50μM β-
mercaptoethanol (2-ME), and 50μg/ml gentamycin (all from Invitrogen). 
2.13 Flow cytometry 
Flow cytometry is a technique used for the measurement of the physical and 
chemical properties of a cell including its size, density and complexity based on 
intensity of signals. The cells are passed through a fluidics system to a laser, which 
sends the signals to the appropriate detectors. These signals are then translated 
electronically so that the end user may be able to interpret their experimental data.  
This is done by the use of antibodies bearing fluorochromes that are able to attach 
to specific epitopes on the cells of interest and allow the emission of light signals. 
The antibodies used for this study were usually directly conjugated to a 
fluorochrome. Single cell suspensions were obtained after homogenising of tissue 
and isolation of cells of interest as described above (section 2.12). 2 x 106 cells were 
fluorescently labelled with antibodies and then incubated in the dark for 20 
minutes at room temperature. This step stains the surface markers and was used 
for cell surface staining of receptors. Antibodies used for surface staining include 
Fluorescein isothiocyanate (FITC)-conjugated antibodies to B220, PD-1, GL7 and 
CD4; eFluor 450 labeled antibody to CD4; phycoerythrin (PE)-conjugated antibodies 
to CD4, CD19, CD25, CD62L, CD69, IgM; PerCP labeled antibody to CXCR5 and B220; 
PE-cy7 labeled antibody to B220; and allophycocyanin (APC)-conjugated antibodies 
to CD44 all obtained from eBioscience. GL7 binds to a neuraminic acid derivative 
called α2-6-sialyl-lacNac and is commonly used as a marker for germinal centre B 
cells. Following surface staining, samples were fixed in fixation/permeabilisation 
(fix/perm) buffer (eBiosciences) for 20 minutes in the dark.  Fix/perm buffer was 
washed away using 1X PBS and was then followed by addition of permeabilisation 
(perm) buffer to the samples which were incubated at room temperature for 20 
minutes in the dark.  Perm buffer was then washed off using wash buffer and 
fluorescently labelled antibodies to nuclear proteins were added. Samples were 
incubated for 20 minutes in the dark at room temperature. Antibodies used for 
nuclear staining include allophycocyanin (APC)-conjugated antibodies to Egr2 and 
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phycoerythrin (PE)-conjugated antibodies to Egr2 and Bcl6 all obtained from 
eBioscience. Following nuclear staining, samples were resuspended in PBS and 
passed through the flow cytometer (Canto II, BD Immunocytometry systems). Data 
obtained from the flow cytometer were analysed using FlowJo software (Treestar 
Inc.). Cell sorting was performed on a FACSAria sorter with DIVA option (BD 
Immunocytometry Systems). Professor Ping Wang at Queen Mary University, 
London, performed flow cytometer runs and cell sorting.  
 
2.13.1 Intracellular cytokine staining 
For intracellular cytokine staining, isolated CD4+ cells were stimulated with 
0.2ug/ml PMA and 0.5ug/ml Ionomycin in the presence of golgi stopper to inhibit 
cytokine transport to the cell surface. The cells were then incubated overnight at 
37°c, 5% CO2. Cells were collected the next day and washed in PBS. Intracellular 
cytokine staining was performed using the Fixation & Permeabilisation Kit from 
eBioscience according to the manufacturer’s protocol. Antibodies specific for 
cytokines of interest were added to cells and cells were allowed to incubate for 20 
minutes at room temperature in the dark. Cells were then either resuspended in 
PBS and run on flow cytometer or fixed for nuclear staining step as described above 
(2.13).  
2.14 Invitro polarization assay  
2.14.1 Tfh Polarisation assay  
24 well co-star plates (Corning Inc., Corning, NY) were coated with anti-CD3 
at 1μg/ml and anti-CD28 (2μg/ml) antibodies for 1 hour at 37°C. Plates were 
washed with 1X PBS and then 2 x 106 CD4+ T cells were seeded into plates for 
stimulation. For generation of Tfh-like cells, 50ng/ml recombinant IL21, 10μg/ml 
anti-IFNγ, 10μg/ml anti-IL4 and 20μg/ml anti-TGF-β (1D11) all from R & D systems 
were added to growth medium.  For Th0 conditions, neither cytokine stimuli nor 
neutralizing antibodies were added. Cells were then incubated at 37°C, 5% CO2. 
After 4 days, all cells were collected for flow cytometry and RT-PCR analysis.  
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2.14.2 Antibody-secreting cell (ASC) Polarisation assay 
25 x 106 CD19+ positive cells were seeded into 6 well co-star plates (Corning 
Inc., Corning, NY). Cells were then stimulated using either 1μg/ml anti-CD40 
(eBiosciences), 10ng/ml recombinant IL4 (rIL4) (eBiosciences) or 20μg/ml 
Lipopolysaccharide (LPS) (Sigma-Aldrich) and rIL4 10ng/ml to generate antibody-
secreting cells. For control, one group of cells had no cytokine treatment, mitogenic 
stimulation or CD40 agonist. Cells were then incubated at 37°C, 5% CO2. After 4 
days, cells were collected for RT-PCR analysis while supernatant was collected for 
antibody isotyping.  
2.15 Lentiviral Transduction 
Lentiviruses are of the virus family retroviridae and are capable of integrating 
their genetic material into host’s genome. Hence they are widely used as an 
effective vector system to deliver genetic material into a host. Lentiviral expression 
utilizes a system whereby viral genes 5’-gag- pol-env-3’ are manipulated for the 
effective transmission of genetic materials. These integrate into the genome of the 
host without resulting in the production of infectious viral particles within this host 
(Swift et al., 2001; Pear et al., 1993).  Dr. Tizong Miao at Bart’s and the London 
School of Dentistry and Medicine, Queen Mary University of London, carried out 
generation of lentivirus. 
 
2.15.1 Gene isolation and cloning 
Open reading frame (OPF) containing mouse cDNA sequence for Egr2 and 
Bcl6 were tagged with flag protein (Plasmid construct and cDNA sequence were 
obtained by Dr Tizong Miao, Barts and the London School of Dentistry and 
Medicine, Queen Mary University of London). These were then amplified by PCR 
using Platinum Pfx DNA Polymerase kit (Invitrogen, Life Technologies) according to 
the manufacturer’s instructions. The PCR step involved the denaturing, annealing 
and extension steps which were repeated for between 30-35 cycles. The primers 
used for Egr2 cloning were sense 5’- 
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ACTCAGATCTCGAGGCCACCATGGACTACAAAGACGATGACGACAAGACCGCCAAGGCCG
TAGAC -3’ and anti-sense 5’- AGCTAGCTAGCGAGAATTCCTACAATTCCGG -3’,  while 
those for Bcl6 were sense 5’- AAGCTGGCTAGCGCCGCCATGGCCTCCCCGGCTGAC -3’ 
and anti-sense 5’- AGGGGCGGATCCTCAGCAGGCTTTGGGGAGC -3’.  
2.15.2 Restriction digestion and ligation of gene and plasmid 
vector 
The cloned cDNA and plasmid vector (pcDNA3.11(-)-IRES EGFP.gb) were 
then digested with appropriate restriction enzymes. In order to limit self-ligation, 
linearized plasmid DNA were treated with calf intestine phospahatase (CIP) for 10 
minutes at 37˚C. This causes dephosphorylation of 5’ and 3’ ends of nucleic acids to 
prevent re-ligation. Digests were run on 0.8% agarose gel and gels were then 
purified using the QIAquick gel extraction kit (Qiagen) protocol. Purified cDNA and 
plasmid were then ligated for 2 hours at room temperature.  
2.15.3 Transformation of bacteria cells and purification of 
plasmid DNA  
Transformation involved freeze-thawing of bacteria cells to create 
perforated and tensed cell membrane to allow bacteria take up ligated plasmid 
DNA containing the gene of interest. 10-beta Competent E. coli (C3019) cells (New 
England Biolabs) were used for bacteria transformation. Transformation was done 
by incubating bacteria-Plasmid mixture on ice for 5 minutes, followed by heating at 
42°C for 30 seconds and then placed on ice again for a further 5 minutes. The cells 
were then treated with Super Optimal broth with Catabolite repression (SOCS) 
medium (Sigma Aldrich) at 37°C for 1 hour at 225rpm. SOCS medium is a nutrient 
rich growth medium that improves the transformation efficiency. The transformed 
bacteria cells were then spread on Luria-Bertani (LB) solid Agar plate (10g/L NaCl, 
10g/L Tryptone, 5g/L Yeast Extract, 2g/L Agar) supplemented with ampicillin 
antibiotic at 100μg/μl for antibiotic growth selection. Bacteria were then incubated 
overnight at 37˚C to grow. Positive bacteria colonies where isolated from agar plate 
and grown overnight in a small volume of LB broth (10g/L NaCl, 10g/L Tryptone, 
5g/L Yeast Extract) supplemented with ampicillin antibiotic. This was incubated at 
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37°C overnight while shaking. Plasmids were then extracted from selected positive 
bacteria using the mini-prep kit from Qiagen according to the manufacturer’s 
instruction.  Briefly, buffers that lyse the bacteria wall resulting in the release of 
plasmids were added (buffers P1 and P2). Plasmid DNA and protein is then 
precipitated in N3 buffer. The lysate was then passed through a silica-gel 
membrane, coated with PB buffer which binds DNA as it pass through column. The 
column was then washed with a PE buffer to discard contaminants and plasmid 
DNA is eluded with EB buffer. Concentration of plasmid DNA was measured using a 
Nano-drop. Plasmids were sent for sequencing to confirm successful gene 
incorporation and that the orientation and position of the insertion was correct. 
Sequencing was done by SourceBioScience.  
 
2.15.4 Transfection of plasmid into lentivirus 
Egr2 and Bcl6 containing plasmids were assembled between two long 
terminal repeats (LTR) regions containing viral genes 5’-gag-pol-env-3’ within the 
lentivirus (PRRL-MCS+gb). Empty lentivirus was used as a negative control. Lentiviral 
construct was then transfected into packaging cell lines using lipofectamin plus 
reagent (Gibco). Once the lentivirus vector is inside the cell, it starts to transcribe 
viral RNA gag, pol, and env along with ψ. This helps it to assemble virions that bud 
off the cell. The virions, now in the supernatant were then collected by 
ultracentrifugation and then quantified to 109 transducing unit per ml. As Egr2 and 
Bcl6 expression constructs were labelled with IRES GFP, Egr2 OR Bcl6 expressing 
cells were isolated by fluorescence activated cell sorting.  
For transfection into Egr2-/-Egr3-/- CD4 cells, 1 x 106 CD4 cells from Egr2-/-Egr3-
/- mice were seeded into each well of a 24 well plate and stimulated with plate 
bound anti-CD3 and anti-CD28. They were then infected with concentrated 
lentivirus at a multiplicity of infection (MOI) of 50–100 (~105–106 transducing 
units/ng of p24). The infected cells were incubated at 37°C for 7 hours while gently 
shaking before addition of growth medium. Positive cells were sorted after 24 
hours using GFP to select.  
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2.16 Adoptive transfer experiments 
Adoptive transfer experiments were all carried out by Dr Su-Ling Li and 
Professor Ping Wang at the animal facility in Brunel University. Briefly 2 x 106 CD4+ T 
or B cells were isolated from 4-week old wild type mice and were then suspended 
in 100µl of physiological saline. This was then injected intravenously into the tail 
vein of 6 week old Egr2-/-Egr3-/- mice. 24 hours after adoptive transfer of cells, the 
recipient mice were infected with VVWR intranasally and samples collected for 
analysis 14 days after infection.  
For RAG-/- adoptive transfer experiments, 2.5 x 106 WT CD4+ T and 2.5 x 106 B 
cells from Egr2-/-Egr3-/- mice, or 2.5 x 106 WT B cells and 2.5 x 106 CD4 cells from 
Egr2-/-Egr3-/- mice were suspended in 100µl of physiological saline. This was then 
injected intraveneously into the tail vein of RAG-/- mice. Forty days following 
adoptive transfer, RAG-/- mice were infected intranasally with VVWR as earlier 
described.  
For adoptive transfer of Egr2 and Bcl6 expression construct into Egr2-/-Egr3-/- 
mice, 106 transduced Egr2-/- Egr3-/- CD4+ T cells were suspended in 100ul of 
physiological saline which was then injected intravenously into the dorsal tail vein 
of CD2-Egr2-/-Egr3-/- mice. 24 hours after transfer, mice were infected with 2 x 105 
PFU of vaccinia virus. Analyses of Tfh and GC B cells differentiation as well as GC 
formation were done 14 days post-infection. 
2.17 RNA extraction 
Extraction of total RNA from cells was done using Trizol reagent (Invitrogen). 
Trizol contains phenol and guanidine isothiocyanate, which denatures proteins like 
RNAse and is capable of separating RNA, DNA and proteins from cells (Chomczynski, 
1993; Chomczynski and Sacchi, 1987). RNA extraction was performed according to 
the manufacturer’s protocol. Briefly, cells were collected in a pellet and then lysed 
in 1ml of Trizol reagent per 10 x 106 cells. This was then allowed to incubate at 
room temperature for 10 minutes. 300μl of chloroform was next added to the 
samples after which the samples are vortexed thoroughly. Samples were then 
incubated for 5 minutes after which they were centrifuged at 13000 rpm (300xg)  
  
  
                                                                                    Chapter 2 – Materials and Methods 
 
67 
 
for 15 minutes at 4°C.  The chloroform increases the efficiency of separation by 
pushing organics to the bottom layer and generating a clearer aqueous phase.  
After centrifugation, the sample separates into a lower red organic phase, 
interphase and a colourless aqueous upper phase. The RNA which is contained in 
the aqueous phase was transferred into a separate tube and precipitated with 
equal volume of isopropanol. This is because nucleic acids like RNA are insoluble in 
alcohol and so can be precipitated from the solution. 2µl of glycogen is added as a 
co-precipitant to ensure maximum RNA recovery. Samples were then incubated at 
−20°C for 1 hour and then centrifuged at 13000rpm (300xg)  for 10minutes at 4°C. 
RNA pellet formed at the bottom of the tube was then washed in 80% ethanol and 
re-suspended in RNAse free water and its concentration measured using a Nano-
Drop.  
2.18 cDNA Synthesis  
Isolated RNA was transcribed into cDNA using SuperScriptTM III (Invitrogen). 
This is a reverse transcriptase enzyme with high thermostability. Reverse 
transcriptase catalyses the production of new complimentary strands of DNA using 
isolated RNA as a template. mRNA concentration was normalised to 2ug per sample 
for cDNA synthesis. Denaturing step was first done with mRNA and 0.5µg oligoDT or 
random primers which were heated to 70°C for 5 minutes in order to denature 
secondary structures associated with the RNA and also to optimise binding of 
nucleotides. OligoDT or random primers have nucleotides that bind to mRNA poly-A 
tails in order to initiate transcription. Following this, 500μM each of dATP, dTTP, 
dCTP, dGTP, 0.01M Dithiothreitol (DDT), 2 Unit/μl of RNase Inhibitor and 10 
Units/μl of SuperScriptTM Reverse Transcriptase in 1x First Strand Buffer (all 
Invitrogen) were all added into each tube. The reaction was mixed and heated to 
25°C for 5 minutes followed by another round of heating at 50°C for 1 hour. The 
reaction was then inactivated by heating to 70°C for 15 minutes. The samples were 
then stored at -20°C for future use. 
2.19 Real time PCR 
 The principle behind Real Time PCR is similar to that of genomic PCR. It differs 
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in the fact that it allows for the real time quantitative comparison of relative gene 
expression profiles between experimental samples or conditions against a 
housekeeping or endogenous gene (Pfaffl, 2001). This is done with the aid of 
primers and a fluorescent dye called SYBR Green. SYBR green is incorporated into 
the nucleic acid with each new synthesis. Following this new synthesis, the amount 
of new copies of a product is then calculated in real time by measuring the 
fluorescence (Morrison, Weis and Wittwer, 1998).  
 Primers were designed so as to be between 20-23 nucleotides long and have a 
G/C content of at least 50%. In addition to these, sense and antisense primers were 
designed so that they anneal to different exons on the gene of interest. These 
primers contain the intervening introns in addition to the identified exons thus 
making them larger and detectable via electrophoresis. The melting temperature 
(Tm) of each primer was estimated using the Wallace rule (Tm = 4 × [G + C] + 2 × [A 
+ T]) and the annealing temperature was initially set to Tm − 2°C and altered as 
necessary. All primers were blasted on the NCBI primer blast software. Primers 
used for Real Time PCR are shown in table 2.4 
 Real time PCR was performed with the QuantiTect SYBR Green PCR kit 
(Qiagen) according to the manufacturer’s instructions. Briefly, 2μl of cDNA from 
samples were added to sense and antisense primers of genes of interest to a final 
concentration of 0.2μM in 1x SYBR Green Master Mix. Real Time PCR was 
performed using the Rotor-Gene system (Corbett Robotics) and the following 
programme: 
 Step 1:  Denaturing of DNA and antibody bound to DNA polymerase at 95°C 
for 10min  
 Step 2: Denaturing at 95°C for 20s  
 Step 3: Annealing at 58°C for 30s  
 Step 4: Extension at 72°C for 20s  
Steps 2-4 were repeated for 30-40 cycles. After each cycle, the level of SYBR green 
was read. Melting curve analysis was performed at the end of the entire run in 
which the level of fluorescence intensity was measured as the temperature rises 
from 50°C to 99°C.  As the melting temperature for a DNA molecule is reached, 50% 
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of that DNA is denatured to become single strand DNA. This is evident by a 
decrease in the level of fluorescence in the melting curve. Hence, melting curve is 
able to identify non-specific binding to primers and the formation of primer dimers. 
After PCR reaction, samples were run on a 0.8% agarose gel electrophoresis to 
confirm the quality and size of the product. 
 
Gene Primer Sequence (5’ – 3’) 
Β-Actin Sense AATCGTGCGTGACATCAAAG 
Antisense ATGCCACAGGATTCCATACC  
Bcl6 Sense  GCAGTTTAGAGCCCATAAGAC 
Antisense GCCATGATATTGCCTTCCCT 
(Prdm1) Blimp1 Sense AACCTGAAGGTCCACCTGAG 
Antisense TGCTAAATCTCTTGTGGCAGAC 
Cxcr5 Sense TATGGATGACCTGTACAAGGA 
Antisense AGGATGTTTCCCATCATACCC 
Egr2 Sense AGAAGGTTGTGATAGGAGGT 
Antisense GGATGTGAGTAGTAAGGTGG 
Egr3 Sense CGACTCGGTAGCCCATTACAATCAGA 
Antisense GAGATCGCCGCAGTTGGAATAAGGAG 
Ascl2 Sense TACTCGTCGGAGGAAAGCA 
Antisense CTAGAAGCAGGTAGGTCCAC 
SH2D1A Sense CCTGTAATAGCATCTCGCCTGAT 
Antisense AGTTTTCCAATCCGCACTTTAAAG 
IRF4 Sense CAGCTCATGTGGAACCTCTG 
Antisense TTGTTGTCTTCAAGTGGAAACCC 
ICOS Sense CAAGAAAGGAACCTTAGTGGA 
Antisense CACTATTAGGGTCATGCACAC 
IL-21 Sense CTCAAGCCATCAAACCCTGG 
Antisense CATACGAATCACAGGAAGGG 
Table 2.4: Primer list for RT-PCR 
2.19.1 Real Time RT-PCR Data Analysis  
Data obtained from RT-PCR were analysed using the Rotor-Gene Software. 
During each reaction, the amount of DNA molecules doubles in a phase known as 
the exponential phase. Eventually, the reaction reaches a plateau phase when the 
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reagents become limiting and increase is not as significant as the exponential 
phase. A threshold value was decided at the point when the reaction is still in an 
exponential phase and the number of cycles (Ct) necessary in order for the 
florescence to reach this threshold is calculated for each run. Ct values for each 
gene are then compared against those of reference endogenous genes (mouse β-
actin or Gapdh) in order to normalise the results. The relative expression was then 
calculated with the ΔΔCt method using the following equation: 2^ (-(Ct target gene 
– Ct Housekeeping gene)) x10000 (Livak and Schmittgen, 2001; Pfaffl, 2001). For 
consistency and rigour of results, samples were all run in triplicates.  
2.20 Microarray 
Microarray is a technique that permits genome wide gene expression 
analysis of cells in order to investigate biological differences. CD4+ T cells from wild 
type and Egr2-/- Egr3-/- mice were isolated as earlier described in section 2.12. Some 
cells were then were stimulated using anti-CD3 and anti-CD28. Total RNA was 
extracted from the cells and purified using RNAeasy kit RNA clean up protocol 
according to the manufacturer’s instructions. Reverse transcription into cDNA was 
done using the method described in section 2.18. Purified RNA was processed in 
the Genome centre at Queen Mary University, London. Here, RNA from the cells 
were fluorescently labeled and hybridized on to Illumina MouseRef-8 v2.0 BeadChip 
expression arrays. These arrays are made up of polymerized oligonucleotide probes 
that are able to recognize over 25,000 RefSeq transcripts from mice and thus RNA 
bind to complimentary sequences. Following hybridization, unbound RNA is washed 
away and array is then scanned to visualize bound RNA. Array data were analysed 
by Dr. Alistair Symonds at Barts and the London School of Medicine and Dentistry, 
Queen Mary University of London using R software for analysis. Briefly, the data 
was normalized at the ‘core genes’ level using the robust multi-array average (RMA) 
method as implemented in the Bioconductor oligo package. The data was filtered to 
remove transcripts that had more than 50% of probe sets with detection above 
background p-value greater than 0.05 and transcripts with cross-hybridizing probe 
sets. Scatterplots were created using the ggplot2. Using the clustering algorithm 
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method, genes were grouped based on self-organization maps (SOMs). SOMs were 
then further clustered using a hierarchical-clustering programme. Microarray data 
are available from the ArrayExpress database (www.ebi.ac.uk/arryexpress) under 
ArrayExpress accession number: E-MTAB-2432.  Genes of interest that are involved 
in inflammation and the regulation of follicular helper T cell differentiation were 
further validated using RT-PCR.   
2.21 Protein Extraction and Quantification 
To extract proteins, cells were isolated as described above (section 2.12) and 
washed in PBS. 100μl of CelLytic M lysis buffer (Sigma, C2978) was then added to 
the cells according to manufacturer’s instructions. CelLytic M lysis buffer is a mild 
detergent that lyses the cells to liberate proteins. In addition to lysis buffer, 1mM 
PMSF (Phenylmethylsulfonyl fluoride) and protease and phosphatase inhibitors 
(Roche) were also added. The cells were then swelled in a hypotonic buffer for 15 
minutes on ice. The cell samples were then centrifuged at 13000rpm (300xg) for 5 
minutes at 4˚C to separate cell debris from protein.  The protein, which was now in 
the supernatant, was collected and quantified using Bradford assay. Briefly, a 
standard curve of absorbance was plotted against the concentration of Bovine 
serum albumin (BSA) by serially diluting purified BSA from 0mg/ml to 10mg/ml. 
freshly prepared proteins were the measured against the BSA standard curve. 
Extracted proteins are then stored in -80˚C for future use. Protein extraction and 
quantification was done by Dr Tizong Miao at Barts and the London School of 
Medicine and Dentistry, Queen Mary University, London 
2.22 SDS PAGE Electrophoresis and Western blotting  
Extracted protein samples were incubated at 95˚C for 5 minutes in 1x LDS 
buffer (Invitrogen) and 2-β mercaptoethanol. This was done in order to denature 
the proteins.  Protein samples were mixed with 5μl of Novex® Sharp Pre-stained 
protein standard (Invitrogen) and loaded into wells on a 12% NuPAGE® Bis-Tris 
Precast Gel (Invitrogen) along with 5μl of Rainbow molecular marker (Amersham). 
The gel was then run using Bio-Rad Western apparatus in 1X SDS-PAGE running 
buffer at 200V for 35 minutes at 4°C. 12% NuPAGE® Bis-Tris precast Gel is an SDS-
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PAGE (Sodium Dodecyl Sulphate PolyAcrylamide Gel Electrophoresis) based gel 
which is capable of separating a wide range of proteins based on molecular 
weights. Sodium dodecyl sulphate was used to coat the proteins in order to confer 
on them the negative charge from the suphate groups. This allows the protein to 
migrate based on their sizes and electric charge within the matrix of the 
polyacrylamide gel. Separated proteins on gel were then transferred to transfer 
buffer-immersed nitrocellulose membrane (Amersham) by placing the gel above a 
nitrocellulose membrane. Whatman filter paper was placed on either side of the 
membrane. These were all then placed in a cassette in a wet transfer system.  
Transfer was done for about 1.5 hours at 30V at 4˚C to allow negatively charged 
protein to transfer onto nitrocellulose membrane, which traps it while retaining the 
same alignment as in the gel.  
Following transfer, the nitrocellulose membrane was blocked in 5% w/v milk 
in TBST (Tris Buffered Saline with 0.1% Tween 20) for 1-2 hours at room 
temperature in order to prevent non-specific binding. Primary antibodies against 
Egr2 (Covance) and Egr3 (Santa Cruz) were then added on the membrane and 
allowed to incubate overnight at 4˚C with agitation. The following day, the 
membranes were washed 3 times in TBST to remove all unbound primary 
antibodies. Polyclonal goat anti-rabbit horseradish Peroxidase conjugated 
antibodies were then diluted in blocking solution and incubated with the 
membrane for 1 hour at room temperature. Secondary antibody enables the 
detection of primary antibody bound to the protein of interest. Following 
incubation with secondary antibody, the membrane was washed 3 times in TBST for 
15 minutes each at room temperature to remove unbound secondary antibody and 
then transferred onto cling film. Detection was done by chemiluminescence using 
the ECL plus kit (Amersham) according to the manufacturer’s instruction. This kit 
contains a reagent that is oxidised by HRP to produce a luminescent signal, which 
can be detected by exposing photographic film to the membrane and then 
subsequently developing this film. Dr. Tizong Miao did western blot as described in 
Li et al., 2012 
  
  
                                                                                    Chapter 2 – Materials and Methods 
 
73 
 
2.23 Chromatin Immunoprecipitation 
Chromatin Immunoprecipitation (ChIP), as a laboratory technique, allows for 
the investigation of interactions between proteins and regions of genomic DNA in 
vivo (Carey, Peterson and Smale, 2009). Protein is crosslinked to DNA and then 
precipitated out of the solution. This is followed by purification and detection of 
bound DNA via PCR or other methods of choice. Dr Tizong Miao at Barts and the 
London School of Medicine and Dentistry, Queen Mary University of London, 
performed chIP. Briefly, 5 x 107 CD4 T cells from WT and CD2-Egr2-/- Egr3-/- mice 
were stimulated with plate bound anti-CD3/anti-CD28 for 16 hours after which 
protein and DNA were crosslinked in 1% formaldehyde for 10 minutes at room 
temperature as described by Solomon, Larsen and Varshavsky (Solomon, Larsen 
and Varshavsky, 1988). Crosslinkage holds protein and DNA together and prevent 
dissociation caused by cell lysis. Crosslinking was stopped with 125mM glycine 
followed by washing of the cells in PBS. Cells were lysed in 1% SDS, 10mM EDTA, 
50mM Tris pH8 and chromatins were then sonicated to shear them into around 
300-1000bp using a Diagenode Bioruptor. Sonication was done on a high output 
setting with 30 seconds sonication separated by 30 seconds intervals for a total of 
10 minutes. To verify sonication, a small volume of chromatin was reverse 
crosslinked by heating at 65˚C overnight and running on a gel. Sonicated chromatin 
was then blocked for 1 hour at 4°C using salmon sperm DNA (ssDNA)/BSA-blocked 
Protein A beads (Amersham) to eliminate any non-specific DNA binding. Anti-Egr2 
antibody or anti-Ig (negative control), were then added to the samples and left to 
incubate overnight at 4˚C. The purpose of adding the antibody is to enable Egr2 
antibody to bind to the Egr2 protein and any associated DNA present within the 
sample. The antibody-protein-DNA complex was then precipitated out using 
ssDNA/BSA-blocked Protein A beads from Staphylococcus Aureus conjugated to 
agarose beads. Protein A binds to the constant region (Fc) region of 
immunoglobulin and the insoluble agarose causes these complexes to be found in 
the pellet after centrifugation. Pellets were then washed in buffers of increasing 
ionic strengths before resuspension in elution buffer containing SDS, which 
denatures protein, A beads and release the immunoprecipitated chromatin 
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complexes. Heating at 65˚C overnight reverses Crosslinks and DNA was purified 
using phenol chloroform extraction and ethanol precipitation. The DNA was 
subsequently used as a template for PCR with specific primers which are listed in 
table 2.5. 
Primer Sequence 5’ – 3’ 
Bcl6 site 1 (Intron 1) Sense GAAGATGAACTGGATTCCTCCC 
Antisense CCCTCAAAGCTCTTAACCGA 
Bcl6 site 2 (Promoter-1) Sense AAAGGTGAATACAGGGCAGAC 
Antisense GAAACAAGAGTCTCACTCATCC 
Bcl6 site 3 (Downstream -1) Sense TGAATCACGGATGCATAAATGG 
Antisense TGACCGACAGACATTCACAG 
Table 2.5: Primer sequences used for Chromatin Immunoprecipitation  
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2.24 Electrophoretic Mobility Shift Assay (EMSA) 
EMSA is a highly sensitive technique that can be employed to investigate the 
DNA binding affinity of a protein (Hellman and Fried, 2007). The principle behind 
EMSA is that heavier organic fragments like DNA-Protein complexes migrate 
through a non-denaturing gel slower and so interactions between protein-DNA can 
be detected. It involves a simple procedure where a consensus region of DNA is 
labelled with a radioisotope or a fluorescent dye (hot probe). This is then incubated 
with a protein of interest and then other DNA site (cold probe) are added in to this 
reaction to compete for protein binding (Hellman and Fried, 2007). Specificity of 
protein-DNA complex binding is confirmed by the addition of protein specific 
antibody which creates a supershift due to heavier complex formation which results 
in an even greater retardation of migration. EMSA was performed by Dr Tizong 
Miao at Barts and the London School of Medicine and Dentistry, Queen Mary 
University of London. For competition, 40μM of sense and antisense 
oligonucleotides from potential Egr2 binding sites on the Bcl6 gene locus were 
generated. These were added together and heated at 95°C for 5 minutes before 
being left to cool at room temperature. Heating at high temperatures is aimed at 
denaturing secondary structures associated with the oligonucleotides so as to 
enhance their binding to complementary sequences upon cooling. The Bcl6 
oligonucleotides used are; Bcl6-1 (Chr16, 23983443-23983464) 5’-
GGAGGGGGCGGGGGAGACAGCT-3’; Bcl6-2 (Chr16, 23990225-23990248) 5’- 
TTGCCCTCCTACTCATCCCTGGAT -3’; and Bcl6-3 (Chr16, 23964461-23964482) 5’- 
ACACAGGAGGAGGTGGCTGAGT -3’). The consensus probe for Egr2 binding (5’ 
TGTAGGGGCGGGGGCGGGGTTA -3’) was labelled with a fluorescent dye cyanine 5.5 
(Sigma Aldrich). This consensus probe was then incubated for 40 minutes at room 
temperature with Egr2 nuclear extracts from CD4 T cells stimulated with anti-CD3 
and anti-CD28 for 16 hours, and then re-stimulated for 30 minutes with PMA and 
Ionomycin in a buffer containing 10mM HEPES pH 7.5, 50mM KCl, 2.5mM MgCl2, 
10mM DTT, 1μg poly (dI-dC), 10% glycerol, 0.5mM ZnCl2 and 5mM spermidine. 
Oligonucleotides from Bcl6 genes locus was then introduced as competition for 
Egr2 binding. For supershift, anti-Egr-2 antibody (eBiosciences) were added after 10 
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minutes of incubation and the samples were electrophoresed on 5% non-
denaturing polyacrylamide gels composed of 30% Acrylamide in 1ml, 300μl of 10x 
TBE, 100μl of 10% APS, 20μl TEMED, 4.6ml of water to give a final concentration of 
0.5x Tris Borate EDTA (TBE). The gels were scanned using an Odyssey Imager (LI-
COR) 
2.25 Statistical analysis 
All data presented within this study were expressed as mean ±SD. All 
Statistical analysis for ELISA was done using two tailed Student’s unpaired t-test 
while the frequency of cells from flow cytometry experiments were analysed using 
Mann-Whitney’s U test. Weight loss data was analysed by two-way analysis of 
variance (ANOVA) using Prism software. These tests determine the level of 
statistical significance of differences between various groups/samples. Only 
p-values of <0.05 were considered to be statistically significant. Microarray data 
was analysed by Dr. Alistair Symonds at Barts and the London School of Medicine 
and Dentistry, Queen Mary University of London using R statistical software. 
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3.1 Identification of the CD2-specific Egr2-/- (CD2-Egr2-/-) mice 
and Egr3-/- mice 
This study was carried out using CD2-specific Egr2-/- (CD2-Egr2-/-) mice and Egr3-
/- mice. 
Neonatal fatalities involving hind brain development is experienced in mice 
with systemic knockout (KO) of the Egr2 gene (Poirier et al., 2008; Topilko et al., 
1994; Schneider-Maunoury et al., 1993). Due to this reason, conditional KO of the 
Egr2 gene was created in our mice to allow for the study of the physiological 
functions of Egr2 in the immune system including organ pathology, Tfh 
differentiation and GC formation. 
 Conditional KO was created using the lymphocyte specific CD2 promoter 
(TURNER et al., 2006). This promoter, a 50KDa protein, is reported to become 
activated in the double negative 3 (DN3) stage of thymocyte development (TURNER 
et al., 2006). It has also been reported to be active in murine mature B cells (Kingma 
et al., 2002; SINKORA et al., 1998).  CD2-specific Egr2-/- mice used for this study 
were generated within our research group as previously described (Zhu et al., 
2008). Briefly, using the Cre-Loxp method, mice with floxed Egr2 gene were cross 
bred with hCD2-Cre mice. This generates mice with a CD2 specific KO of the Egr2 
gene (Zhu et al., 2008). These mice were then further cross bred with Egr3-/- mice 
(Tourtellotte and Milbrandt, 1998) to establish the CD2-Egr2 -/- and Egr3-/- mice 
referred to in this thesis as Egr2-/- Egr3 -/- mice.  
Before use in any experiment, KO mice were authenticated for the complete 
excision of the Egr2 and Egr3 genes by Polymerase Chain Reaction (PCR). This was 
done using DNA extracted from tails of the mice and primers for Cre, Loxp and Egr3 
genes. Only mice homozygous for the Loxp allele and retain the presence of Cre 
gene and Egr3 Neomycin cassette (Neo) were used for further studies (figure 3.1.1). 
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Figure 3.1.1: PCR products obtained from genotyping of CD2-specific Egr2-/- and 
Egr3-/-. The PCR analysis of genomic DNA of transgenic Egr2-/- Egr3 -/- mice show 
bands for PCR products of Cre, LoxP, Egr3 and Neo alleles in transgenic mice. CD2-
specific homozygous deletion of Egr2 was evident in mice expressing only LoxP 
homozygous bands and Cre PCR product while mice with Egr3 homozygous deletion 
were those that expressed the neomycin-resistant cassette that disrupts the Egr3 
gene.  Lane 1 shows Egr2 heterozygous and Egr3 heterozygous, lanes 2 and 3 show 
Egr2 homozygous and Egr3 heterozygous, lanes 4, 6 and 7 show Egr2 homozygous 
and Egr3 homozygous and lane 5 shows Egr2 heterozygous and Egr3 homozygous. 
Only mice with homozygous deletion for both Egr2 and Egr3 allele (lane 4, 6, 7 – 
lane 4 highlighted in red) were considered for this study.  
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Deletion of the Egr2 and Egr3 genes were confirmed at protein level in T and 
B cells by flow cytometry (figure 3.1.2 - performed by Prof. Ping Wang and Dr. 
Tizong Miao) and western blot (Li et al, 2012). 
 
Figure 3.1.2: Absence of Egr2 protein expression in Egr2-/-Egr3-/- mice  
Flow cytometry analysis of the Egr2 genes using Egr2 specific antibody confirms the 
absence of Egr2 protein in CD4 T cells in Egr2-/- Egr3-/- mice. This has also been 
shown by Li et al (2012) who analysed the Egr2 expression in CD4 T cells and B cell 
by western blot (Li et al., 2012) 
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3.2 Inflammation pathology in Egr2-/- 
Egr3 -/- mice 
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3.2.1 Histological analysis of Inflammation pathology in Egr2-/- Egr3 
-/- mice 
 We have previously reported that Egr2-/- Egr3-/- mice present with chronic 
inflammation evident by the high levels of serum pro-inflammatory cytokines 
including GM-CSF, IFNγ, IL-17 and IL-6(Miao et al., 2013; Li et al., 2012). Li et al., 
2012 were further able to demonstrate that Egr2 and Egr3 genes control 
inflammation by the regulation of the suppressors of cytokine signalling (SOCS) 1 
and 3 genes. SOCS 1 and 3 are inhibitors of the activity of STAT1 and STAT3. Our 
group has also previously elaborated how the absence of Egr2 and Egr3 genes 
posits the rapid development of inflammatory autoimmune syndrome with high 
levels of serum immunoglobulins (Ig) and lymphoid infiltrates into numerous organs 
(Li et al., 2012). Although, the development of autoimmunity in Egr2-/- Egr3-/- mice 
model has already been well established (Li et al., 2012), the link between 
inflammation and the progressive pathology in the Egr2-/- Egr3-/- mice is yet to be 
investigated. Therefore, I sought to investigate the correlation between chronic 
inflammation and the development of systemic inflammation pathology in the Egr2-
/- Egr3-/- mice. 
 To achieve this, morphological analysis of multiple organs including the 
spleen, lung, liver and kidney from Egr2-/- Egr3 -/- mice was carried out at different 
ages.  Histological analysis showed that young Egr2-/- Egr3-/- mice of about 1 month 
old did not display any signs of inflammation pathology and the morphology of their 
organs was very similar to their WT counterpart (figure 3.2.1). However, at 2 
months of age, Egr2-/- Egr3-/- mice started to show the presence of lymphocyte 
infiltrates in the liver (figure 3.2.2). Using macrophage marker CD11b, early organ 
pathology with a change in cellularity and loss of splenic architecture was observed 
in Egr2-/- Egr3 -/- mice from this age (figure 3.2.5). This was consistent with previous 
publications from our group where we reported signs of chronic inflammation and 
high pro-inflammatory cytokines from this age (Miao et al., 2013; Li et al., 2012). 
From 3 months of age, other signs of chronic inflammation pathology including 
increased damage to tissues were observed. There were also changes in the splenic 
architecture including splenomegaly which was accompanied by the disintegration 
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of the white pulp area. The liver of 3 - 4 months old Egr2-/- Egr3 -/- mice showed the 
presence of infiltrating lymphocytes especially around the blood vessels. The alveoli 
of the lungs were reduced and septa generally showed enlargement and increased 
cellularity suggesting prolonged inflammatory response (see figure 3.2.3). 
Lymphocyte infiltration was more remarkable in aged Egr2-/- Egr3-/- mice (figure 
3.2.4). After 5 months of age, there was severe white pulp fragmentation as seen by 
CD11b staining (figure 3.2.5). There were no longer distinctions between white pulp 
and red pulp areas (figure 3.2.5). Chronic inflammation often results in organ 
pathology and this may have eventually led to the total splenic derangement and 
increased cellularity observed in the glomerulus of the kidney in aged Egr2-/- Egr3 -/- 
mice as well as the massive lymphocyte infiltration into the kidney, liver and lungs 
of these mice (figure 3.2.4).  
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Figure 3.2.1: Organ architecture is preserved in 1 months old Egr2-/- Egr3 -/- mice and it is comparable with WT mice. Heamatoxylin and 
eosin staining performed on tissue sections from mice that were 1 month old showing an absence of severe pathology in these young Egr2-/- 
Egr3 -/- mice when compared with WT counterparts. Image taken using Axioscope X10 objective and data was collected from 4 
representative mice. 
 
                                                                                                                 Chapter 3 – Results 
 
85 
 
 
Figure 3.2.2: Haematoxylin and eosin staining of tissue sections from 2 months old Egr2-/- Egr3 -/- mice shows signs of early inflammation 
pathology with lymphocyte infiltrate in the liver and lungs. Image taken using Axioscope X10 objective and data was collected from 4 
representative mice
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Figure 3.2.3: Analysis of tissue sections using haematoxylin and eosin staining show the presence of lymphocytic infiltrates into the 
kidney, liver and lungs of 3-4 months old Egr2-/- Egr3 -/- mice. Infiltrations were also accompanied by moderate changes in organ 
architecture in the lungs and kidney. Image taken using Axioscope X10 objective and data was collected from 4 representative mice  
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Figure 3.2.4: Haematoxylin and eosin staining show severe organ pathology and lymphocyte infiltrate in Egr2-/- Egr3 -/- mice aged 5 
months and older. Image taken using Axioscope X10 objective and data was collected from 4 representative mice 
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Figure 3.2.5: Pathological analysis show splenic derangement in Egr2-/- Egr3 -/- mice from 2 months of age. Morphology of the organs was 
analysed using H and E stain and confirmed by Immunofluorescence using anti-CD11b antibody on spleen sections from WT and Egr2-/- 
Egr3 -/- mice. CD11b stains for an integrin which is upregulated on activated macrophages and facilitates their trafficking to sites of 
inflammation. It is commonly used as a marker for chronic inflammation. Immunofluorescence and haematoxylin and eosin stained images 
were taken using a x5 objective   
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3.2.2 Cytokine profile of CD4 T cells from Egr2-/- Egr3 -/- mice 
Cytokines are key players in inflammatory responses and have been 
implicated in the onset of autoimmune diseases. Microarray analysis carried out on 
anti-CD3/anti-CD28 stimulated and unstimulated CD4 T cells from WT and Egr2-/- 
Egr3-/- mice identified cytokines with deregulated expression in the Egr2-/- Egr3-/- 
mice when compared to their WT counterpart (Figure 3.2.6). When pro-
inflammatory cytokines expressions in the WT mice were compared with Egr2-/- 
Egr3-/- mice, there was an increased expression of interferon ƴ (IFNƴ), IL-17A and F, 
IL-1A and B, IL-6, IL-3 and IL-21 in total CD4 T cells from Egr2-/- Egr3-/- mice as 
presented in table 3.1. This data was confirmed by RT-PCR which showed 
significantly higher levels of IFN-γ, IL-21 and IL-1A and B in Egr2-/- Egr3-/- mice 
(Figure3.2.7). All of this cytokines are known to promote the inflammatory process 
and the development of autoimmune disease (HELLMICH, CSERNOK and GROSS, 
2005). As expected, the data obtained from microarray was consistent with the 
high levels of pro-inflammatory cytokine reported to be present in the serum of 
Egr2-/- Egr3-/- mice (Li et al., 2012).  
 
Figure 3.2.6: Microarray data analysis show deregulated expression of cytokines 
in stimulated and unstimulated Egr2-/- Egr3-/- CD4 T cells when compared with its 
WT counterpart.   
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Gene 
name 
Expression in Egr2-/- 
Egr3-/- mice 
Fold change between 
WT and Egr2-/- Egr3-/- 
(Unstimulated) 
Fold change between 
WT and Egr2-/- Egr3-/- 
(stimulated) 
IFNƴ Upregulated 12.58 7.89 
IL-17a Upregulated 1.12 1.8 
IL-17f Upregulated 1.19 3.48 
IL-6 Upregulated 1.5 0.58 
IL-3  Upregulated 1.42 46.1 
IL-10 Upregulated 5.26 6.91 
IL-1a Upregulated 1.26 5.24 
IL-1b Upregulated 1.34 5.02 
Table 3.1: Microarray data was analysed for fold difference in cytokine 
expression. Data shows higher expression levels of pro-inflammatory cytokines in 
CD4 T cells from Egr2-/- Egr3-/- mice. 
 
Figure 3.2.7: High levels of pro-inflammatory cytokines in Egr2-/- Egr3-/- mice. 
RT-PCR on PMA-Ionomycin stimulated and unstimulated CD4 T cells shows 
significantly higher expression of pro-inflammatory cytokines IFN-γ, IL-21, and IL-1A 
and B in Egr2-/- Egr3-/- mice.   
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3.2.3 Autoimmune disease development in Egr2-/- Egr3 -/- mice 
From observations in this study, Egr2-/- Egr3-/- mice exhibited severe 
inflammations with lympho-proliferative disorders and developed symptoms 
related to autoimmune diseases like splenomegaly and swollen limbs (figure 3.2.8). 
This is in line with previous reports from our group stating that the Egr2-/- Egr3-/- 
mice develop autoimmune diseases (Li et al., 2012). Autoimmune diseases are 
characterised by high levels of pro-inflammatory cytokines and are often diagnosed 
by the presence of antibodies that react to self-antigens termed anti-nuclear 
antibodies (ANA) (LYONS et al., 2005). Li et al in their 2012 paper compared total 
immunoglobulin and ANA levels between WT and Egr2-/- Egr3-/- mice. They reported 
significantly higher levels of total immunoglobulin (Ig), anti-histone and anti-dsDNA 
in the serum of 8 weeks old Egr2-/- Egr3-/- mice (Li et al, 2012). This is consistent 
with the age from which early signs of chronic inflammation pathology were 
observed in Egr2-/- Egr3-/- mice model (figure 3.2.2).  In addition to high ANA levels, 
Egr2-/- Egr3-/- mice were also reported to produce significantly more proteinuria (Li 
et al., 2012). This is in line with a phenotype consistent with organ pathology.  
Morphological analysis of the kidney identified lupus-like autoimmune 
symptoms including increased glomeruli cellularity, reduction in bowman space due 
to infiltrates and immunoglobulin deposits in the kidney (figures 3.2.9). The results 
presented here suggest that chronic inflammation accompanied by high levels of 
pro-inflammatory cytokines in the Egr2-/- Egr3-/- mice may contribute to systemic 
organ pathology that may play a pathogenic role in the development of systemic 
inflammatory autoimmune disease observed in the Egr2-/- Egr3-/- mice. 
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Figure 3.2.8: Egr2-/- Egr3-/- mice developed symptoms associated with 
inflammation pathology and autoimmunity. Figure above shows pathologically 
enlarged Spleens and swollen ankles in 2 months old Egr2-/- Egr3-/- mice (A and B). 
These symptoms can be associated with an autoimmune phenotype. 
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Figure 3.2.9: Morphology of Kidney from Egr2-/- Egr3-/- mice shows glomerulonephritis with increased cellularity of glomeruli and reduced 
Bowman space. H and E staining of Kidney section from WT and 3 month old Egr2-/- Egr3-/- mice show pathology in the kidney in line with an 
autoimmune phenotype. This is in line with a publication from Li et al, 2012 showing Egr2-/- Egr3-/- mice had Immunoglobulin (Ig) deposits in 
the glomeruli of the Kidney (Li et al, 2012).  
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3.3 Egr2-/- Egr3-/- mice fail to develop 
germinal centres 
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3.3.1 Histological analysis show that GCs are absent in Egr2-/- Egr3 -/- 
mice  
The spleen, much like the lymph nodes, tonsils and payers patch, is a 
secondary lymphoid organ and home to mature lymphocytes. It is divided into 2 
main areas: the white pulp containing the T and B cell zones and red pulp which are 
blood filled sinuses made up of macrophages, DC and granulocytes (Mebius and 
Kraal, 2005). Splenic architecture is optimal for the generation of immune 
responses (Mebius and Kraal, 2005). Spleens were harvested from 6-8 weeks old 
WT and Egr2-/- Egr3-/- mice for morphological analysis. It was found, that the 
germinal centre (GC), which is responsible for the generation of T cell dependent 
humoral immune response was conspicuously absent from the Egr2-/- Egr3-/- mice 
(figure 3.3.1). This was further confirmed by Immunofluorescence staining using the 
GC B cell marker peanut agglutinin (PNA). An absence of GC suggests that T cell 
dependent humoral immune responses could be severely abrogated.  
   
Figure 3.3.1: Morphological analysis of the spleen of WT and Egr2-/- Egr3-/- mice 
highlight an absence of GC in the Egr2-/- Egr3-/- mice. (H and E images were 
acquired using an X5 objective on an Axioscope light microscope while 
Immunofluorescence images were acquired using a X5 objective on an Zeiss 
fluorescence microscope). 
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3.3.2 Egr2-/- Egr3 -/- mice show severe clinical pathology and high 
viral load 
Given the importance of the spleen in immune response and the observed 
absence of GC in Egr2-/- Egr3-/- mice, it became important therefore, to assess the 
immune response in these mice and determine what clinical implications the 
absence of GC may present upon antigenic challenge in vivo. Mice were then 
infected with sub lethal doses of Vaccinia Virus Western Reserve strain (VVWR) and 
mice weights were used as an indication of clinical pathology.  
% weight loss in WT and Egr2/3 deficient mice after infection with VV WR
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Figure 3.3.2: Egr2-/- Egr3-/- mice show severe clinical symptoms in response to 
VVWR challenge in vivo. This graph is representative of over 10 experiments done 
using different ages and sexes of mice. 3-4 mice were used per group for each of 
these experiments. Statistical significance calculated using a 2 way ANOVA showing 
a p value of <0.001 in % weight loss between the WT and Egr2/3 deficient mice over 
the course of the infection. 
The figure presented above shows that after viral challenge, Egr2-/- Egr3-/- 
mice showed rapid and more severe clinical pathology compared to its WT 
counterpart. This was consistent over the course of the infection. In terms of 
recovery from infection, which was determined as the day mouse weights was 
equal to or more than baseline weights (day 0 weights), Egr2-/- Egr3-/- mice took 
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twice as much time as the WT mice to recover from VVWR antigenic challenge. WT 
recovered 27 days after infection whilst Egr2-/- Egr3-/- mice recovered on day 53 
post infection (figure 3.3.2). Interestingly, it was discovered that the Egr2-/- Egr3-/- 
mice did not show any clinical pathology when re-challenged using same dose of 
VVWR antigen indicating that these mice may have developed immunological 
protection from re-challenge (figure 3.3.2). It is important to note also that there 
was no difference in clinical pathology in response to VVWR among the different 
ages and sexes of Egr2-/- Egr3-/- mice studied. The rest of this study was focused on 
mice aged 8-10 weeks old.  
Viral pathogens cause the immune system to initiate immune responses. 
Humoral immune response via ADCC, CDC, antibody opsonisation and viral 
neutralisation enhances viral clearance and allows for the processing and 
presentation of viral antigens by phagocytic cells (Carrasco, 2009). In order to 
investigate why Egr2-/- Egr3-/- mice showed such severe clinical pathology and 
delayed recovery after primary challenge with VVWR, the lung viral load was 
measured 8 days after infection for the clearance of virus. It was observed that the 
Egr2-/- Egr3-/- mice had about 100 times higher viral load in its lungs compared to its 
WT counterpart (figure 3.3.3). Severe clinical pathology and high viral load suggests 
defective immune response in Egr2-/- Egr3-/- mice. 
 
Figure 3.3.3: Impaired VVWR clearance in Egr2
-/- Egr3-/- mice following viral 
infection. Analysis of Lung viral titre done 8 days after infection show that the Egr2-
/- Egr3-/- mice had about 100 times higher viral load compared to their WT 
counterparts 
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3.3.3 Egr2-/- Egr3-/- mice failed to generate GC in response to VVWR 
infection  
During infection, the GCs expand and increase in number in order to mount 
optimal humoral immune responses. Within the GC, T follicular helper (Tfh) cells 
provide help to cognate GC B cells causing them to expand and proliferate. This in 
turn will lead to the production of plasma cells that generate long-lived, high 
affinity, isotype-switched antibodies and the development of B cell immunological 
memory. Due to the relatively weak anti-viral immune response observed in mice 
lacking the Egr2/3 genes, spleens were again harvested from WT and Egr2-/- Egr3-/- 
mice before and after infection with VVWR and assessed for development of GC. 
These spleens were then stained using GC B cell marker peanut Agglutinin (PNA) 
and markers for B and CD4+ T cells 
 
 
Figure 3.3.4: Egr2-/- Egr3-/- mice failed to develop GC in response to VVWR infection. 
Immunofluorescence staining for GC B cells using PNA (red), CD4+ T cells (green) 
and non-GC B cells stained with IgD (blue) on WT and Egr2-/- Egr3-/- mice show lack 
of GC in the Egr2-/-Egr3-/- mice before and 14 days after VVWR challenge. This data is 
representative of 3 experiments. Magnification indicates objective used to acquire 
images 
From the figure above (figure 3.3.4), it can be seen that in uninfected WT 
mice, there was sporadic GC in the spleen, which as expected, became enlarged 
and increased in number after viral challenge. In the Egr2-/- Egr3-/- mice however, 
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there was an absence of these structures in these mice both uninfected and 14 days 
after primary challenge with VVWR (Figure 3.3.4). Although Egr2
-/- Egr3-/- mice did 
contain normal T and B cell areas confirming inflammation pathology had not set in, 
they, however, failed to generate GCs. The absence of GCs in these mice indicates a 
defect in normal immune response and demonstrates that the Egr2/3 genes may 
play a role in the development of GC during T cell dependent humoral immune 
response.   
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3.3.4 Single Egr2 or Egr3 deficient mice showed normal GC 
development  
I had earlier reviewed the compensatory function of the Egr3 gene in the 
absence of Egr2 gene in section 1.8.2. When the spleens from VVWR infected CD2-
Egr2 single deficient mice were analysed for the development of GC 14 days after 
infection, It was found that in CD2-Egr2-/- mice, GC development was normal (figure 
3.3.5A). Analysis of the LN of Egr3 deficient mice also showed normal GC 
development when compared to its WT counterpart (figure 3.3.5B). This validates 
the compensatory role of the Egr3 gene in the absence of Egr2 and points to an 
overlapping function of the Egr2 and Egr3 genes in the regulation of Tfh 
differentiation and GC development. 
 
 
Figure 3.3.5: Single CD2-Egr2-/- and single Egr3-/- mice show no defects in germinal 
centre formation. A. immunofluorescence on spleen of 3 month old Egr2 
conditional knockout mice showing normal germinal centre formation.  B. H and E 
and immunostaining of LN of Egr3 deficient mice and WT mice showed normal GC 
development  
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3.3.5 GC function is defective in Egr2-/- Egr3-/- mice 
As earlier stated, the GC is responsible for the production of high affinity 
antibodies, immunoglobulin class switching of these antibodies and B cell memory. 
Having observed an absence of GC in Egr2-/- Egr3-/- mice, we next investigated GC 
functions in these mice. To do this, 2 systems were employed. They are the VVWR 
infection system and the OVA protein immunisation system. The merits and de-
merits of the two methods are highlighted below (table 3.2). Both Viral and OVA 
protein systems are able to generate T dependent immune responses (Choi et al., 
2011; Johnston et al., 2009; Yu et al., 2009).  
 
Table 3.2: Advantages and disadvantages of the 2 systems employed for antigenic 
challenge in vivo. 
Somatic hypermutation leads to the production of antibodies with high 
affinity for pathogens. 21 days after VVWR infection, Serum was collected from 
infected mice. This was then analysed for the production of anti-VVWR neutralising 
antibodies. Results obtained showed there was significantly higher plaque number 
in plated TK143 cells containing serum from Egr2-/- Egr3-/- mice. This higher number 
of plaques in Egr2-/- Egr3-/- mice compared to WT mice indicates less production of 
neutralising antibodies against the VVWR 21 days after infection (figure 3.3.6). Using 
the OVA protein immunisation system, we further confirmed the results obtained 
from neutralisation assay by evaluating the production of total anti-OVA specific 
antibodies following immunisation with OVA protein. In line with the failure to 
generate GC in Egr2-/- Egr3-/- mice and the impaired production of VVWR neutralising 
antibodies, there was a significantly lower production of anti-OVA antibodies from 
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the serum in the Egr2-/- Egr3-/- mice. This was consistent over the period of primary 
immunisation (figure 3.3.7).  
 
 
Figure 3.3.6: Production of neutralising antibody is impaired in Egr2-/- Egr3-/- mice 
in response to VVWR infection. Following co-incubation of VVWR and sera from 
infected mice, TK143 cells were then cultured in VVWR-sera mix overnight and 
plaques indicating cell lysis were counted after 48 hours.   
 
 
Figure 3.3.7: Defective production of anti-OVA specific antibody in Egr2-/- Egr3-/- 
mice. (* = day of immunisation). WT and Egr2-/- Egr3-/- mice were immunised with 
OVA protein emulsified in complete Freund’s adjuvant (CFA) and mice were bled 
every seven days. Total anti-OVA specific immunoglobulin was then measured in 
these mice. From the data presented above, it was determined that the Egr2-/- Egr3-
/- mice showed impaired production of antigen-specific antibody against OVA 
protein.  
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Another function of the GC is class switch recombination (CSR). This occurs 
in order to generate other antibody isotypes with different effector functions. As 
IgG1 is produced during class switching in T cell dependent humoral immune 
response (Liu et al., 2014b; Ise et al., 2011), class switching from IgM to IgG1 
antibody in response to viral challenge in the WT and Egr2-/- Egr3-/- mice was 
investigated. IgG1 antibody levels were found to be significantly higher in the serum 
of WT mice from 21 days after viral challenge when compared with the Egr2-/- Egr3-
/- mice at same time points (p=0.000137 and 0.006772 respectively) (Figure 3.3.8).  
 
 
Figure 3.3.8: Impaired IgG1 titres in serum pooled from Egr2-/- Egr3-/- mice 21 days 
after VVWR infection.  
A and B: IgG1 antibody isotype levels analysed by ELISA in Egr2-/- Egr3-/- mice was 
significantly less than its WT counterpart 21 days after infection with VVWR. As 
measured by sandwich ELISA C) Kinetics shows that IgG1 levels were consistently 
higher in WT mice and significantly different from that of Egr2-/- Egr3-/- mice 21 and 
28 days after VVWR infection. Data presented here have been normalised by 
subtracted baseline values for day 0 from that of subsequent days. This result is 
representative of serum from 2 independent experiments each with at least 4 mice 
per group. Student T test used P<0.001 = ***; P<0.01 = **; P<0.05 = *    
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Humoral immune response during secondary immunisation was next 
investigated. To do this, the OVA system was used. WT and Egr2-/- Egr3-/- mice were 
re-immunised 42 days after the first dose. In line with defective GC functions, 
production of OVA-specific antibodies in the serum of Egr2-/- Egr3-/- mice 7 days 
after re-immunisation was found to be significantly lower (Figure 3.3.9). When 
antibody production during primary and secondary immune responses in WT and 
Egr2-/- Egr3-/- were compared, it was observed that WT mice had 3 folds higher 
antigen-specific antibody in their serum compared to their Egr2-/- Egr3-/- 
counterparts during both primary and secondary immune response indicating 
aberrant GC function during re-immunisation (Table 3.3).  
 
 
 
Figure 3.3.9: Defective anti-OVA antibody production during primary and 
secondary immune response in Egr2-/- Egr3-/- mice. This was analysed by ELISA. 
Student T test used P<0.001 = ***; P<0.01 = **; P<0.05 = *    
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Table 3.3: Fold change in anti-OVA antibody production between WT and Egr2-/- 
Egr3-/- mice during primary and secondary immune response.  
 
Taken together, these results indicate that GC functions like somatic 
hypermutation, isotype class-switching and generation of antibody during memory 
immune responses are impaired in Egr2-/- Egr3-/- mice consistent with a lack of GC. 
This suggests that the Egr2/3 genes may play a role in the generation of GC and GC 
functions.  
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3.4 Egr2/3 regulate the differentiation of 
follicular helper T cell (Tfh) development 
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3.4.1 Bcl6 expression is defective in Egr2-/-Egr3-/- mice 
We have established that in the absence of the Egr2/3 genes, mice did not 
develop GC and lacked GC functions. We then sought to investigate the reason this 
occurred by looking into the regulation of Tfh cells, a cellular mediator of GC 
immune response. Tfh cell differentiation and development much like any 
physiological process within any biological entity is regulated by a number of 
molecules including transcription factors, chemokines and cytokines. Using 
microarray, the gene expression profile of Tfh-related genes in anti-CD3/anti-CD28 
stimulated and unstimulated total CD4+ T cells from WT and Egr2-/- Egr3-/- mice was 
analysed. It was observed that the expression of Tfh-related genes, Bcl6 and Prdm1 
(the gene that codes for Blimp1), were altered (figure3.4.1) 
Microarray data were further analysed by scatter plot analysis. The result 
showed a 2 fold down regulation of Bcl6 in both stimulated and unstimulated Egr2-/- 
Egr3-/- CD4+ T cells while Prdm1 (Blimp1) had at least 2 fold upregulation in the 
stimulated and unstimulated conditions in the CD4+ cells from Egr2-/- Egr3-/- mice 
(Figure 3.4.2A). To further confirm this microarray data, mRNA was extracted from 
anti-CD3/anti-CD28 stimulated and unstimulated total CD4+ T cells for RT-PCR and 
indeed the results showed a similar expression pattern for Bcl6 and Blimp1 in the 
WT and Egr2-/- Egr3-/- CD4+ T cells (Figure 3.4.2B).  
Next, Tfh and non-Tfh cells were sorted and the mRNA expression levels of 
Bcl6 and Blimp1 were measured. Again, there was a downregulation of Bcl6 and an 
upregulation of Blimp1 specifically within these CD4+ CXCR5+ PD-1+ Tfh cells (figure 
3.4.2C). Bcl6 is the signature transcription factor responsible for Tfh cell 
differentiation while Blimp1 (Prdm1), another transcription factor, promotes the 
differentiation of CD4 T cells into other T cell lineages by repressing Bcl6 (Johnston 
et al., 2009). Differential expression of these genes in Egr2-/- Egr3-/- mice in relation 
to their WT counterpart suggest that Egr2/3 genes play a role in the regulation of 
Tfh cell differentiation and function. 
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Figure 3.4.1: Microarray expression profile show altered gene expression of Bcl6 
and Blimp1 in CD4 cells from Egr2-/- Egr3-/- mice. RNA was extracted from 2-month-
old WT and Egr2-/- Egr3-/- mice to perform microarray. Data acquired from 
microarray show deregulated expression of Tfh related genes Bcl6 and Blimp1.  
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Figure 3.4.2: The expression of Tfh cell-related genes is defective in CD4 cells from Egr2-/- Egr3-/- mice. 
  A: Scatterplot analysis of data obtained from microarray show Tfh cell-related genes with at least 2 fold change in Egr2-/- Egr3 -/- CD4 T cells 
in stimulated and unstimulated conditions. B: Validation of the microarray data was done at mRNA level in total CD4 T cells from WT and 
Egr2-/- Egr3 -/- mice. C: CD4 T cells were stained for Tfh markers CXCR5 and PD-1 and then sorted for CXCR5+ PD-1+ CD4 cells and CXCR5- 
PD-1 CD4 cells. mRNA was then extracted from these cells and used for RT-PCR.  
 
                                                                                                            
                                                                                                                                       Chapter 3 – Results 
                          Chapter 3 – Results 
 
110 
 
3.4.2 Aberrant Tfh cell differentiation in Egr2-/- Egr3-/- mice  
In order to ascertain the effect of defective expression of Tfh-related genes 
in the Egr2-/- Egr3-/- mice, CD4 and B220 cells were isolated before and 14 days after 
infection with VVWR. The differentiation of both Tfh and GC B cells were then 
analysed based on the expression of surface markers and signature transcription 
factors. In line with an absence of GC, levels of CD4+ CXCR5+ PD-1+ Tfh cells from the 
Egr2-/- Egr3-/- mice was significantly lower at day 0 when compared with WT mice 
(figure 3.4.3A). Analysis of the Bcl6+ cells in uninfected Egr2-/- Egr3-/- CD4 T cells was 
also severely diminished when compared to its WT counterpart (figure 3.4.4A). 14 
days after infection with VVWR, the expression levels of CD4
+ CXCR5+ PD-1+ Tfh cells 
in WT mice was significantly increased compared to Egr2-/- Egr3-/- mice and more 
than half of these CD4+ CXCR5+ PD-1+ Tfh cells in WT mice expressed the Bcl6 gene. 
However, in the Egr2-/- Egr3 -/- mice, VVWR infection did not increase the expression 
of Bcl6 within these Tfh cells (figure 3.4.3B).  
 
Figure 3.4.3: Deregulated Tfh cell differentiation in Egr2-/- Egr3-/- mice after VVWR 
infection. Each dot presents an individual mouse from different experiments; 
Mann-Whitney’s U test was used to evaluate statistical significance. P<0.001 = ***; 
P<0.01 = **; P<0.05 = *    
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Next, GC B cell differentiation was analysed in these mice before and after 
infection. Prior to infection, GC B cell numbers were found to be significantly higher 
in the WT mice (figure 3.4.4A). As expected, this increased in response to VVWR 
challenge and was significantly more than the percentage number of GC B cells 
from Egr2-/- Egr3-/- mice after infection (figure 3.4.4B). Interestingly, the levels of 
Bcl6 in GC B cells from WT and Egr2-/- Egr3-/- mice were found to be similar after 
VVWR challenge (figure 3.4.5). 
 
 Figure 3.4.4: GC B cells numbers are reduced in the absence of Egr2/3 genes. Each 
dot presents an individual mouse from different experiments; Mann-Whitney’s U 
test was used to evaluate statistical significance. P<0.001 = ***; P<0.01 = **; P<0.05 
= *    
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Figure 3.4.5: Bcl6 levels in GC B cells were similar in WT and Egr2-/- Egr3 -/- mice 
following VVWR infection. Histogram plots of Bcl6 expression from WT and Egr2
-/- 
Egr3 -/- B220+ GL7+ cells following infection show similar expression of Bcl6 in these 
2 mice groups 
These results suggest that Egr2/3 genes may play a role in maintaining the 
basal numbers of Tfh cells and the differentiation of these Tfh cells after viral 
challenge. As there was no difference in Bcl6 expression in GC B cells from WT and 
Egr2-/- Egr3-/- mice, we considered a possibility that the Egr2/3 may not play a role 
in Bcl6 regulation of GC B cells. This suggested that the decrease in the number of 
GC B cells may be due to a lack of cognate Tfh cell activity to support GC B cells 
differentiation.  
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3.4.3 Egr2/3 expression is essential for Tfh differentiation 
As seen in the previous section (section 3.4.2), a T cell defect in GC 
responses was very much likely. However, in order to confirm if the failure to 
generate GC and the consequences of that including impaired GC functions, was as 
a result of defective Egr2/3 expression in CD4+ T cells or in B cells, WT CD4+ cells or 
WT B220 cells were adoptively transferred into Egr2-/- Egr3-/- mice. This was 
followed by infection with VVWR 24 hours after transfer. 14 days after infection, the 
spleens were harvested and analysed for the differentiation of Tfh, GC B cells and 
development of GCs (figure 3.4.6).  
 
Figure 3.4.6: GC was induced in Egr2-/- Egr3 -/- mice that received WT CD4 cells but 
not WT B220 cells. Immunofluorescence on spleen sections from WT and Egr2-/- 
Egr3 -/- mice using GC marker PNA, CD4 and IgD on spleen. Magnification on images 
indicates objective used to acquire image.  
Staining for GCs showed that GCs developed in Egr2-/- Egr3-/- mice that 
received the WT CD4+ T cells and not in those that received WT B220 cells (figure 
3.4.6). Next, CD4+ T cells were isolated from the spleen and LN of these mice and 
stained for Tfh cell markers CXCR5 and PD-1. Using flow cytometry, Tfh cells were 
gated (figure 3.4.7A). The results obtained showed that Egr2-/- Egr3-/- mice receiving 
WT CD4 cells had significantly more Tfh cells and over half of them expressed Bcl6 
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similar to what was observed in WT mice (figure 3.4.7A and 3.4.3). Bcl6 and Egr2 
expression was also increased in Egr2-/- Egr3-/- mice that received WT CD4 T cells 
compared to those that did not (figure 3.4.7B). Bcl6 was co-expressed with the Egr2 
genes indicating that the Tfh cells were from the transferred WT CD4 cells (figure 
3.4.8A and B). When the expression of GC B cells as indicated by GL7+ and B220+ 
cells was analysed, there was significantly higher numbers of GC B cells in Egr2-/- 
Egr3-/- mice receiving WT CD4 cells (figure 3.4.8). These results demonstrate that for 
the formation of GC, Egr2/3 expression is critical in Tfh cells.  
 
Figure 3.4.7: WT CD4 T cells transferred into Egr2-/- Egr3-/- mice increased Tfh cell 
numbers and Bcl6 expression. 2 X 106 WT CD4 T cells or B220 cells were transferred 
into Egr2-/- Egr3-/- mice. 24 hours after transfer, mice were infected with VVWR. 14 
days after infection, spleens were harvested and splenocytes isolated and stained 
to evaluate CD4+, CXCR5+, PD-1+, Bcl6+ and Egr2+ T cells. Each dot presents an 
individual mouse from different experiments; Mann-Whitney’s U test was used to 
evaluate statistical significance. P<0.001 = ***; P<0.01 = **; P<0.05 = *    
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Figure 3.4.8: Transfer of WT CD4 cells into Egr2-/- Egr3-/- mice rescued the GC B cell phenotype. 2 X 106 WT CD4 T cells or B220 cells were 
transferred into Egr2-/- Egr3-/- mice. 24 hours after transfer, mice were infected with VVWR. 14 days after infection, spleens were harvested 
and splenocytes isolated and stained for B220+ and GL7+ B cells. Each dot presents an individual mouse from different experiments; Mann-
Whitney’s U test was used to evaluate statistical significance. P<0.001 = ***; P<0.01 = **; P<0.05 = *; N.S = not significantly different 
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To verify that these findings were as a result of a CD4+ T cell intrinsic 
mechanism rather than environmental influence including inflammatory 
environment found in Egr2-/- Egr3-/- mice, equal numbers of WT CD4/ Egr2-/- Egr3-/- 
B220 or Egr2-/- Egr3-/- CD4/WT B220 cells were adoptively transferred into RAG-/- 
mice. These cells were allowed to home for 10 weeks and thereafter infected with 
VVWR. 14 days after infection, the spleens were harvested and analysed for GC 
development, Tfh cell and GC B cell differentiation in each of these mice. Mice that 
received WT CD4/ Egr2-/- Egr3 -/- B220 were able to form germinal centres. This was 
in contrast to mice that received Egr2-/- Egr3-/- CD4/ WT B220 (figure 3.4.9). 
 
Figure 3.4.9: RAG-/- mice receiving WT CD4/ Egr2-/- Egr3-/- B220 were able to 
generate GC. 2.5 X 106 WT CD4 T cells/Egr2-/- Egr3-/- B220 cells or 2.5 X 106 Egr2-/- 
Egr3-/- CD4 T cells/WT B220 cells were transferred into Rag deficient mice. 10 weeks 
after transfer, mice were infected with VVWR. 14 days after infection, spleens were 
harvested and analysed for the formation of germinal centres. Magnification on 
images indicates objective used to acquire image.   
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RAG-/- mice lack a natural lymphocyte population, and so gating for 
transferred lymphocytes, a distinct population of CD4+ T cells and B220 was 
established for further analysis (figure 3.4.10). Following sorting for CD4+ cells, Tfh 
cells were gated in the 2 groups of mice. It was observed that there was 
significantly higher amount of Tfh cells in mice that received WT CD4/ Egr2-/- Egr3-/- 
B220 compared with those that received Egr2-/- Egr3-/- CD4/ WT B220 (figure 
3.4.11). This suggests that the increased number of Tfh cells in these mice that 
received WT CD4/ Egr2-/- Egr3-/- B220 cells restored GC formation. When GC B cell 
differentiation was analysed, it was found that there were significantly more GC B 
cells in RAG-/- mice that received WT CD4/ Egr2-/- Egr3-/- B220 (figure 3.4.12). This 
indicated that B cells from Egr2-/- Egr3-/- mice were capable of differentiating into 
GC B cells in response viral challenge provided adequate T cell help is present. 
 
Figure 3.4.10: Staining for CD4 T cells and B220 in splenocytes isolated from RAG-
/- mice receiving identified distinct population of lymphocytes in RAG-/- mice 
following adoptive transfer. 
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Figure 3.4.11: Adoptive transfer of WT CD4/Egr2-/- Egr3-/- B220 into RAG-/- mice 
increased CD4+ CXCR5+ PD-1+ Tfh cells. Each dot presents an individual mouse from 
different experiments; Mann-Whitney’s U test was used to evaluate statistical 
significance. P<0.001 = ***; P<0.01 = **; P<0.05 = *    
 
Figure 3.4.12: RAG-/- mice with adoptive transfer of WT CD4/Egr2-/- Egr3-/- B220 
had significantly higher percentage of GC B cells. Each dot presents an individual 
mouse from different experiments; Mann-Whitney’s U test was used to evaluate 
statistical significance <0.001 = ***; P<0.01 = **; P<0.05 = *    
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In order to further confirm that GC B cells from Egr2-/- Egr3-/- were 
intrinsically normal and the absence of GC formation and function was due to a Tfh 
cell defect, B cells from WT and Egr2-/- Egr3-/- mice were isolated 8 days after VVWR 
infection and gated for GC B cells (Figure 3.4.13). These GC B cells were then 
analysed for the expression of Bcl6 and Egr2. Almost all GC B cells from WT and 
Egr2-/- Egr3-/- mice expressed Bcl6 however, in the WT GC B cells; there was no Egr2 
expression (figure 3.4.13). This indicates that Egr2/3 may not be responsible for the 
regulation of GC B cell differentiation and confirms that defective GC formation and 
function was as a result of Tfh cell defect. 
 
Figure 3.4.13: GC B cells from WT mice do not express Egr2 protein.  B cells from 
VVWR infected mice were isolated 8 days following infection and analysed for GC B 
cell differentiation and the expression of Egr2 and Bcl6 transcription factors. We 
found no expression of Egr2 in these B cells from WT and Egr2-/- Egr3-/- mice.  
Anti-CD40 and IL-4 stimulation has been reported to initiate B cell 
differentiation into antibody-secreting cells (ASC) by mimicking T cell help in vitro 
(Kallies et al., 2007). Lastly, we assessed the ability of CD19+ B cells isolated from 
Egr2-/- Egr3-/- mice to differentiate into ASC using anti-CD40 and IL-4 stimulation.  
The results obtained from that experiment showed significantly higher levels of 
secreted immunoglobulin isotypes IgG1, IgG2a, IgG2b, IgG3, IgM and IgA in Egr2-/- 
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Egr3-/- B220 cells after in vitro stimulation compared to the in vivo stimulated Egr2-/- 
Egr3-/- B220 cells (Figure 3.4.14). This suggests that the class switch machinery in B 
cells from Egr2-/- Egr3-/- mice is functional and would undergo isotype switching in 
the presence of appropriate helper cells. 
 
 
Figure 3.4.14: B cells from Egr2-/- Egr3-/- mice show significantly higher antibody 
titres in the presence of T cell help.  In vitro stimulation of Egr2-/- Egr3-/- B220 cells 
was done using anti-CD40 and IL-4. Antibody titre for in vivo stimulated B cells were 
obtained from VVWR infected sera. WT control shows comparable Ig levels in both in 
vitro and in vivo stimulations (Appendix figure 2, page 198) 
Taken together these results illustrate that after antigenic challenge, Egr2/3 
genes appear to be essential for Tfh cell differentiation and in the absence of these 
genes, GC formation and function fails. It further suggests that Bcl6 regulation of GC 
B cells may be regulated through an Egr2/3 independent mechanism. Thus GC B 
cells in Egr2-/- Egr3-/- mice are in essence, intrinsically normal and will respond to Tfh 
cells normally. This indicates that Egr2/3 function in a Tfh cell-intrinsic manner to 
regulate the differentiation of Tfh cells as well as the formation of GC and its 
functions. 
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3.4.4 Adoptive transfer of Egr2 or Bcl6 expressing CD4 cells rescue 
GC formation and Tfh phenotype in Egr2-/- Egr3 -/- mice 
We have demonstrated that Egr2/3 expression was necessary for the 
maintenance of basal numbers of Tfh cells and its subsequent differentiation after 
antigenic stimulation. We next assessed if adoptive transfer of Egr2 into Egr2-/- Egr3-
/- CD4+ T cells would rescue GC formation and Tfh differentiation in vivo. Expression 
construct for Egr2 were transfected into Egr2-/- Egr3-/- CD4+ T cells. These were then 
transferred into Egr2-/- Egr3 -/- mice. 24 hours after adoptive transfer, the mice were 
then infected with VVWR and 14 days post infection, spleens were collected for 
analysis.  Constitutive expression of the Egr2 gene in Egr2-/- Egr3-/- CD4+ T cells was 
able to mitigate the absence of germinal centres in the Egr2-/- Egr3-/- mice (figure 
3.4.15). 
 
Figure 3.4.15: The development of GC was rescued by the forced expression of 
Egr2 in CD4 T cells from Egr2-/- Egr3-/- mice. 2 x 106 Egr2 expressing lentivirus were 
transfected into CD4 T cells from Egr2-/- Egr3-/- mice which were then adoptively 
transferred into Egr2-/- Egr3-/- mice, next day, mice were infected and 14 days after 
infection, spleens were collected for analysis of GC formation Magnification on 
images indicates objective used to acquire image.  
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Forced expression of the Egr2 gene in CD4+ T cells of Egr2-/- Egr3-/- mice was 
also able to rescue the phenotype of the CD4+ CXCR5+ PD-1+ Tfh cells to levels very 
similar to WT counterpart (figure 3.4.16).  Indeed this was also the case for GC B 
cells differentiation. GC B cell numbers as assessed by GL7+ B220 cells were 
elevated in Egr2-/- Egr3-/- mice receiving Egr2- expressing CD4+ T cells (figure 3.4.16). 
 
 
Figure 3.4.16: Constitutive expression of Egr2 in Egr2-/- Egr3-/- CD4 cells restored 
Tfh cell differentiation and GC B cell differentiation. 2 x 106 Egr2 expressing 
lentivirus were transfected into CD4 T cells from Egr2-/- Egr3-/- mice which were 
then adoptively transferred into Egr2-/- Egr3-/- mice, next day, mice were infected 
and 14 days after infection, spleens were collected for analysis of Tfh and GC B cell 
differentiation.  
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To investigate the possibility that Egr2 controls Tfh differentiation by 
regulating Bcl6 expression, Bcl6 expression construct were transfected into CD4+ T 
cells from Egr2-/- Egr3-/- mice. This was then subsequently adoptively transferred 
into Egr2-/- Egr3-/- mice. Following this, the mice were infected. Similar to Egr2-
expressing CD4 cells transferred into Egr2-/- Egr3-/- mice, forced expression of Bcl6 in 
Egr2-/- Egr3-/- CD4 T cells permitted the formation of GCs in these Egr2-/- Egr3-/- mice 
(figure 3.4.17). Analysis of the expression of CD4+ CXCR5+ PD-1+ Tfh cells showed 
Egr2-/- Egr3-/- mice that received Egr2-/- Egr3-/- CD4 T cells with constitutively 
expressed Bcl6 were able to restore the Tfh cell phenotype as well as rescue the 
differentiation of GC B cell in response to viral challenge (figure 3.4.18).  The results 
presented here demonstrate that Egr2 may control Tfh differentiation by the 
regulation of the Bcl6 gene.   
 
Figure 3.4.17: GC development is rescued in Egr2-/- Egr3-/- mice receiving Bcl6 
transfected Egr2-/- Egr3 -/- CD4 T cells. 2 x 106 Bcl6 expressing lentivirus were 
transfected into CD4 T cells from Egr2-/- Egr3-/- mice which were then adoptively 
transferred into Egr2-/- Egr3-/- mice, next day, the mice were challenged using VVWR. 
14 days after challenge, mice were sacrificed and samples analysed for GC 
formation. Magnification on images indicates objective used to acquire image.  
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Figure 3.4.18: Forced expression of Bcl6 in CD4 T cells from Egr2-/- Egr3-/- mice is able to restore Tfh differentiation and GC B cell 
development in Egr2-/- Egr3 -/- mice. 2 x 106 Bcl6 expressing lentivirus were transfected into CD4 T cells from Egr2-/- Egr3-/- mice which were 
then adoptively transferred into Egr2-/- Egr3-/- mice, next day, the mice were challenged using VVWR. 14 days after challenge, mice were 
sacrificed and spleens were collected for analysis of Tfh and GC B cell differentiation.Each dot presents an individual mouse from different 
experiments; Mann-Whitney’s U test was used to evaluate statistical significance. P<0.001 = ***; P<0.01 = **; P<0.05 = *; N.S = not 
significantly different 
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3.4.5 Differentiation of Tfh-like cells in in vitro culture is impaired 
in Egr2-/- Egr3 -/- mice  
I had earlier reviewed how IL-21, IL-6 and Bcl6 amongst other molecules are 
necessary for Tfh differentiation in vivo. Nurieva et al, 2008 has also reported that 
in in vitro culture, IL-21 recombinant protein in the presence of Th1, Th2 and Th17 
cytokine antagonists would drive the differentiation of Tfh-like cells (Nurieva et al., 
2008). We sought to determine the role of the Egr2/3 genes in the in vitro 
differentiation of Tfh-like cells in the presence of IL-21. For this, Isolated CD4+ T cells 
were stimulated and cultured under Th0 or Tfh-like inducible cultures. For cells 
treated under Tfh conditions, over 60% of the WT cells differentiated into Tfh-like 
cells and majority of these cells co-expressed Egr2 and Bcl6 (Figure 3.4.19A) again, 
highlighting the importance of Egr2 expression in these Tfh cells. In the Egr2-/- Egr3-
/- CD4+ cells, culturing under Tfh conditions resulted in only about 20% of CD4+ cells 
differentiating into Tfh-like cells (Figure 3.4.19A). WT CD4+ T cells cultured under 
Tfh-like conditions show high Bcl6 mRNA expression while contrastingly low levels 
of Bcl6 were observed in Tfh-like CD4+ T cells from Egr2-/- Egr3 -/- mice suggesting a 
role for Egr2/3 genes in the upregulation of Bcl6 in Tfh-like cells (figure 3.4.19B). 
This is consistent with in vivo data.  
When IL-21 expression levels were analysed by RT-PCR, it was found to be 
down regulated in Egr2-/- Egr3-/- Tfh-like cells (Figure 3.4.19B). IL-21 is an important 
cytokine that supports Tfh cell differentiation, GC B cell differentiation and function 
(Bollig et al., 2012; Linterman et al., 2010; Zotos et al., 2010; Johnston et al., 2009; 
Bryant et al., 2007). Absence of this cytokine indicates deregulation of normal Tfh 
activity in the Egr2-/- Egr3-/- mice. This supports earlier data showing a failure to 
generate GC B cells due to deregulated Tfh help in the Egr2-/- Egr3-/- mice. These 
results indicate a possible role for Egr2/3 in the upregulation of IL-21 production 
during Tfh differentiation. 
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Figure 3.4.19: Lack of the Egr2/3 genes impairs the differentiation of CD4 T cells 
into Tfh-like cells in in vitro cultures. A. Isolated CD4 T cells were cultured for 5 
days in the presence (Tfh-like conditions) or absence (Th0 conditions) of 
recombinant IL-21, anti-IFN-γ and anti-IL4 for 5 days after which they were stained 
and analysed for the differentiation of Tfh cells. B. RT-PCR was also performed on 
these cells to analyse the expression of effector cytokines. 
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3.5 Molecular mechanism of Bcl6 
regulation by Egr2 
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3.5.1 CD4+ Th cell are activated after antigenic stimulation in Egr2-/- 
Egr3-/- mice 
In the previous sub-chapters, I had elaborated on the absence of GC in Egr2-
/- Egr3-/- mice and the defective differentiation of Tfh cells within these mice. This 
may have been responsible for the reduced number of GC B cells and defective GC 
formation and function in Egr2-/- Egr3-/- mice.  It became imperative, therefore, to 
understand the molecular mechanism that governs Egr2/3 gene regulation of Tfh 
cell differentiation. For this 2 possibilities were assessed. The first was if impaired 
CD4+ Th cell activation after antigenic stimulation was responsible for the defective 
Tfh differentiation in Egr2-/- Egr3-/- mice. The second was if Egr2 directly interacted 
with Bcl6, the signature transcription factor for Tfh cells, to promote Tfh cell 
differentiation.  
In order to investigate Th differentiation in Egr2-/- Egr3-/- mice in vivo, the 
activation of CD4 T cells and the production of effector cytokines before and after 
VVWR infection were analysed. Our results show that following VVWR infection, CD4 
T cells in Egr2-/- Egr3-/- mice differentiated into CD44high effector phenotype and 
upregulated effector cytokine levels (figure 3.5.1 and 3.5.2). These suggest that 
activation and differentiation into effector subsets was not defective in Egr2-/- Egr3-
/- mice and thus could be excluded as the cause for defective Tfh cell differentiation 
in Egr2-/- Egr3-/- mice.   
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Figure 3.5.1: High expression of CD44+ CD4 T cells in Egr2-/- Egr3-/- mice following 
VVWR infection. CD4 T cells from WT and Egr2
-/- Egr3-/- mice were analysed for 
activation marker CD44 before and after VVWR infection. Egr2
-/- Egr3-/- mice show 
high expression of activation marker CD44. 
 
 
Figure 3.5.2: Effector cytokines are upregulated in Egr2-/- Egr3-/- mice following 
VVWR infection. mRNA expression levels for effector cytokines from CD4 T cells 
before and after infection show increased production of effector cytokines after 
VVWR infection. Data is presented relative to the expression of β-actin mRNA. 
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3.5.2 Egr2 interaction with the Bcl6 gene 
We have shown that the Egr2/3 genes are capable of increasing the 
expression of Bcl6 in WT Tfh cells after infection and that Egr2-/- Egr3-/- mice had 
reduced Bcl6 expression levels. The impaired expression of Bcl6 in Egr2-/- Egr3-/- 
mice points towards a possible role of the Egr2 or Egr3 genes in the regulation of 
Bcl6 in Tfh cells. Therefore, the possibility of Egr2 interaction with the Bcl6 gene 
was assessed. Using the multiTF utility software, we investigated the potential role 
of Egr2 in Bcl6 regulation of Tfh cells. Analysis of the Bcl6 gene locus highlighted 3 
potential Egr2 binding sites on the 1st intron (site 1), distal promoter region (site 2) 
and downstream of the Bcl6 gene (site 3) on the Bcl6 gene (figure 3.5.3).  
 
Figure 3.5.3: Analysis of Bcl6 gene locus shows it has 3 potential Egr2 binding 
sites.  
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Using EMSA (performed by Dr. Tizong Miao at Queen Mary University, 
London), we next analysed the interaction between the Egr2 protein and these 
potential Egr2 binding sites on Bcl6 gene by probing the ability of oligos obtained 
from these binding sites to competitively bind to Egr2 protein. We found that the 3 
different binding sites were able to effectively compete for Egr2 binding against a 
probe containing the Egr2 consensus sequence (5’-TGTAGGGGCGGGGGCGGGGTTA 
-3’) (Figure 3.5.4). In order for us to verify gene interaction obtained via EMSA, we 
used chromatin Immunoprecipitation (ChIP) assay (performed by Dr. Tizong Miao at 
Queen Mary University, London), on WT CD4 T cells and found that Egr2 was able to 
bind to 2 of the 3 potential binding sites (Figure 3.5.4). This demonstrates that Egr2 
protein does indeed interact with these binding sites on the Bcl6 gene locus and can 
therefore regulate the expression of Bcl6 in Tfh cells.  
 
Figure 3.5.4: EMSA and ChIP assay confirms that Egr2 interacts with the Bcl6 gene. 
A. EMSA shows the interaction between Egr2 protein and the 3 binding sites on the 
Bcl6 gene locus B. Chromatin immunoprecipitation confirms Egr2 protein interacts 
with the 2 of the potential Egr2 binding sites on the Bcl6 gene. 
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3.5.3 Forced expression of Bcl6 or Egr2 restored the normal 
expression of Tfh regulatory genes Bcl6 and Blimp1 
To confirm the functionality of Egr2 regulation of the Bcl6 gene, CD4 T cells 
from Egr2-/- Egr3-/- mice were transfected with either Egr2 or Bcl6 expression 
constructs and then analysed for the expression of Tfh regulatory genes Bcl6 and 
Blimp1. Expression of Egr2 drove the expression of Bcl6 while reducing the relative 
expression of Bcl6 antagonist, Blimp-1.  Similarly, Bcl6 lentivirus increased the 
expression of Bcl6 in these Egr2-/- Egr3-/- CD4 cells while downregulating the Blimp1 
mRNA level (figure 3.5.5). This indicates that Egr2 interaction with Bcl6 may be 
necessary for its physiological function.  
 
Figure 3.5.5:  Constitutive expression of Egr2 or Bcl6 in vectors transferred into 
Egr2-/- Egr3-/- mice restored Bcl6 expression in CD4 T cells from these Egr2-/- Egr3-/- 
mice. mRNA was extracted and RT-PCR was performed on Egr2-/- Egr3-/- CD4 T cells 
transfected with either an empty lentivirus or an Egr2 or Bcl6 expressing lentivirus 
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Finally, when the expression of some of the other genes involved in Tfh cell 
regulation were analysed, IRF4, cMaf, CXCR5 and SH2D1A were found to remain 
relatively similar in WT and Egr2-/- Egr3-/- mice (figure 3.5.6). All of these data taken 
together demonstrates that Egr2 control of Tfh cells differentiation is by direct 
regulation of the Tfh signature transcription factor Bcl6.   
  
 
Figure 3.5.6: Relative expression of other Tfh related genes were similar in WT 
and Egr2-/- Egr3-/- mice. RT-PCR performed on sorted CXCR5+ PD1+ and CXCR5- 
PD1- CD4 T cells from WT and Egr2-/- Egr3-/- mice show that the expression of IRF4, 
cMAF, SH2D1A, CXCR5 were relatively similar between both mice groups 
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Studies into the early growth response genes 2 and/or 3 have achieved 
significant strides in recent years (Du et al., 2014; Miao et al., 2013; Li et al., 2012). 
These transcription factors are gaining grounds as regulators of the immune 
system. They are reported to control development, activation and effector function 
of cellular mediators of the innate and adaptive immune system including NK cells 
(Lazarevic et al., 2009a; Bassiri and Nichols, 2009), macrophages (Syed et al., ) and 
lymphocytes (Li et al., 2012; Li et al., 2011). Limitations in Egr2 in vivo studies 
include neonatal fatalities arising from the systemic knockout (KO) of the Egr2 gene 
(Baloh et al., 2009). While some researchers have used siRNA to study Egr2 
functions (Barbeau et al., 2014; Fang et al., 2011), this can be limiting in the sense 
that in vitro studies do not necessary correlate with in vivo studies as it is an 
arduous task replicating the cellular microenvironment found within an organism. 
This necessitated the creation of conditional KO of the Egr2 gene in order to study 
its role in various systems. For this study, I have used the lymphocyte-specific CD2-
promoter to knockout the Egr2 gene in order to investigate the role of Egr2/3 in the 
control of inflammation pathology and regulation of follicular helper T cell 
differentiation. 
4.1 Loss of Egr2/3 in lymphocytes leads to organ pathology 
due to chronic inflammation 
It has been  previously reported that in the absence of the Egr2/3 genes, mice 
show high levels of pro-inflammatory cytokines such as IFNγ, IL-17A, IL-17F and 
GM-CSF as well as develop autoimmune diseases (Li et al., 2012; Zhu et al., 2008). Li 
et al, found that Egr2/3 genes directly regulated the expression of the SOCS1 and 
SOCS3 genes (Li et al., 2012). These genes control the Th1 and Th17 lineage specific 
STATS (STAT1 and STAT3) (Li et al., 2012). They proposed that Egr2 and 3 might be 
necessary for reducing immunopathology during immune responses (Li et al., 
2012). Data from that study is supported by other researcher’s findings showing 
increased levels of IFNγ and IL-17 in Egr2 single KO mice (Miao et al., 2013; Iwasaki 
and Medzhitov, 2010; Zhu et al., 2008) 
From this study, it has now been shown that the onset of immunopathology 
within these Egr2-/- Egr3-/- mice coincides with the age from which high levels of 
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pro-inflammatory cytokines are visible in the serum of Egr2-/- Egr3-/- mice as 
reported by Li et al, 2012. This information could further understanding of the 
molecular basis of organ pathology arising from inflammation. 
Egr2 and Egr3 genes have previously been associated with the development 
of autoimmune diseases (Li et al., 2012, Zhu et al., 2008). The results presented by 
this thesis identified severe organ damage in these Egr2-/- Egr3-/- mice. The link 
between organ damage and autoimmunity is supported by reports associating the 
presence of autoantibodies, pro-inflammatory cytokines and activated self-reactive 
CD4 T cells in the observed pathology in SLE and MS autoimmune disease patients 
as well as in mouse models of autoimmunity (Ichinose et al., 2011; Blair et al., 
1994). Other reports also show that organ pathology arising from axon damage is 
closely associated with the presence of chronic inflammation within the nervous 
tissues in MS patients (Brück, 2005). A publication by Miao et al., 2013 also showed 
defective Egr2 expression in MS patients (Miao et al., 2013). From these 
publications, organ pathology in Egr2-/- Egr3-/- mice can be linked with inflammation 
and autoimmune diseases development. This indicates that our model of Egr2-/- 
Egr3-/- mice can serve as an appropriate model for the study of autoimmune 
diseases. 
The Th1 cytokine IFNγ has long been known to be capable of activating 
macrophages (Schroder et al., 2004). As high IFNγ levels are a feature of Egr2-/- 
Egr3-/- mice, IFNγ could contribute to organ pathology by activating macrophages as 
observed by CD11b staining in the spleens of Egr2-/- Egr3-/- mice. The presence of 
APCs like macrophages at inflammatory sites has been implicated in the 
presentation of auto-antigens to T lymphocytes in some studies (Bailey et al., 2007; 
Gutcher and Becher, 2007). The role of macrophages within the spleens of Egr2-/- 
Egr3-/- mice in promoting autoimmunity is yet to be investigated however; 
macrophages produce IL-1 and TNF which can further drive chronic inflammation 
and the ensuing organ pathology (Gutcher and Becher, 2007). In essence, Egr2/3 
genes are necessary to prevent organ pathology that may contribute to the 
development of autoimmune diseases.  
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4.2 Transcriptional programme involved in Tfh cell 
differentiation  
As mentioned earlier in the literature review, antigen presentation and co-
stimulation by dendritic cells along with cytokine production induces the 
differentiation of naïve CD4 T cells into one of a number of effector subsets. Egr2/3 
have been identified to play a role in effector T cell differentiation (Du et al., 2014).  
In naïve CD4+ T cells, upregulation of Tbx21 (the gene encoding Tbet) skews the 
differentiation of Th cells into the Th1 pathway. Th1 cells mediate the activation of 
cytotoxic CD8+ T cells. Researchers have shown increased numbers of Th1 cells after 
prolonged stimulation of CD4+ T cells in Egr2cKO (Zhu et al., 2008). IFNγ produced 
by Th1 cells was increased in our mouse model as well and was implicated in the 
development of autoimmunity (Li et al., 2012; Zhu et al., 2008). Th17 cells are 
induced by the expression of the Rorc (gene encoding RORγt) transcription factor in 
the presence of Tgfβ, IL-6 and IL-21. Th17 levels in Egr2cKO mice were increased 
following TCR ligation leading to enhanced production of IL-17 (Miao et al., 2013; Li 
et al., 2012; Zhu et al., 2008). High IL-17 levels have been linked with organ 
pathology in CD2-Egr2-/- mice (Miao et al., 2013). 
 T Follicular helper cells, a newer member of the effector T cell subset 
develops when Bcl6 expression is elevated in newly activated CD4+ T cells in the 
presence of IL-6 and IL-12 in mouse and IL-6, IL-12, IL-21 and IL-23 in humans. 
Differentiated Tfh cells provide help to follicular B cells inducing their 
differentiation into germinal centre (GC) B cells. GC B cells then migrate back into 
follicles to form GC that mediates T cell dependent humoral immune responses. In 
the absence of Tfh cells, GC responses are defective and an immunodeficient 
phenotype arises (Pratama and Vinuesa, 2014; Yusuf et al., 2010). As the signature 
transcription factor for this lineage, the expression of Bcl6 is paramount for Tfh 
differentiation and consequently for optimal T cell dependent humoral immunity. 
Bcl6-/- T cells were unable to differentiate into Tfh cells (Hollister et al., 2013; Yu and 
Vinuesa, 2010; Yu et al., 2009). Lack of Tfh cells in these Bcl6-/- mice meant they 
were unable to provide help to GC B cells and consequently these mice failed to 
develop GC and had defective GC responses in response to antigens (Yu et al., 
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2009). In this study, using Egr2-/- Egr3-/- mice model, array analysis measured Bcl6 
expression levels in total CD4+ T cells from Egr2-/- Egr3-/- to be at least 2 fold 
downregulated in stimulated and unstimulated conditions compared to WT mice. 
Bcl6 expression levels was also found to be defective in stimulated and 
unstimulated total CD4+ T cells and Tfh cells isolated from Egr2-/- Egr3-/- mice invitro.  
In vivo analysis of Tfh differentiation in Egr2-/- Egr3-/- mice before and after acute 
viral infection showed reduced Bcl6 protein levels and significantly lower numbers 
of Tfh cells in these mice. These findings are in line with those of Robert Johnson et 
al and Yu et al both in 2009. They demonstrated higher levels of Bcl6 mRNA in WT 
Tfh cells, lower levels in non-Tfh cells as well as a lack of Tfh cells in Bcl6 null mice 
(Johnston et al., 2009; Yu et al., 2009). When the Bcl6 gene was overexpressed in 
lentiviral constructs, and then adoptively transferred into Egr2-/- Egr3-/- mice before 
viral challenge, it rescue of the differentiation of Tfh cells and GC B cells in Egr2-/- 
Egr3-/- mice. This is in agreement with previous studies showing overexpression of 
Bcl6 induced Tfh differentiation (Johnston et al., 2009; Yu et al., 2009) and pointing 
to a role of Egr2 in driving Tfh cells differentiation by Bcl6 regulation. This role of 
Egr2 in Bcl6 regulation was confirmed by the discovery that Egr2 directly interacted 
with the Bcl6 gene. 
Although Bcl6 is regarded as the master transcription factor for this lineage, a 
number of other transcription factors work alongside Bcl6 to promote or inhibit the 
Tfh cell program and thus regulate T cell dependent humoral immune responses. 
Blimp1 is a direct repressor of Bcl6 (Hollister et al., 2013; Johnston et al., 2009). 
Bcl6 was shown to directly inhibit Blimp1 expression in Tfh specifically (Hollister et 
al., 2013).  Blimp1 levels are elevated in non-Tfh CD4+ T cells and mice 
overexpressing the Blimp1 protein had severely impaired Tfh differentiation 
(Johnston et al., 2009). This correlates with the findings of this study showing 
increased Prdm1 (gene coding for Blimp1) levels in array analysis of total CD4+ T 
cells from Egr2-/- Egr3-/- mice. This was confirmed by RT-PCR on Tfh cells from the 
same mice. Consequently, these mice had reduced differentiation of Tfh cells 
evident by staining for Tfh markers CXCR5, PD-1. More so, overexpression of Egr2 
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or Bcl6 in Egr2-/- Egr3-/- CD4 T cells reduced the expression of Blimp1 in these cells 
suggesting a role for Egr2 in Bcl6 physiological function in Tfh cells. 
Ascl2, a transcription factor active in Tfh cells is reported to be critical for 
CXCR5 expression and is upregulated early to initiate Tfh migration to T-B cell 
border (Liu et al., 2014b). There was no significant difference in the expression of 
CXCR5 mRNA levels in Egr2-/- Egr3-/- mice inferring that Egr2/3 genes were not 
involved in upregulation of CXCR5 expression during Tfh cell differentiation. This is 
supported by the works of Liu et al., 2014. They found that in Bcl6lo T cells, CXCR5 
expression was upregulated after NP-OVA immunisation (Liu et al., 2014b).  
cMaf and IRF4 induce IL-21 production in Tfh cells and is expressed at high 
levels in human Tfh cells (Kroenke et al., 2012). Constitutive expression of cMaf was 
able to significantly increase IL-21 and CXCR5 expression to drive Tfh differentiation 
(Kroenke et al., 2012). Interferon regulatory factor 4 (IRF4) is reported to be 
involved in Th2, Th17, Th9 and Tfh differentiation (Bollig et al., 2012). IRF4-/- mice 
failed to differentiate into Tfh cells and lacked GC (Bollig et al., 2012). Although a 
comprehensive study has not been carried out on the mechanism for IRF4 
regulation of Tfh cell differentiation, Bollig et al., 2012, suggests that it may be 
through interaction with Bcl6 as they found Bcl6 levels to be significantly altered in 
their model (Bollig et al., 2012). It is therefore important to mention there was no 
difference in the expression levels of cMaf and IRF4 between WT and Egr2-/- Egr3-/- 
mice. 
Batf is reported to directly regulate Bcl6 and cMaf expression in CD4+ T cells 
and Batf-/- CD4+ T cells showed reduced expression of both Bcl6 and cMaf (Ise et al., 
2011). We previously reported enhanced Batf activity in Egr2-/- Egr3-/- mice (Li et al., 
2012). High Batf levels and low Tfh levels in our model suggest that Egr2 inhibition 
of Batf activity in AP-1 signalling does not hinder Batf and Bcl6 interaction.  
In this study, a novel transcriptional regulator of Tfh differentiation in the 
form of the Egr2/3 genes has now been identified. Our model of CD2-Egr2-/- Egr3-/- 
is very similar in phenotype to the Bcl6-/- model showing upregulation of Blimp1 in 
CD4+ T cells, aberrant Tfh differentiation, impaired GC B cell differentiation and 
aberrant GC formation and function (Yu et al., 2009; Johnston et al., 2009; Fukuda 
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et al., 1997). Normal expression of Blimp1 was only restored in Egr2-/- Egr3-/- mice 
by the expression of Egr2 or Bcl6 in lentiviral constructs. This is in agreement with 
experiments conducted by other researchers showing down regulation of Blimp1 
expression after forced Bcl6 expression (Johnston et al., 2009). As expected, 
adoptive transfers of WT CD4+ T cells with endogenous expression of Egr2 and Bcl6 
into Egr2-/- Egr3-/- mice, restored Tfh and GC B cell differentiation as well as GC 
formation. Indeed this was the case with transfer of Egr2 or Bcl6 expression 
construct into Egr2-/- Egr3-/- mice. Although GC B cell numbers were significantly 
reduced in Egr2-/- Egr3-/- mice, it was proposed that Egr2 regulated Bcl6 in a Tfh-
specific manner because transfer of WT B220 cells into Egr2-/- Egr3-/- mice did not 
have a similar effect in restoration of GC B cell differentiation and GC responses. 
Certainly other studies have shown how a reduction in Tfh numbers can severely 
abrogate GC B cell differentiation (Liu et al., 2014b; Bollig et al., 2012; Yu et al., 
2009; Johnston et al., 2009; Fukuda et al., 1997). Finally, the interaction between 
Egr2 – Bcl6 was confirmed in CD4+ T cells by EMSA and ChIP assay thereby 
identifying Egr2 as a novel regulator of the all-important Tfh cell differentiation.  
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Figure 4.1: Proposed model showing molecular interactions involved in the 
differentiation of T follicular helper (Tfh) cells including Egr2/3 genes. 
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4.3 Tfh cells are indispensable for induction of GC function 
GC B cells require help from Tfh cells to undergo clonal proliferation, somatic 
hypermutation, class switch recombination and the development of B cell 
immunological memory in the GCs (Nutt and Tarlinton, 2011). GC B cells first 
initiate contact with Tfh cells at the T-B cell border to induce the genetic program 
required for their differentiation. As mentioned earlier, in the absence of Tfh cells, 
GC B cell differentiation, GC formation and T dependent antibody immune response 
is defective in our model and other models (Liu et al., 2014b; Bollig et al., 2012; Yu 
et al., 2009; Johnston et al., 2009; Fukuda et al., 1997). Although we found that 
Egr2/3 did not seem to play a direct role in the regulation of GC B cell 
differentiation in our model, GC functions like class switching and high affinity 
antibody production were severely diminished presumably due to lack of help from 
Tfh cells. This is supported by the findings of researchers where severely impaired 
GC functions were observed in their models in the absence of Tfh cells (Liu et al., 
2014b; Ise et al., 2011; Johnston et al., 2009; Yu et al., 2009). 
During somatic hypermutation (SHM), point mutation occurs at high 
frequency on the V region of the immunoglobulin heavy chain. This changes the 
immunoglobulin receptor affinity which results in the production of high affinity 
antibodies (Muramatsu et al., 2000). In Egr2-/- Egr3-/- mice, in line with defective Tfh 
differentiation and absence of GCs, there was impaired production of neutralising 
antibodies and OVA-specific antibodies. This is consistent with reports from Bcl6 
conditional knockout mice model where absence of Tfh cells lead to severely 
abrogated levels of antigen-specific antibody production following sheep red blood 
cell (SRBC) immunisation (Hollister et al., 2013) 
Class switch recombination (CSR) involves the change in the constant region 
of immunoglobulin heavy chain (CH) from Cμ coding for IgM, to the CH of other 
immunoglobulin isotypes like IgG, IgE or IgA depending on nature and location of 
antigen (Muramatsu et al., 2000). Class switching is necessary in order to improve 
and expand antibody effector functions.  T cell intrinsic defect in Tfh differentiation 
in Batf-/- mice led to a loss of IgG1 and IgG3 production in response to T cell–
dependent hapten nitrophenol–chicken γ-globulin (Ise et al., 2011). Similarly, in 
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Egr2-/- Egr3-/- mice, there was defective productive of antibodies marked by low 
serum levels of IgG1 in response to viral challenge and OVA protein immunisation. 
Consequently, our mice fared much worse than WT mice showing more severe 
clinical pathology and an inability to clear virus as efficiently as WT after VVWR 
challenge. IL-21 levels were found to be significantly less in Tfh-like cells in Egr2-/- 
Egr3-/- mice. As IL-21 is reported to be essential for B cell activation and antibody 
secretion (Hollister et al., 2013), lack of IL-21 may contribute to defective antibody 
production.  
In line with the absence of GC, antibody production during secondary 
exposure to antigens was defective in Egr2-/- Egr3-/- mice. As B cell immunological 
memory is still very much unclear (Berkowska et al., 2011; Toyama et al., 2002). The 
Egr2/3 mouse model could be used to study the development of GC dependent B 
cell immunological memory.   
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Mouse model  Similarities with Egr2-/- Egr3-/-  
mice model 
Reference 
Bcl6-/- bone marrow 
cells in Rag-/- mice 
and Bcl6fl/fl/CD4-Cre 
mice 
Defective differentiation of Tfh 
cells and GC B cells leading to 
diminished numbers of these 
cells.  Absence of GC, defective 
SHM and CSR, defective antibody 
immune responses, low affinity 
memory B cell formation  
(Hollister et al., 2013; Yu et al., 
2009; Johnston et al., 2009; 
Toyama et al., 2002; Fukuda et 
al., 1997) 
 
Blimp1 
overexpression 
Lack of Tfh phenotype, severely 
reduced T cell dependent 
antibody responses 
(Johnston et al., 2009) 
IRF4-/- mice Impaired Tfh cell differentiation, 
Absence of GC, lack of GC B cells, 
GC function is defective. 
(Ochiai et al., 2013; Bollig et 
al., 2012) 
 
Ascl2fl/fl/CD4-Cre Defective humoral immune 
response, impaired Tfh and GC B 
cell differentiation 
(Liu et al., 2014b) 
c-Maf-/- fetal liver 
cells in Rag-/- mice  
Low Tfh numbers, Dysregulated. 
IL-21 and CXCR5 production. 
(Kroenke et al., 2012; Bauquet 
et al., 2009) 
 
Batf-/- mice Impaired Tfh differentiation, 
Absence of GC, defective GC B 
cell differentiation and aberrant 
GC function including class 
switching, failure to induce AID 
(Ise et al., 2011) 
Table 4.1: Summary of mouse models used in the study of transcription factors 
reported to be involved in Tfh differentiation, GC B cell differentiation, GC 
formation and function presented along with similarities shared between these 
models and  our Egr2-/- Egr3-/- mouse model. 
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4.4 Relevance of this study in human diseases and the design 
of therapeutic strategies 
As elaborated earlier, studies looking into Tfh cell biology are actively gaining 
grounds due to the role these cells play in diseases and the potentials of 
manipulating them in rational therapeutic strategies. A lot of knowledge of the 
molecular signatures of Tfh cells only became clear in the last 10 years with the 
discovery of regulators of its biology (Liu et al., 2014; Johnston et al., 2009; Yu et al., 
2009; Fukuda et al., 1997; Ye et al., 1997; Dent et al., 1997). Studies using mouse 
models of diseases like X-linked lymphoproliferative disorders (Crotty et al., 2003; 
Czar et al., 2001), common variable immunodeficiency diseases (CVID) (Warnatz 
and Voll, 2012) and autoimmune diseases (Ma and Deenick, 2014) have found 
deregulated expression of Tfh-related molecules and consequently dysregulated 
Tfh cell numbers (Fahey et al., 2011; Simpson et al., 2010). Indeed, these were 
similar with the disease phenotype observed in human sufferers of these diseases 
(Ma and Deenick, 2014). 
25% of patients suffering from CVID develop early onset autoimmunity with 
altered T and B cell homeostasis (Warnatz and Voll, 2012). CVID patients also show 
dysregulated expression pattern for IL-2 and IFN-γ although researchers are yet to 
uncover what roles these cytokines may play in the development of autoimmunity 
within these patients (Warnatz and Voll, 2012). Interestingly, these deregulated 
immune functions are linked with defective antigen receptor signaling similar to 
what is observed in Egr2-/- Egr3-/- mice (Warnatz and Voll, 2012; Fischer et al., 
1996). As the phenotype of Egr2-/- Egr3-/- mice strongly correlates with that of CVID 
with low Tfh numbers, deregulated cytokine expression, autoimmunity and TCR 
defects, there is a possibility of a role of the Egr2/3 genes in CVID and its associated 
pathologies. Thus Egr2/3 studies may highlight potential immunotherapeutic 
targets for the treatment of these diseases.  
In this study, severe reduction in Tfh cell numbers was observed during 
primary infection with VVWR. This resulted in adverse clinical pathology, high viral 
retention and failure to produce neutralising antibodies. Our findings correlate with 
those of other researchers showing that reduced Tfh cell numbers severely 
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abrogates anti-viral immune response to LCMV (Crotty, 2014; Fahey et al., 2011; 
Harker et al., 2011). This indicates that Tfh cell levels are crucial in mediating 
antigen specific humoral immune responses.  Adoptive transfer of Egr2 was able to 
rescue Tfh cell numbers and the GC phenotype. Egr2 interaction with the Tfh 
signature transcription factor Bcl6 to generate Tfh cells was also aptly validated. As 
Tfh cells are paramount in providing B cell help for the generation of long lasting 
affinity-matured isotype-switched antibodies, our discovery of a novel regulator of 
this all important Th subset, Tfh cells, sheds more light on the programming of Tfh 
cell differentiation.  Such knowledge of Tfh biology is imperative in the design or 
improvement of therapeutic strategies for diseases like malaria, hepatitis B virus 
(HBV), HCV and influenza where increasing antigen specific Tfh cell levels would 
enhance humoral immune responses (Ma and Deenick, 2014; Moon et al., 2012; 
XING, XU and YU, 2012). 
Knowledge of Tfh cell biology can also be utilised in the studies of secondary 
immunodeficiencies like Human Immunodeficiency Virus (HIV).  HIV may result in 
acquired immunodeficiency syndrome (AIDS) which had a remarkable death toll of 
1.5 million adult and children in 2013 (World Health Organisation, 2015). In HIV 
patients, there is a reported accumulation of Tfh cells in circulation and within 
secondary lymphoid organs leading to the development of 
hypergammaglobulinimea with high IgG levels against GAG proteins (Lindqvist et 
al., 2012). Due to the high mutation rates of the HIV virus, anti-GAG antibodies are 
ineffective in controlling disease progression (Ma and Deenick, 2014). The challenge 
therefore is to generate broadly neutralising antibodies (bNAB) that target highly 
conserved sequences such as those against the envelop proteins gp120 (Cubas et 
al., 2013). This way, antibodies will recognise a large range of different mutated 
strains of the virus (Ma and Deenick, 2014). Studies in Tfh cell biology are currently 
being manipulated for the generation of these bNAB in HIV (Pissani and Streeck, 
2014). Our study elucidating how Egr2/3 genes regulate Tfh cell levels and GC 
dependent immune responses could certainly contribute positively to anti-HIV 
therapy design as it throws more light into the regulation of Tfh biology and 
antibody immune responses mediated by Tfh cells. 
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Finally, in the absence of the Egr2/3 genes, mice are reported to develop 
autoimmune diseases with high pro-inflammatory cytokine levels (Li et al., 2012; 
Zhu et al., 2008). Results from this study have demonstrated that increased levels 
of inflammation-inducing cytokines coincide with organ pathology in the Egr2-/- 
Egr3-/- mice. In diseases like multiple sclerosis (MS), the cause of organ pathology 
that drives the disease is still very much unknown (Ma and Deenick, 2014). 
Recently, Egr2 was found to be downregulated in T lymphocytes of patients 
suffering from multiple sclerosis (MS) (Miao et al., 2013). The study by Miao et al, 
2013 along with the link between Egr2/3 and organ pathology highlighted by this 
study could provide better understanding of MS and potentially other autoimmune 
diseases. These studies could highlight potential therapeutic targets for the 
treatment of MS. Immunotherapy involving Egr2/3 could possibly be utilised to 
abrogate disease progression or severity.  The Egr2-/- Egr3-/- model could thus be 
ideal; for the development of novel therapeutic strategies that can be manipulated 
for the treatment of autoimmune diseases.  
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4.5 Egr2/3 are essential regulators of optimal humoral 
immune responses and inflammation pathology 
The immune system is tightly regulated to facilitate optimal immune response while 
averting adverse immune pathology.  Studies on the phenotype of Egr2-/- Egr3-/- 
mice suggest a model of aberrant immune function and deregulated homeostasis 
(Miao et al., 2013; Li et al., 2012; Zhu et al., 2008). To add to this, our study has now 
identified Egr2/3 as novel transcription factors that regulates Tfh differentiation 
and plays a role in immunopathology arising due to chronic inflammation. 
Egr2/3 genes are reported to be upregulated after in vitro antigenic 
stimulation where they interact with Batf. Egr2 interaction with Batf prevents Batf 
mediated blocking of AP-1 signalling and thus drives optimal T cell antigen receptor 
induced proliferation (Li et al., 2012). In the study undertaken here, I have been 
able to demonstrate that the differentiation of T follicular helper cells is defective in 
Egr2-/- Egr3-/- mice. This led to severely impaired GC B cell differentiation and a lack 
of GC, which contributed to severe pathology, high viral load, and an absence of 
neutralising antibodies in these mice. WT CD4+ T cells containing endogenous Egr2 
or Egr2 expressing lentivirus was however able to reverse these defects. It is can be 
said, therefore, that in the absence of Egr2/3 genes, Tfh differentiation and 
humoral immune responses to T cell dependent antigens are impaired thus 
identifying a crucial role for these molecules in T cell dependent antibody 
responses.   
Based on these findings, a schematic model is presented below to illustrate 
the novel role of the Egr2/3 genes in the differentiation of Tfh cells and promotion 
of humoral immune responses in the GC (figure 4.2).   
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Figure 4.2: Schematic model showing how Egr2 interacts with Bcl6 to promote Tfh 
cell differentiation. In the presence of all other mediators of Tfh cell 
differentiation, Egr2 expression will promote the differentiation of Tfh cells, GC B 
cells and the formation of GC leading to optimal T cell dependent immune 
responses  
Egr2/3 genes have also been reported to regulate immune homeostasis (Du 
et al., 2014; Li et al., 2012; Zhu et al., 2008). In the absence of Egr2/3 genes, 
homeostatic proliferation in T and B lymphocytes led to the appearance of highly 
activated phenotype with associated high levels of inflammatory cytokines. These 
mice also developed autoimmune disease and became moribund after about 8 
months (Li et al., 2012).  Our study has linked organ pathology to the ensuing 
chronic inflammatory phenotype observed in Egr2-/- Egr3-/- mice. It is therefore clear 
from our research and those of others that the Egr2/3 genes are fundamental in the 
regulation of vital antibody responses while limiting chronic inflammation 
pathology.  These newly elucidated roles of the Egr2/3 genes, along with findings of 
other researchers are hence summarised in figure 4.3. 
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Figure 4.3: A propose model showing the updated functions of the Egr2 and 3 
genes within the immune system. Contributions made by this study into 
understanding the role of the Egr2/3 genes within the immune systems are 
highlighted in blue 
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The work presented by this thesis places emphasis on the essential role of 
the early growth response genes 2 and 3 (Egr2/3) in the regulation of systemic 
inflammation pathology and effector T cell differentiation. The most significant 
finding of this thesis is the novel role for the Egr2/3 genes in the regulation of Tfh 
cell differentiation, which, by extension, leads to the generation of optimal T cell 
dependent antibody immune responses. These roles of the Egr2/3 genes illustrate 
the paramount functions they play in the regulation of the immune system where 
they avert inflammation pathology while promoting potent humoral immune 
responses. The findings of this thesis can thus be summarised as follows: 
 Increased levels of pro-inflammatory cytokines in the Egr2-/- Egr3-/- mice may 
contribute to systemic organ pathology. This may play a pathogenic role in 
the development of systemic inflammatory autoimmune disease observed 
in the Egr2-/- Egr3-/- mice. This therefore makes the Egr2 and 3 genes 
essential for the prevention of organ pathology arising due to chronic 
inflammation.  
 In the absence of the Egr2 and 3 genes, GCs are absent and GC functions 
including the production of high affinity antibodies and class switching are 
severely impaired.   
 The Egr2/3 genes control GC formation and functions by regulating the 
differentiation of Tfh cells, which provide cognate help to GC B cells that 
populate the GC. 
 The molecular mechanism of Egr2 regulation of Tfh cell differentiation is 
through its interaction with Bcl6, the Tfh signature transcription factor. This 
promotes the physiological function of Bcl6.  
 This study has contributed greatly to the knowledge of Tfh biology and can 
be used in the development of therapeutic strategy. 
 The Egr2/3 mouse model can therefore serve as an appropriate model for 
further studies into autoimmune disease development, Tfh biology and 
therapy design. 
This study did not however go without limitations including validating the 
roles of the Egr2/3 genes in the generation of immunological memory. Current 
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concepts in GC responses indicate that the GC mediates class switch recombination, 
somatic hyper mutation and the development of immunological memory. Very little 
is known about memory B cell once they are generated and researchers have 
proposed that memory B cells may be generated in the absence of GCs (Berkowska 
et al., 2011; Toyama et al., 2002). The Egr2-/- Egr3-/- mice showed protection from 
re-challenge during secondary infection. As this study was unable to delineate the 
mechanism of immunological protection in these KO mice following re-challenge, 
an area of future research could be investigations into the development of 
immunological memory in our mouse model. Studies looking into the development 
of immune memory during second exposure to antigens in Egr2-/- Egr3-/- mice would 
increase the understanding of immunological memory during T cell dependent 
immune responses. As immunological memory is the bedrock of vaccinations, 
findings from that study could also be manipulated in vaccine discovery. Other 
potential areas of future research are highlighted below.  
It has been reported that although Tfh and Tfr cells arise from distinct 
precursor cells, they both still require similar cues including Bcl6, CD28, SAP 
expression and B cell interaction for their formation and maintenance (Linterman et 
al., 2011; Chung et al., 2011).  As Egr2-/- Egr3-/- mice had impaired Bcl6 expression, 
further investigation into Tfr cells in the Egr2-/- Egr3-/- mice model could highlight 
more regulatory functions of these genes and holds potentials in the therapy for 
auto-antibody mediated diseases.  
The interferons are very prominent anti-viral mediators inducing non-
specific cytolytic effects in affected organs. IFNγ levels in our model are elevated 
however we consistently observe very severe clinical pathology in these mice after 
primary infection.  It would be interesting to examine what functions IFNγ may play 
in the context of viral infection within Egr2-/- Egr3-/- mice.  
In line with high IFNγ, another important area for future exploration would 
be to understand the mechanism of how Egr2 and 3 regulate IFNγ during 
inflammation and thus control organ pathology. This would further highlight the 
roles of these genes in immune function and can aid in targeted therapeutics in the 
future.  
                                                       Chapter 5 – Conclusion, Limitations and Future work  
154 
 
IL-21 is an important cytokine necessary for Tfh development and also 
implicated in the pathogenesis of autoimmune diseases (Liu and King, 2013). 
Microarray data indicated high levels of IL-21 in total CD4 T cells from Egr2/3 
deficient mice. However when these cells were polarized to induce Tfh-like cells in 
vitro, IL-21 production was severely compromised. The increased IL-21 levels in 
total CD4 cells can be attributed to the highly activated Th17 cell phenotype which 
is reported to be present in Egr2/3 deficient mice (Li et al., 2012). These 
pathological levels of IL-21 may drive autoimmunity in these mice (Liu and King, 
2013). In order to understand the differential expression of IL-21 in Egr2/3 deficient 
mice, further investigation is necessary in order to elucidate the mechanism by 
which IL-21 is regulated specifically in Tfh cells by the Egr2 and/or Egr3 genes.  
The GC is reported to play a role in the development of autoantibodies in 
autoimmunity (Ma and Deenick, 2014; Ma et al., 2012; Deenick et al., 2010). In our 
mouse model, we observe the contrary; an absence of GC yet, a lupus-like 
autoimmune phenotype. There is a growing body of work linking other B cell 
populations with autoantibody production. Some reports have shown that 
circulating B cells in the blood and red pulp B cells are able to respond to antigens 
and switch immunoglobulin classes especially under inflammatory conditions 
(Giltiay, Chappell and Clark, 2012). Another study by William J et al., (2002), used a 
mouse model of autoimmunity, MPR.FasLPR, and found that autoreactive B cells 
producing hypermutated anti-IgG rheumatoid factor autoantibodies were found in 
the T cell zone and red pulp area of the spleen and these antibodies were produced 
independent of the GC and did not require CD4 T cell help (Giltiay, Chappell and 
Clark, 2012; William et al., 2002).  As the levels of pro-inflammatory cytokines are 
profound in Egr2/3 deficient mice, this may contribute to the development of 
autoreactive B cells outside of the GC in our mice model however this is yet to be 
investigated. The findings from this study has identified a mouse model that can be 
used for the study of GC independent autoantibody production and may provide 
insights into some of the key cellular and molecular players in GC independent 
autoantibody production which could be targeted for therapeutic purposes.  
A number of cytokines and STATs have been reported to be required for Tfh 
differentiation. IL-6, IL-12 and IL-21 are reported to be essential for Tfh 
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differentiation in vivo and in vitro (Crotty, 2011; Eto et al., 2011; Linterman et al., 
2010) and STAT 1 is important for the IL-6 dependent induction of Bcl6 in Tfh cells 
and their subsequent differentiation (Choi et al., 2013). In another review by Choi 
et al, 2013, IL-21 signalling via STAT3 was found to be partially involved in the 
upregulation of Bcl6 and thus promote Tfh cell differentiation (Choi, Yang and 
Crotty, 2013). Egr2/3 deficient mice are reported to have high expression of STAT 1 
and 3 due to an absence of Egr2 induced regulation of SOCS1 and 3  (Li et al., 2012). 
As IL-6 together with Tgf-β have been shown to induce Egr2 expression in CD4 cells 
(Miao et al., 2013), The role of STAT 1 and 3 in Tfh cell differentiation in Egr2/3 
deficient mice may depend upon factors such as the cytokine milieu present during 
activation and differentiation, when these cytokines are produced, whether or not 
their receptors are expressed, and also the interplay between these and other 
signalling pathways including STAT 5 which regulates IL-2 production that dampens 
Tfh differentiation. 
It is clear from this thesis and publications from our group that the Egr2/3 
genes are essential in maintaining homeostasis and inducing optimal immune 
responses after antigenic stimulation (Miao et al., 2013 Li et al, 2012, Li et al., 
2011). Egr2 has been found to interact with Bcl6 (Ogbe et al., 2015), Batf (Miao et 
al., 2013), SOCS1 and 3 (Li et al., 2012), T bet and Notch (Du et al, 2014). These 
genes regulate important aspects and components of the immune system. It is 
therefore important to investigate other potential genes that may be regulated by 
these transcription factors. This holds the potentials of discovering novel regulators 
of the immune system or novel functions of these Egr2/3 genes. A possible method 
of approaching this question can be through ChIP-Seq analysis which will enable the 
identification of genes that interact with Egr2 and/or Egr3. 
In conclusion, this thesis highlights that the Egr2 and 3 genes are imperative 
for preventing the development of systemic inflammation pathology and also 
critical for the differentiation of Tfh cells. These genes can therefore be targeted in 
the design of therapeutic strategies that can be used for the benefit of humanity. 
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Appendix 
 
 
Appendix figure 1: Graphical representation of IgG1 production in Egr2-/- Egr3-/- 
mice over the course of VVWR infection. Data presented as an appendix to figure 
3.3.8 on page 103.  
 
 
Appendix figure 2: Immunoglobulin isotypes produced by WT control after in vitro 
stimulation using anti-CD40 and rIL-4 compared with serum from 22 days post VVWR 
infection in WT mice. Data shows comparable Ig levels in the in vitro stimulated VS 
in vivo stimulated WT B cells. Data is presented as an appendix to figure 3.4.14 on 
page 120 
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